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ABSTRACT
Modular peptide-based fluorescent chemosensors utilizing the chelation-sensitive
fluorophore 8-hydroxy-5-(N,N-dimethylsulfonamido)-2-methylquinoline are powerful tools for
sensing Zn2+ and for sensing protein kinase activity. This signaling component is prepared as the
protected amino acid derivative Fmoc-Sox-OH, and integrated into peptide sequences.
Selective and tunable chemosensors for Zn2+ can afford qualitative and quantitative
information about the presence, distribution and concentration of this biologically-important
metal ion. Nineteen synthetic peptides incorporating Sox exhibit a range of affinities for Zn2+
through variation of the type and number of Zn2+ ligands, ligand arrangement and the -turn
sequence that acts as a preorganization element between the ligands. The binding stoichiometry
and fluorescence response to pH changes and various relevant competing metal ions was
carefully characterized. Eleven of these sequences form only 1:1 complexes with Zn2+ and their
affinities range from 10 nM to nearly 1 tM. When used in concert, the relative intensities of
different chemosensor readouts can provide Zn2+ concentration information in a valuable range.
This modular scaffold is useful for ratiometric sensing when an additional fluorophore is
incorporated in the peptide sequence.
New methods to quantify protein kinase activities are critical for understanding biological
regulatory pathways. Fluorescent chemosensors of protein kinase activity utilizing Sox and
physiological Mg 2+ concentrations report phosphorylation with dramatic fluorescence changes in
a continuous, high-throughput sensing format. The chemosensor comprises a small sensing
module, containing Sox and a S-turn sequence, appended to an optimized peptide substrate for
the target kinase. The Mg2+-binding affinity of the product phosphopeptide is much greater than
the substrate peptide, which results in a large fluorescence increase upon phosphorylation.
Notably, the reactivity of substrates is not affected by introduction of the sensing module on
either side of the serine, threonine or tyrosine to be phosphorylated. Further, a homogeneous
kinase assay utilizing these probes was developed that was reproducible, linear and highly
preferential for monitoring changes in cellular activity of the target kinase in unfractionated cell
lysates. These kinase chemosensors are powerful tools for studying the activity of recombinant
kinases in vitro and endogenous kinases ex vivo.
Thesis Supervisor: Barbara Imperiali
Title: Class of 1922 Professor of Chemistry and Professor of Biology
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Introduction to Biological Signaling
Signaling processes in biological systems are extremely complex. Within an individual
cell, signaling events are carefully orchestrated in location and time by diverse cellular species,
including metal ions, small molecules, enzymes, and multi-protein complexes. Individual
signaling events within signaling cascades are vital for cellular function; for example, they
mediate the cell cycle. Signaling cascades also transduce extracellular signals, such as growth
factor presence, into a myriad of cellular responses. These signaling pathways afford signal
amplification and implement a variety of control mechanisms to tightly regulate changes in
cellular function. Due to their complexity, understanding the spatial and temporal roles of each
signaling species remains a significant challenge in biology.
Many biological, biochemical and physical approaches have provided a wealth of
information regarding the high specificity of cellular signaling. Genes can be knocked out to
determine their function, and certain species may be studied by immunoblot analysis or
reconstitution in vitro. Further, metal ions can be detected by methods such as atomic absorption
spectroscopy. However, these methods all lack the critical element of real-time analysis. Genetic
methods require several days or weeks to perform,' and other methods either provide total
concentration measurements that are often not relevant to signaling or alternatively remove the
components from their native environment.2
To study species in their native cellular environment on a significant signaling time-scale,
chemically-driven strategies that allow for spatial and temporal resolution are finding widespread
use."3'4 These chemical strategies provide a means to perturb cellular signaling to observe
downstream effects. Certain small molecules can modulate of cellular function"s and caged
bioactive species allow controlled release of function.6'7 In addition, chemosensors report the
location and activity of signaling species, such metal ions,8 small molecules, 4 or enzymes. 9
Specifically, chemosensors are an attractive approach for studying signaling because they
generate an electrically or spectroscopically measurable signal upon binding or modification.
Chemosensors may be of biotic or abiotic origin. Biotic chemosensors can be produced
exclusively via genetic methods and are expressed and used within cells; for example, sensors
based on the Aequoria victoria fluorescent proteins (AFPs). These endogenous probes have the
advantage that introduction into the cell is not disruptive and that chemosensor size is not
17
prohibitive. Abiotic probes are prepared ex vivo and may be introduced into living cells via
mnicroinjection, transfection, or through utilization of protein transduction domains. These
exogenous chemosensors include both small molecules and peptides; they provide unique and
versatile sensing approaches because nonnatural elements may be incorporated. At the current
time, abiotic and biotic probes complement each other; while the endogenous probes are large
and limited in their composition, exogenous probes can be difficult to introduce to cells. An
exciting combination of the power of both biotic and abiotic approaches has been achieved by
site-specifically directing an exogenous label to an endogenous species. 10-12
The chemosensing strategies described in this dissertation are designed to monitor two
very different signaling species in biological systems: divalent zinc cations and protein kinase
enzymes. The individual chapters will provide detailed descriptions of work in these fields while
this introductory chapter will provide a general background to chemosensing and the general
strategy utilized herein.
Properties of an Ideal Chemosensor
The ultimate goal is to study physiological processes in their native environment in a
noninvasive manner. Fluorescence detection is ideal since it is noninvasive and exhibits a low
background signal. The properties of an ideal fluorescent chemosensor have been discussed in
depth elsewhere (refs. 2,3,13,14), and are summarized in Figure 1-1. Notably, chemosensors
should rapidly bind the species that is relevant for signaling with good selectivity and signal
sensitivity (Figure 1-1la-d). Additionally, the affinity for the target analyte should approximate
the expected concentration; this condition prevents disruption of normal cellular signaling
processes and allows detection of increases and decreases of the analyte (Figure 1-le). The
chemosensor should be stable to all aspects of the sensing environment (Figure 1-lf) and have
appropriate fluorescence properties (Figure 1-1 g). Ideally, a readout independent of chemosensor
concentration is desirable; chemosensor concentration can be difficult to determine within a cell
(Figure 1-1h). Finally, the chemosensor should be easily introduced and distributed uniformly
within a cell (Figure 1-1 i).
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Figure 1-1. Properties of an ideal chemical sensor.
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Advantages of Peptide-Based Chemosensors
A chemosensor built from a modular peptide scaffold offers many advantages. The
modular architecture allows incorporation of both natural and nonnatural amino acids via
combinatorial or rational design approaches, made facile via solid-phase peptide synthesis.
Optimization and tuning can be easily achieved by altering the peptide sequence. A number of
fluorescence-based sensing mechanisms have been implemented with peptide-based
chemosensors in the Imperiali laboratory: chelation-enhanced fluorescence,15-8 environment-
sensitive fluorescence,9 -22 fluorescence quenching,23 '24 fluorescence resonance energy transfer
(FRET),2 5 and in some cases, metal-based fluorescence.2 6 27 Incorporation of other functionalities
is also feasible via amide bond formation, e.g. an additional fluorophore for an internal standard
or a cellular internalization sequence28-31 to transport the chemosensors into cells. In addition, the
chemosensors could be attached to a solid support for diagnostic applications.
Metal-Chelating Peptides
Both sensing strategies described in this dissertation were inspired by previous work in
this laboratory on the design of metal-binding peptides, many of which contained novel
nonnatural chelating amino acids. In all cases, the -turn motif (Figure 1-2), which causes a
directionality change in a peptide sequence, has been used as a template for metal coordination
between sets of natural or nonnatural amino acid ligands. p3-turn motifs are classified into many
different types, defined by the and p dihedral angles of the i+1 and i+2 residues. Many of these
conformations promote hydrogen-bond formation between the carbonyl of the i residue and the
amide proton of the i+3 residue. In particular, optimized type II and II' p3-turns contain a
heterochiral sequence in the two core residues (one D-amino acid and one L-amino acid) and are
defined by the dihedral angles listed in Table 1-1 .32
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Figure 1-2. Structure of a 1-turn
Table 1-1. and p dihedral angles and examples of Type II and II' 3-turns
Turn C, p, + Cb+2 tP,+2 Literature examples
II -60 120 80 0 Pro-DSer, Pro-Gly
II' 60 -120 -80 0 DPro-Ser, Ser-DPro
Previous researchers in the Imperiali laboratory have defined reverse-turn motifs in short
peptides sequences in aqueous solution and applied this knowledge to preorganize a metal-
binding site. When a peptide sequence with significant type II -turn propensity, Ac-Val-Pro-
i)Ser-Phe-NH2 ,3 3 was flanked by metal-binding histidine or carboxylate ligands, chelation of Zn2+
and Co2 + was effectively promoted. The turn sequence was essential for metal-binding, as no
metal-binding was observed when both i+1 and i+2 were glycine residues.3 4 Further work
involved replacing natural histidine and aspartate residues with nonnatural phenanthroline metal-
chelating residues to alter the affinity of the peptide for Zn2+ and Co2 +. In addition, the use of
sequences with a weaker propensity for type II 13-turn structure, such as Thr-Pro-DAla-Val, could
be incorporated to weaken the affinity for the metal ion. Thus, the affinity could be tuned over 5
orders of magnitude through modulation of both the turn sequence and the ligating residues.35
Since these seminal investigations, the 3-turn has been used as an important structural element in
the dtie novo design of independently-folded proteins36 '37 and in metal-coordinating peptides5' 1 6. In
this dissertation, the 3-turn sequence has been optimized for metal binding.
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Dissertation Objective
Herein two types of modular peptide-based fluorescent chemosensors will be reported:
tunable Zn2+ chemosensors and versatile probes of protein kinase activity. Both of these sensing
strategies exploit a chelation-enhanced fluorescence (CHEF) sensing mechanism with an
optimized two-residue 3-turn sequence and the novel sulfonamidohydroxyquinoline amino acid
Sox (Figure 1-3). This amino acid contains a derivative of the bidentate chelate fluorophore 8-
hydroxyquinoline (Oxn) as the side chain and is named for the fluorophore unit sulfonamido-
oxine. Oxn derivatives undergo an increase in fluorescence quantum yield upon metal binding to
enable detection of certain metal ions. Additional background on the choice of fluorophore can
be found in Chapter 2. The synthesis of the Sox amino acid will be presented in Chapter 2, and
employs an asymmetric alkylation as the key synthetic step. Chapter 2 also provides relevant
spectroscopic properties of the fluorophore.
A family of intensity-based Zn2+ chemosensors for use in monitoring a range of Zn2+
concentrations will be described in Chapter 3. This family of smaller, improved chemosensors
for Zn2+ was inspired by previous metallopeptide designs. The optimized 2-residue 3-turn
sequence provided a smaller chemosensor with improved metal-binding properties. The binding
stoichiometry, as well as the influence of other metal ions and pH, was carefully characterized
for each chemosensor. Chapter 3 highlights the ability to design probes whose affinities have
been tuned over two orders of magnitude with a modular peptide scaffold. The use of these
chemosensors in concert for monitoring Zn2 + concentration will be illustrated. An extension of
this peptide-based sensing platform to design ratiometric peptide-based Zn2+ chemosensors is
also investigated.. These chemosensors employ an additional fluorophore to provide internal
calibration, and include both excitation and emission ratiometric chemosensors.
The Zn2+ chemosensors inspired a novel approach to use the Sox amino acid, a 3-turn
motif and the biologically available Mg2+ ion to sense phosphorylation of protein kinase peptide
substrates. This versatile strategy, introduced in Chapter 4, allows detection of serine, threonine
and tyrosine phosphorylation. These probes are the most sensitive for assessing kinase activities
reported to date. The design involves an optimized peptide substrate for the target kinase, with a
small sensing module appended, containing Sox and a 3-turn. This module may be placed either
N- or C-terminal to the residue to be phosphorylated. The probes are extremely effective due to
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the large signal change upon phosphorylation and good reactivity with the target kinase. Notably,
the reactivity of substrates is not affected by introduction of the sensing motif. High-throughput
applications are introduced and further described in the following chapter. Chapter 5 details one
valuable application of these probes in a multiplex high-throughput assay of kinase activity in
unfractionated cell lysates. These kinase chemosensors are powerful tools for studying the
activity of recombinant kinases in vitro and endogenous kinases ex vivo.
Figure 1-3. The metal-binding framework for fluorescent chemosensors containing the amino
acid Sox, a two-residue 0-turn motif and an additional ligand for the metal ion. Inset: chemical
structure of Sox.
References
(1) Shogren-Knaak, M. A.; Alaimo, P. J.; Shokat, K. M. Recent advances in chemical
approaches to the study of biological systems. Annu. Rev. Cell Dev. Biol. 2001, 17, 405-
433.
(2) Tsien, R. Y. Fluorescent and photochemical probes of dynamic biochemical signals
inside living cells. In Fluorescent Chemosensors for Ion and Molecule Recognition;
Czarnik, A. W., Ed.; American Chemical Society: Washington, DC, 1993, p 130-146.
(3) Czarnik, A. W. Desperately seeking sensors. Chem. Biol. 1995, 2, 423-428.
(4) Zhang, J.; Campbell, R. E.; Ting, A. Y.; Tsien, R. Y. Creating new fluorescent probes for
cell biology. Nat. Rev. Mol. Cell. Biol. 2002, 3, 906-918.
(:5) Schreiber, S. L. The small-molecule approach to biology. Chem. Eng. News 2003, 81, 51-
61.
(6) Shigeri, Y., Tatsu, Y., Yumoto, N. Synthesis and application of caged peptides and
proteins. Pharmacol. Ther. 2001, 91, 85-92.
(7) Marriott, G., Roy, P., Jacobson, K. Preparation and light-directed activation of caged
proteins. Methods Enzymol. 2003, 360, 274-288.
23
SON(CH) 2 l
2
(8) Kikuchi, K.; Komatsu, K.; Nagano, T. Zinc sensing for cellular application. Curr. Opin.
Chem. Biol. 2004, 8, 182-191.
(9) Baruch, A.; Jeffery, D. A.; Bogyo, M. Enzyme activity - it's all about image. Trends Cell
Biol. 2004, 14, 29-35.
(10) Chen, I.; Ting, A. Y. Site-specific labeling of proteins with small molecules in live cells.
Curr. Opin. Biotechnol. 2005, 16, 35-40.
(11) Miller, L. W.; Cornish, V. W. Selective chemical labeling of proteins in living cells.
Curr. Opin. Chem. Biol. 2005, 9, 56-61.
(1 2) Jessani, N.; Cravatt, B. F. The development and application of methods for activity-based
protein profiling. Curr. Opin. Chem. Biol. 2004, 8, 54-59.
(13) Lakowicz, J. R. Principles of Fluorescence Spectroscopy; 2nd ed.; Kluwer
Academic/Plenum Publishers: New York, 1999.
(14) Czarnick, A. W. Supramolecular chemistry, fluorescence and sensing. In Fluorescent
Chemosensors for Ion and Molecule Recognition; Czarnick, A. W., Ed.; American
Chemical Society: Washington, DC, 1993, p 1-9.
(']15) Walkup, G. K.; Imperiali, B. Stereoselective synthesis of fluorescent ac-amino acids
containing oxine (8-hydroxyquinoline) and their peptide incorporation in chemosensors
for divalent zinc. J. Org. Chem. 1998, 63, 6727-6731.
( 6) Jotterand, N.; Pearce, D. A.; Imperiali, B. Asymmetric synthesis of a new 8-
hydroxyquinoline-derived ac-amino acid and its incorporation in a peptidyl sensor for
divalent zinc. J. Org. Chem. 2001, 66, 3224-3228.
(17) Shults, M. D.; Pearce, D. A.; Imperiali, B. Modular and tunable chemosensing scaffold
for divalent zinc. J. Am. Chem. Soc. 2003, 125, 10591-10597.
(18) Shults, M. D.; Imperiali, B. Versatile fluorescence probes of protein kinase activity. J.
Am. Chem. Soc. 2003, 125, 14248-14249.
(19) Walkup, G. K.; Imperiali, B. Design and evaluation of a peptidyl fluorescent
chemosensor for divalent zinc. J. Am. Chem. Soc. 1996, 118, 3053-3054.
(20) Walkup, (G. K.; Imperiali, B. Fluorescent chemosensors for divalent zinc based on zinc
finger domains. enhanced oxidative stability, metal binding affinity, and structural and
functional characterization. J. Am. Chem. Soc. 1997, 119, 3443-3450.
(21) Vazquez, M. E.; Nitz, M.; Stehn, J.; Yaffe, M. B.; Imperiali, B. Fluorescent caged
phosphoserine peptides as probes to investigate phosphorylation-dependent protein
associations. J. Am. Chem. Soc. 2003, 125, 10150-10151.
(22) Vazquez, M. E.; Blanco, J. B.; Imperiali, B. Photophysics and biological applications of
the environment-sensitive fluorophore 6-N,N-dimethylamino-2,3-naphthalimide. J. Am.
Chem. Soc. 2005, 127, 1300-1306.
(23) Torrado, A.; Imperiali, B. New synthetic amino acids for the design and synthesis of
peptide-based metal ion sensors. J. Org. Chem. 1996, 61, 8940-8948.
(24) Torrado, A.; Walkup, G. K.; Imperiali, B. Exploiting polypeptide motifs for the design of
selective Cu(II) ion sensors. J. Am. Chem. Soc. 1998, 120, 609-610.
(25) Pearce, D. A.; Walkup, G. K.; Imperiali, B. Peptidyl chemosensors incorporating a FRET
mechanism for detection of Ni(II). Bioorg. Med. Chem. Lett. 1998, 8, 1963-1968.
(26) Franz, K. J.; Nitz, M.; Imperiali, B. Lanthanide-binding tags as versatile coexpression
probes. ChemBioChem 2003, 4, 265-271.
24
(27) Nitz, M.; Franz, K. J.; Maglathlin, R. L.; Imperiali, B. A powerful combinatorial screen
to identify high-affinity terbium(III)-binding peptides. ChemBioChem 2003, 4, 272-6.
(28) Wadia, J. S.; Dowdy, S. F. Protein transduction technology. Curr. Opin. Biotechnol.
2002, 13, 52-56.
(29) Kabouridis, P. S. Biological applications of protein transduction technology. Trends
Biotechnol. 2003, 21, 498-503.
(30) Zorko, M.; Langel, U. Cell-penetrating peptides: mechanism and kinetics of cargo
delivery. Adv. Drug Deliv. Rev. 2005, 57, 529-545.
(31) Dunican, D. J.; Doherty, P. Designing cell-permeant phosphopeptides to modulate
intracellular signaling pathways. Biopolymers 2001, 60, 45-60.
(32) Rose, G. D.; Gierasch, L. M.; Smith, J. A. Turns in peptides and proteins. Adv. Protein
Chem. 1985, 37, 1-109.
(33) Imperiali, B.; Fisher, S. L.; Moats, R. A.; Prins, T. J. A conformational study of peptides
with the general structure Ac-L-Xaa-Pro-D-Xaa-L-Xaa-NH2: Spectroscopic evidence for
a peptide with significant -turn character in water and in dimethyl sulfoxide. J. Am.
Chem. Soc. 1992, 114, 3182-3188.
(34) Imperiali, B.; Kapoor, T. M. The reverse turn as a template for metal coordination.
Tetrahedron 1993, 49, 3501-3510.
(35) Cheng, R. P.; Fisher, S. L.; Imperiali, B. Metallopeptide design: tuning the metal cation
affinities with unnatural amino acids and peptide secondary structure. J. Am. Chem. Soc.
1996, 118, 11349-11356.
(36) Struthers, M. D.; Cheng, R. P.; Imperiali, B. Design of a monomeric 23-residue
polypeptide with defined tertiary structure. Science 1996, 271, 342-345.
(37) Struthers, M. D.; Cheng, R. P.; Imperiali, B. Economy in protein design: evolution of a
metal-independent I3Ipc motif based on the zinc finger domains. J. Am. Chem. Soc. 1996,
118, 3073-3081.
25
Chapter 2:
Synthesis, Characterization and Fluorescence Properties of (S)-2-Amino-N-(9-
fluorenylmethyloxycarbonyl)-3-(8-hydroxy-5-(N,N-dimethylsulfonamido)quinoline-2-yl)
Propionic Acid (Fmoc-Sox-OH)
A significant portion of the work described in this chapter has been published in:
Shults, M. D.; Pearce, D. A.; Imperiali, B. Modular and tunable chemosensing scaffold for
divalent zinc. J. Am. Chem. Soc. 2003, 125, 10591-10597.
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Introduction
Fluorescence chemosensors utilizing CHEF to signal metal ion binding with a
fluorescence signal consist of receptor and fluorophore domains; typically, these domains are
separated by a spacer and can be quite large.' Analyte binding to the receptor is signaled to the
attached fluorophore by a variety of mechanisms, reviewed in reference 2. A few CHEF
fluorophores have receptor and fluorophore moieties that coexist; one example of such a
fluorophore was introduced in Chapter 1, 8-hydroxyquinoline (Oxn, Figure 2-1). Oxn has been
substantially used in analytical chemistry for metal ion detection.3 4 Its small size and low
susceptibility to photobleaching are desirable for sensing applications.
Oxn is weakly fluorescent in aqueous solution, but strongly fluorescent in the presence of
certain metal ions. There are two theories regarding the origin of this large fluorescence change.
The first is that the lowest electronic excited state of unbound Oxn (n -> J* transition) is non-
fluorescent due to rapid intersystem crossing. Metal chelation modulates the lowest energy
excited state to the Jr -> r* transition, which does not undergo intersystem crossing and thus is
fluorescent. 3 Since intersystem crossing in unbound Oxn has been difficult to verify, an alternate
theory is that photo-induced proton transfer from the phenolic hydroxyl to the quinoline nitrogen
in the excited state of unbound Oxn results in fluorescence quenching.5 6 Metal complexation
results in deprotonation of the phenolic hydroxyl (due to a significantly lowered pKa), thereby
disrupting the quenching mechanism.7
The bidentate chelate moiety of Oxn is capable of binding many metal ions, with varying
affinities. For example, the affinity of Oxn for Zn2+ is 4 orders of magnitude greater that that for
Mg+.8 Metal ions with filled valencies exhibit fluorescent complexes with Oxn, including Mg 2+,
Ca 2+, Al3+, Zn2+, and Cd2+;9 the emission wavelengths and quantum yields of these complexes
vary moderately depending on the metal ion.9'10 Complexes of Oxn with paramagnetic ions or
"heavy atoms" are nonfluorescent because these ions perturb the electron spins of the ligand to
favor intersystem crossing.3
A number of substituted derivatives of Oxn have been prepared with a range of
fluorescence properties, in this laboratory" as well as in the Anzenbacker laboratory' 2 . Chemical
substitutions on the Oxn core dramatically alter the excitation wavelength, emission wavelength,
F8max and quantum yield of the fluorophore. In particular, the Zn2 + complex of 8-hydroxy-5-(N,N-
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dimethylsulfonamido)-2-methylquinoline (1, Figure 2-1) is 150 times "brighter" than that of the
parent fluorophore, 2-methyl-8-hydroxyquinoline (2-Me-Oxn, Figure 2-1), when compared at
their respective fluorescence emission maxima." Brightness is a product of the extinction
coefficient (), which measures the probability of the electronic transition, and the quantum yield
(P), which measures how efficiently photons absorbed are translated into photons emitted.
Individual values for the Zn2+ complexes of 2-Me-Oxn and 1 in aqueous solution are mx = 2290
lV-i cm', cI = 0.004 and ma = 5560 M-' cm-', PI = 0.24, respectively. A building block
containing the sulfonamidohydroxyquinoline moiety would allow for unlimited placement within
any peptide sequence. Indeed, less sensitive derivatives of Oxn have been successfully
incorporated into peptide-based Zn2+ chemosensors in the Imperiali laboratory.3 '4
SO2 NMe2
OH OH OH
Oxn 2-Me-Oxn 1
Figure 2-1. Chemical structures of 8-hydroxyquinoline (Oxn), 2-methyl-8-hydroxyquinoline (2-
Me-Oxn) and 8-hydroxy-5-(N,N-dimethylsulfonamido)-2-methylquinoline (1).
This chapter reports the integration of the enhanced CHEF fluorophore 8-hydroxy-5-
(N,N-dimethylsulfonamido)-2-methylquinoline into the novel amino acid, Sox. The synthesis of
optically pure nonnatural amino acids has been achieved by both asymmetric synthesis 15 16 and
enantiomeric resolution.7 8 Asymmetric synthetic methods typically require fewer synthetic
steps and result in a higher yield of the desired enantiomer. In particular, the Corey
adaptation 19.20 of the O'Donnell asymmetric alkylation method s has been shown to give
outstanding yields of target enantiomers, and thus was chosen for the synthesis of Sox.
The general spectroscopic properties of Sox pertinent to the sensing strategies presented
in this dissertation will also be investigated. Future chapters will describe the successful
application of the Sox fluorophore for Zn2+ sensing and for phosphorylation sensing in concert
with Mg 2+.
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Results and Discussion:
Synthesis of Fmoc-Sox-OH
The synthesis of the protected amino acid is outlined in Scheme 2-1. Two modifications
to the previously reported" synthesis of 1 from 8-hydroxyquinaldine resulted in an improved
yield of sulfonamide 1. First, dilution of the reaction mixture by 4-fold prevented the formation
of a side-product with a mass corresponding to a dimer (m/z = 488). Second, restriction of the
amount of dimethylamine base to 5 equivalents prevented the formation of a side product (m/z =
294) where the phenolic hydroxyl group was replaced by dimethylamine. This side reaction
presumably proceeds through the semiquinone tautomer under highly basic conditions. The
phenolic hydroxyl group of 1 was then protected as the tert-butyldiphenylsilyl ether. Smaller
silyl ether protecting groups such as TBS and TBDMS were found to be significantly more labile
on this compound (N. Jotterand, unpublished results).
Installation of a bromide on the 2-methyl group of the quinoline ring was desired to
provide an appropriate precursor for the asymmetric alkylation. Conversion to the bromide in
one step via a radical bromination was not successful because 2 was not soluble solvents
compatible with this reaction (benzene or carbon tetrachloride). To circumvent this difficulty, a
three-step procedure was performed without intermediate purification and included oxidation to
the aldehyde 3 with selenium dioxide, reduction to the alcohol 4 with sodium borohydride, and
bromination with N-bromosuccinimide and triphenylphosphine. Intermediate purification was
not performed due to the instability of the aldehyde and alcohol on silica gel. Purification of
bromide 5 was accomplished via chromatography on florisil. NMR analysis revealed that the
purified bromide contains 15% of 1, brought through from the selenium dioxide oxidation step.
This impurity does not affect future reactions and can be washed away during peptide synthesis.
Synthesis of the Sox amino acid from 5 was performed by the Corey adaptation' 9 20 of the
O'Donnell asymmetric alkylation method, 5 utilizing (8S,9R)-O-(9)-allyl-N-9-anthracenyl
methylcinchonidium bromide as the phase-transfer catalyst. Since the benzophenone imine and
tert-butyldiphenylsilyl ether are relatively acid labile, the adduct from the alkylation reaction was
not purified by silica gel chromatography but instead hydrolyzed immediately upon complete
formation in refluxing 6 M hydrochloric acid. The product, Sox, was isolated as the
hydrochloride salt and used without further purification.
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A pure sample of this amino acid was derivatized with Marfey's reagent (1-fluoro-2,4-
dinitrophenyl-5-L-alanine amide)21 to determine that the reaction gave 96% e.e. in favor of the L-
enantiomer. Preference for L-enantiomer formation with the catalyst O-(9)-allyl-N-9-anthracenyl
mnethylcinchonidium bromide is well-established over a wide range of electrophiles.2° Marfey's
reagent derivatized the phenolic hydroxyl group in addition to the free amine (Scheme 2-2).
Because bis-derivatization began prior to complete consumption of the free amino acid, rigorous
e.e. determination required that bis-derivatization to proceed to completion. At this point, it was
confirmed that integration of signals from mono-derivatized peaks after 24 hours gave a
reasonable estimate of the e.e. for analysis of additional samples.
For subsequent peptide synthesis, the free amine was protected with the 9-fluorenyl-
methoxycarbonyl (Fmoc) group by treatment with 9-fluorenylmethyl succinimidyl carbonate
(Fmoc-OSu) to give Fmoc-Sox-OH in 70% yield over 3 steps by NMR. For the synthesis of
peptides throughout the remainder of this dissertation, Fmoc-Sox-OH is used without further
purification in standard Fmoc solid-phase peptide synthesis (SPPS). The small amount of
peptide containing D-Sox is separated from the desired peptide during HPLC purification.
Scheme 2-1. Synthesis of Fmoc-Sox-OH
SO2NMe2 TBDPSiCI SO2NMe2 SO2NMe2
'midazole SeQ2¢;S> 57°O - e O2 '[ >I~~~~ O57%
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Scheme 2-2. Derivatization of Sox with Marfey's reagent.
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Spectroscopic Prioperties of Sox
Both UV-Vis and fluorescence spectroscopy were used to characterize Sox. Due to
limited solubility of the amino acid, fluorescence properties were assessed with peptides
containing Sox. The specific sequences used to obtain spectra are not particularly relevant to the
data presented in this chapter but have been noted in the figure legends; their synthesis is also
reported in subsequent chapters.
A UV-Vis spectrum of the free Sox ligand shows maximum absorbance bands at 246 nm
and 316 nm (Figure 2-2). Upon binding of a variety of metal ions, these bands shift to 260 nm
and 360 nm (Figure 2-2). The fact that the same shift is observed with increasing pH indicates
that deprotonation of the hydroxyl group results in the observed change in electronic properties
upon metal ion binding. The intensity of the 360 nm band does not depend on the type of metal
ion but is sensitive to solvent.
31
U)
C,
-0
.0
250 300 350 400 450
Wavelength (nm)
Figure 2-2. UV-Vis absorbance spectra of a peptide containing Sox (Ac-Sox-Val-Pro-DSer-Phe-
Glu-Ser-Ser-NH 2, 4 tM) in absence (- -) and presence (-) of Zn2+ (80 tM) in 50 mM Hepes
(pH 7.0), 150 mM NaCl.
The excitation and emission spectra for the fluorescent complexes of Sox with Zn2+, Cd2+,
Mg2+, Ca2+ were investigated (Figure 2-3). Saturating concentrations of these metal ions were
used to ensure that the 1:1 complex was observed. It is immediately apparent that the
fluorescence intensities differ significantly depending on the metal ion. The maximum
excitation wavelengths all occur at 360 nm, but there are slight differences in the maximum
emission wavelength (Table 2-1). These differences allow some discrimination between metal
ions based on the fluorescence emission spectra.
The separation between the excitation and emission wavelengths (the Stokes' shift) for all
complexes is quite large. This large Stokes' shift results in low background at the emission
wavelength and allows many different excitation and emission wavelengths to be used for
sensing applications.
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Figure 2-3. Excitation and emission spectra of a peptide containing Sox (Ac-Sox-Pro-DSer-Glu-
Ser-Ser-NH 2, 10 tM) in the presence of Zn2+ (-, 10 tM), Mg2+ (- -, 50 mM), Ca"+ (- -, 400
:rrM), and Cd2+(..--, 10 M) in 50 mM Hepes (pH 7.0), 150 mM NaCl.
Table 2-1. Fluorescence properties of various Sox-metal ion complexes.a
Metal Ion Xexmax (nm) ,emmax (nm) Relative Intensity
Zn 2+ 360 500 1
Mg2+ 360 485 2
Ca2+ 360 483 1.5
Cd2+ 360 503 1.2
a Data were obtained from spectra in Figure 3.
Conclusion:
The Sox amino acid has been synthesized in good yield and enantiomeric excess for
peptide-based sensing applications. This work provides a chemical building block for peptide-
based chemosensor construction that can be utilized in laboratories that are not equipped to do
chemical manipulations. The spectroscopic properties of peptides containing Sox are influenced
by the type of bound metal ion. While absorption and excitation spectra are identical, the
fluorescence emission spectra vary in intensity and maximum wavelength. This understanding of
the fluorescence properties of Sox will be useful for chemosensing applications.
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Experimental
General Synthetic Procedures and Materials
All starting materials, solvents and reagents except N-bromosuccinimide (NBS) from
commercial suppliers were used without further purification. The NBS (Aldrich) was
recrystallized from 10 times its weight in water to form white flakes.22 Dry dioxane and N,N-
dimethylformamide (DMF) were purchased from Aldrich. Selenium dioxide (98%+, less than a
year old from Aldrich) and was a fine off-white powder (bright white or chunky solid is not
effective). O-(9)-Allyl-N-9-anthracenylmethylcinchonidium bromide was prepared according to
the method described by Corey. 9 Dry dichloromethane was distilled from calcium hydride. Dry
tetrahydrofuran was distilled from sodium/benzophenone. Glassware for anhydrous reactions
was oven-dried overnight, and cooled under nitrogen. Water or air-sensitive reactions were
carried out under a positive pressure of nitrogen. Glass-backed thin layer chromatography plates
were obtained from EM Science (silica gel 60 F254, 0.25 micron thickness) and visualized by UV
or for free amines, 0.2% ninhydrin solution followed by heat. Flash column chromatography
was performed on 230-400 mesh silica gel according to the Still procedure.2 3 Chemical shifts are
reported relative to a value of 0 ppm for TMS or 0 ppm for 3-(trimethylsilyl)-1-propane-sulfonic
acid sodium salt for samples in DMSO-d 6 or D2 0.
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Instrumentation
NMR Spectrometers: Varian 500 MHz instrument.
Iligh-Performance Liquid Chromatography (HPLC): Waters 400 and 600 systems (solvent A =
water, 0.1% v/v TFA; solvent B = MeCN, 0.1% v/v TFA). Columns used: C18 analytical,
Beckman U]trasphere ODS, 5 [tm, 150 x 4.6 mm; C 8 preparatory, YMC-Pack Pro, 5 [tm,
250 x 20 mmn.
5-(N,N-Dimethyl)sulfonamido-8-hydroxy-2-methylquinoline (1):
A solution of dirnethylamine in tetrahydrofuran (2 M, 7 ml, 14 mmol), was added under nitrogen
to tetrahydrofuran (300 ml). The 8-hydroxy-2-methylquinoline-5-sulfonyl chloride (665 mg,
2.58 mmol) was added in small portions over 3 hours (about 15 mg per addition every 4
minutes). The solution was stirred an additional 10 minutes, and the solvent was removed by
rotary evaporation. Excess dimethylamine was removed by re-dissolving the sticky solid in
dichloromethane and removing by rotary evaporation (3 x 50 ml). The slightly pink-orange solid
obtained was purified by flash chromatography (silica gel, ethylacetate/hexane, 1:2) to yield a
white solid (626 mg, 91%). TLC Rf = 0.38 (silica, 2:1 hexanes/ethyl acetate) H NMR, ESI-MS
and other data is consistent with that obtained by Pearce et. al."'
8-tert-Butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfonamido-2-methylquinoline (2):
8-Hydroxyquinaldine-5-(N,N-dimethyl)sulfonamide (515 mg, 1.93 mmol), imidazole (141 mg,
2.07 mmol), dry DMF (3 ml) and tert-butyldiphenylsilyl chloride (0.55 ml, 2.11 mmol) were
sequentially added to a dry flask under nitrogen and the mixture was stirred for 2 hours. The
solution was diluted with ethyl acetate (250 ml), washed with saturated ammonium chloride
solution (50 ml), brine (2 x 50 ml) and dried (MgSO4). The solvent was removed by rotary
evaporation and the white solid was purified by flash chromatography (silica gel, 9:1
hexanes/ethyl acetate) to yield a white solid (0.55 g, 57%). The silica gel was pretreated by
stirring with acetone for 15 min. to decrease product decomposition on the column. m.p. 157.5-
158°C. TLC Rf = 0.10 (silica, hexanes/ethyl acetate, 9:1), Rf = 0.32 (silica,
hexanes/ethylacetate, 4:1) H NMR (500 MHz, CDC13) 8.78 (d, J = 8.5 Hz, H), 7.96 (d, J 
8.5 Hz, 1 H), 7.73 (dd, J = 7.5 Hz, 0.5 Hz, 4 H), 7.34 (pseudo-triplet, J = 7.5 Hz, 2 H), 7.28 (t, J
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= 7.5 Hz, 4 H), 7.17 (d, J = 8.5 Hz, 1 H), 7.13 (d, J = 8.0 Hz, 1 H), 2.70 (s, 6 H), 2.17 (s, 3 H),
1.15 (s, 9H). C NMR (125 MHz, CHC13) 6 157.6, 156.8, 140.6, 134.8, 134.0, 133.1, 131.1,
]29.4, 127.4, 124.5, 123.5, 123.4, 115.0, 37.4, 26.6, 23.7, 20.2. HRMS (+ESI-MS): Calcd for
C28H33N203SSi [M+H] + 505.1976, Found 505.1973.
8-tert-Butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfonamido-2-formylquinoline (3):
8-tert-Butyldiphenylsilyloxy-2-methyl-5-(N,N-dimethyl)sulfonamidoquinoline (0.92g, 1.83
mmol) was added to a dry flask under nitrogen, followed by dry dioxane (13.3 ml) and molecular
sieves (4 A, 600 mg). Selenium dioxide (250 mg, 2.25 mmol) was added and the reaction was
stirred at 95°C for 17 hours and then cooled to room temperature. The reaction mixture was
filtered through celite to remove the black residue and molecular sieves, and the celite was
washed with dioxane ( 30 ml, until no chromophore was detected by UV when spotting on
silica gel TLC plates). The dioxane was removed by rotary evaporation and the yellow oil was
re-dissolved in ethyl acetate (900 ml), washed with brine (100 ml), water (100 ml), saturated
potassium carbonate solution (100ml) and dried (MgSO4). Rotary evaporation of the solvent
yielded a sticky yellow oil (932 mg, 95%) which was used in the next step without further
purification. TLC Rf = 0.50 (silica, 2:1 hexanes/ethyl acetate). H NMR (500 MHz, CDCl 3) 
9.58 (d, J = 0.5 Hz, 1 H), 9.10 (dd, J = 9 Hz, 1 H), 8.14 (d, J = 8.5 Hz, 1 H), 7.95 (d, J = 9.0 Hz,
11H), 7.70-7.76 (, 4 H), 7.29-7.46 (m, 6 H), 7.17 (d, J = 8.5 Hz, 1 H), 2.74 (s, 6 H), 1.21 (s, 9
H).
8-tert-Butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfonamido-2-(hydroxymethyl)quinoline (4):
Sodium borohydride (70 mg, 1.80 mmol) was dissolved in absolute ethanol (15 ml) and cooled
to 0°C. To this solution was added dropwise a solution of the crude aldehyde (932 mg, 1.80
mmol) in dry dichloromethane (30 ml). The reaction mixture was stirred for 15 minutes, then
diluted with diethyl ether (800ml), washed with saturated ammonium chloride (200 ml), water (2
x 100 ml), brine (100 ml), and dried (MgSO4). The solvent was removed by rotary evaporation
to yield a pale yellow sticky solid (804 mg, 86%). This material was used in the subsequent step
without purification. TLC Rf = 0.14-0.37 (silica, ethyl acetate). H NMR (300 MHz, CDC13) 
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8.98 (d, J = 8.7 Hz, 1 H), 7.95 (d, J = 8.1 Hz, 1 H), 7.70-7.77 (m, 4 H), 7.27-7.44 (m, 7 H), 7.05
(d, J = 8.1 Hz, H), 4.67 (s, 2 H), 2.72 (s, 6 H), 1.19 (s, 9 H).
2-Bromomethyl-8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfonamidoquinoline (5):
The alcohol from the previous reaction (804 mg, 1.54 mmol) was dried over P20 5 overnight and
then was dissolved in dry dichloromethane (8 ml) under nitrogen. The solution was cooled to
0°C and then N-.bromosuccinimide (275 mg, 1.54 mmol) and triphenylphosphine (445 mg, 1.69
nimol) were added to the reaction. The reaction was stirred at 0°C for 4 hours, after which it was
diluted with diethyl ether (1200 ml), washed with water (150 ml), brine (100 ml) and dried
(MgSO4 ). The solvent was removed by rotary evaporation to give a white solid (1.32 g), which
was purified by flash chromatography (florisil, 100-200 mesh, 9:1 hexanes/ethyl acetate) to yield
a clear oil (538 mg, 49% over 3 steps). This sample contains a 10% impurity, which was not
present in its first fractions off the column. These first fractions (also a clear oil) were used for
characterization. TLC Rf = 0.10 (silica, hexanes/ethyl acetate, 9:1), Rf = 0.31 (silica,
hexanes/ethylacetate, 4:1) H NMR (500 MHz, CDC13) 8.93 (d, J = 8.9 Hz, 1 H), 8.02 (d, J =
8.2 Hz, 1 H), 7.73 (dd, J = 7.9, 1.2 Hz, 4 H), 7.51 (d, J = 9.1 Hz, H), 7.37 (tt, J = 7.3, 2.4 Hz, 2
Ht), 7.30 (t, J = 7.3 Hz, 4 H), 7.16 (d, J = 8.5 Hz, 1 H), 4.12 (s, 2 H), 2.72 (s, 6 H), 1.17 (s, 9 H).
13C NMR (125 MHz, CDC13) 6 157.4, 155.6, 140.5, 135.1, 134.8, 133.6, 132.6, 129.9, 127.8,
125.6, 124.0, 122.9, 116.0, 37.5, 32.9, 26.8, 20.4. HRMS (+ESI-MS): Calcd for
C,8H3,BrN203SSi [M+H]+ 583.1083, Found 583.1059.
(S)-2-Amino-3-(8-hydroxy-5-(N,N-dimethylsulfonamido)quinoline-2-yl)propionic acid
hydrochloride salt (Sox HCl): To a dry flask was added N-(diphenylmethylene)glycine tert-butyl
ester (141 mg, 0.477 mmol), (8S, 9R)-O-(9)-allyl-N-9-anthracenyl methylcinchonidium bromide
(29 mg, 0.047 rnmmol), and cesium hydroxide monohydrate (800 mg, 4.76 mmol). Dry
dichloromethane (12 ml) was added and the solution was stirred vigorously. The flask was
cooled to -78°C, whereafter a solution of the bromide (300 mg, 0.514 mmol) was added
dropwise. The solution was kept at -78°C for 20 hours, and -55°C until the imine was
consumed by TLC (31 hours). The suspension was poured into diethyl ether (300 ml), then
washed with water (50 ml), brine (40 ml), and dried (MgSO4 ). The solvent was removed by
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rotary evaporation to give a yellow oil (391 mg). This oil was immediately hydrolyzed, due to
its instability under column chromatography conditions. 6N HC1 (6.8 ml) was added to the flask
and the reaction mixture was refluxed for 2 hours. The solution was diluted with 1 M HCl (15
ml) and washed with ethyl acetate (2 x 10 ml). The solvent was removed under reduced pressure
to give an orange solid (200 mg). An analytical sample was obtained via preparatory HPLC tR (5
min. 15% B followed by linear gradient 15-60% B over 25 min.) = 14.9 min. TLC Rf = 0.57
(silica, n-butanol/water/acetic acid/ethyl acetate, 1:1:1:1), Rf = 0.34 (silica, n-
butanol/water/acetic acid, 4:1:1). m.p. 185-186°C (dec.) 1H NMR (500 MHz, (CD3)2SO) 6 8.97
(d, J = 8.8 Hz, 1 H), 8.08 (d, J = 8.2 Hz, 1 H), 7.72 (d, J = 8.8 Hz, 1 H), 7.28 (d, J = 8.2 Hz, 1 H),
4.75 (bs, 1 H), 3.67 (dd, J = 16.5 Hz, 4.3 Hz, 1 H), 3.52 (dd, J = 16.8 Hz, 7.6 Hz, 1 H), 2.70 (s,
6 H). 13C NMR (125 MHz, (CD 3 )2 SO) 172.6, 159.2, 157.5, 139.0, 135.8, 133.9, 126.0, 125.9,
122.3, 111.6, 52.3, 38.7, 38.6. HPLC (C 8 ; solvent A = water, 0.1% v/v TFA; solvent B =
MeCN, 0.1% v/v TFA), tR (5 min. 25% B followed by linear gradient 25-45% B over 25 min. =
11.42 min. HRMS (+ESI-MS): Calcd for Ci4H18CIN30 5S [M]+ 340.0962, Found 340.0963. [] 2 0 D
= +6.0 (c = 1.0, MeOH/lM HC1, 9:1).
Determination of Enantiomeric Excess
Derivatization of the amino acid with 1-fluoro-2,4-(dinitrophenyl)-5-L-alanineamide (FDAA,
Marfey's reagent) was used to determine the enantiomeric excess. To a solution of (S)-2-amino-
3-.(8-hydroxy-5-(N,N-dimethyl)sulfonamidoquinoline)propionic acid hydrochloride salt (1.0 mg,
2.66 tmol) in acetonitrile/water (235 tl, 1:1) was added sodium bicarbonate solution (21 tl, 
M, 21 [tmol, 7.9 eq.) and FDAA solution (140 dtl, 14 mg/ml, 7.2 /tmol). The solution was
vc)rtexed and stinrred at 40°C. Free amino acid disappeared after 24 hours, but bis-derivatization
began after 15 hours and continued up to 7 days, during which additional sodium bicarbonate
solution (20 p1) and FDAA solution (50 [tl1) were added every 24 hours. After completion, the
reaction was adjusted to pH 4 with 1 M hydrochloric acid. Following centrifugation, a 10 [tl1
aliquot was diluted to 100 1tl with acetonitrile/water (1:1) to be analyzed by HPLC tR: S
derivative = 32.2 min, R derivative = 30.2 min. A 96.5% e.e was calculated by comparison of
peak areas at both monitoring wavelengths (228 nm, 340 nm). The identities of both peaks were
confirmed by ESI-MS (calcd for C 32H 33NlIOl 5S [M+H] + 844.2, Found 844.3).
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('S,)-2-Amino-Na-(9-fluorenylmethyloxycarbonyl)-3-(8-hydroxy-5-(N,N-
dimnethylsulfonamido)quinoline-2-yl) Propionic Acid (Fmoc-Sox-OH): To a suspension of crude
amino acid (145.1 mg, 0.386 mmol) and sodium bicarbonate (164.8 mg, 1.96 mmol, 5 eq.) in
water (2.2 ml) was added dropwise a solution of (9-fluorenylmethyl)succinimidyl carbonate
(144.1 mg, 0.42 7 mmol, 1.1 eq.) in dioxane (6 ml). The reaction was stirred at room temperature
for 18 h, after which the dioxane was removed by rotary evaporation. The aqueous phase was
washed with diethyl ether (3 x 7 ml) and then acidified to pH 3 with 1 N hydrochloric acid. The
aqueous phase was then extracted with ethyl acetate (4 x 8 ml). The combined ethyl acetate
phases were dried (MgSO4) and the solvent was removed by rotary evaporation to yield a yellow
solid (160 mg, 74%). An analytical sample was obtained via preparatory HPLC tR (5 min. 45 %
B followed by linear gradient 45-70% B over 25 min.) = 28.6 min. m.p. 114-116°C. TLC Rf =
'0.24 (silica, dichloromethane/methanol, 9:1), Rf = 0.17 (silica, dichloromethane/methanol/acetic
acid, 94:5:1) 'H NMR (data for major rotamer reported) (400 MHz, CDC13) 6 9.06 (d, J = 8.8 Hz,
1 H), 8.07 (d, J = 8.4 Hz, H), 7.71 (d, J = 6.8 Hz, 2 H), 7.45-7.53 (m, 3 H), 7.32-7.37 (m, 2 H),
7.19-7.24 (m, 2 H), 7.11 (d, J = 8.4 Hz, 1 H), 5.79 (d, J = 8 Hz, 1 H), 5.05-5.15 (m, 1 H), 4.32-
4.44 (m, 2 H), 4.14-4.19 (m, 1 H), 3.69 (d, J = 4Hz, 2 H), 2.73 (s, 6 H). 3C NMR (125 MHz,
CDCl 3) 176.4, 173.1, 156.8, 156.5, 156.0, 143.6, 141.1, 137.0, 135.4, 132.8, 127.7, 127.0,
109.4, 67.2, 51.9, 46.9, 39.0, 37.4. HRMS (+ESMS): Calcd for C 29H27 N3 0 7S [M+H] + 562.1642,
Found 562.1663. [oa]20D = + 44.3 (c = 1.8, CH 2 Cl2).
Spectroscopic Studies:
Instrumentation: Beckmann DU7500 UV-Vis spectrophotometer, Jobin Yvon FluoroMax-3
fluorimeter (5 nm slits)
Solution preparation: Stock solutions of peptides containing Sox were quantified by UV-Vis
based on the extinction coefficient of the fluorophore unit, 5-(N,N-dimethylsulfonamido)-8-
hydroxy-2-methylquinoline (355 = 8247 M-' cm -' in 0.1 M NaOH, 1 mM Na2EDTA). Metal ion
stock solutions were prepared from ZnCl2 (Aldrich, 99.98%), MgC12 (Alfa Aesar, Puratronic
grade), CaCl2 (Alfa Aesar, Puratronic grade), CdC12 (Mallinckrodt) and were quantified by
standardized solution of EDTA (Aldrich) in the presence of an Eriochrome Black T (Aldrich).24
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Chapter 3:
Modular and Tunable Chemosensing Scaffold for Divalent Zinc
A significant portion of the work described in this chapter has been published in:
Shults, M. D.; Pearce, D. A.; Imperiali, B. Modular and tunable chemosensing scaffold for
divalent zinc. J. Am. Chem. Soc. 2003, 125, 10591-10597.
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Introduction
Selective and tunable chemosensors for selected transition metal ions have the potential
to afford qualitative and quantitative information about the presence, distribution and
concentration of these metal ions in cells or tissues. Sensing for divalent zinc is particularly
desirable because it is a prominent transition metal ion in biological systems.' 1-4 Zn2+ is involved
in cellular signaling pathways, 5 6 signaling at neural synapses, 7-9 and it is co-released with insulin
from glucose-stimulated pancreatic islet -cells.0-2 Concentrations of Zn2`  associated with
physiological signaling are in the nM-[tM range. 9
A plethora of examples exist in the literature of zinc fluorophore sensors, for extensive
reviews, please see references 13-17. Small-molecule probes as well as peptide- and protein-
based chemosensors have been developed for Zn2+. These chemosensors signal the presence of
Zn:+ by either changes in intensity ("intensity sensors") or a change in the excitation or emission
wavelength ("ratiometric sensors"). These two classes will be introduced separately.
intensity-based 2tn2+ Chemosensors
Intensity-based Zn2+ chemosensors report the present of Zn2+ with an increase in
fluorescence emission intensity. The original Zn2 chemosensors TSQ 8 and Zinquin19 (Figure 3-
][ a,b) were the first to be used to identify pools of free Zn>+ available for signaling. Since this
time, small-molecule intensity probes with improved properties, notably ZPs,2 0-23 ZnAFs,2 4 '25 and
FluoZin-3 26 '2 7 (Figure 3-lc-e), have been used extensively to study Zn2+ in signaling. These
chemosensors contain a chelate moiety attached to a fluorophore such that, in the presence of
Zn 2 , photoinduced electron transfer (PET) quenching, which occurs in the unbound probe, is
disrupted to afford enhanced fluorescence emission. PET occurs when an electron from the
nitrogen lone pair in the chelate moiety relaxes before fluorescence emission can occur; PET is
disrupted when this lone pair is engaged in binding Zn2+. ZPs, ZnAFs and FluoZin-3 are based
on fluorescein, so they are quite bright. However, the majority contain aliphatic nitrogen ligands
and thus suffer from protonation at physiological pH, which also disrupts PET quenching. The
latest variants, ZP8 and ZnAF-2F, have improved pKa properties and are useful over a broader
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pH range. These probes generate 2-11-fold increases in fluorescence upon binding Zn2+,
depending on the efficiency of PET-quenching in the unbound state.
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Figure 3-1. Structures of existing small-molecule Zn2+ chemosensors: (a) TSQ;18 (b) Zinquin;19
c) ZP8;2° (d) ZnAF-2F; 24 (e) FluoZin-3. 26
Most peptide- and protein-based Zn2+ intensity sensors (Figure 3-2) have been inspired by
natural Zn2+-binding motifs. One protein-based sensor is an altered blue fluorescent protein
(BFP, Figure 3-2a).28 The BFP fluorophore comprises a dipyrrole unit of a porphyrin, which can
bind Zn2+ in biological systems. Mutations were introduced in the protein to allow Zn2+ binding.
This construct signaled Zn2+-binding with a 2-fold fluorescence enhancement and a dissociation
constant of 50 tM. In the Imperiali laboratory, zinc finger domains have been engineered with a
single and small modification, an environment-sensitive dansyl fluorophore (Figure 3-2b).29
When the dansyl fluorophore is appropriately placed in the sequence, it is solvent-exposed prior
to Zn '+ binding but becomes packed into the hydrophobic core upon recognition of Zn2+. This
environment change results in an increase in fluorescence intensity and a shift in the emission
wavelength. Several variants have been prepared with dissociation constants in the low pM to
low nM range.30 The large size of all of these peptide and protein probes can be prohibitive from
a synthetic standpoint. Thus, Walkup and Imperiali generated a small, peptide-based Zn2+
chemosensor with an amino acid containing an 8-hydroxyquinoline moiety (Figure 3-2c).31
However, this chemosensor exhibited weak fluorescence intensity. Finally, the most elegant
protein-based sensing approach has been developed by the laboratories of Carol Fierke and
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Richard Thompson.3 2'33 These sensors are based on the enzyme carbonic anhydrase, which
utilizes a Zn2+ co-factor. Apo-carbonic anhydrase variants sense Zn2+ by formation of a ternary
complex with a fluorophore containing a sulfonamide moiety (Figure 3-2d). Certain sulfonamide
fluorophores have a high affinity for Zn2+ bound in the carbonic anhydrase active site, and
exhibit an increase in fluorescence intensity. Fierke and Thompson have generated a family of
carbonic anhydrase-based Zn2' sensors whose affinities span 7 orders of magnitude through
modulation of the Zn2+ binding ligands and nearby residues. To overcome the limitation of
ternary complex formation, a "reagentless" carbonic anhydrase-based sensor has been reported.34
a h r_ d
Figure 3-2. Schematic depictions of peptide and protein intensity-based Zn2+ chemosensors. (a)
The site surrounding the BFP fluorophore is modulated to bind Zn2+ and trigger a fluorescence
change.28 (b) An environment-sensitive fluorophore incorporated into a side chain in a Zn2+
finger domain is buried in the hydrophobic pocket upon Zn2+ binding and exhibits in a
fluorescence increase.29 (c) A peptide-based chemosensor containing cysteine, the fluorophore 8-
hydroxyquinoline, and a U-turn sequence to preorganize Zn2+ binding. 3 (d) A two-component
system utilizing a carbonic anhydrase mutant and a sulfonamide-based fluorophore signals Zn2+
when the sulfonamide becomes deprotected upon binding.3 2
Ratiometric Zn2 + Chemosensors
Ratiometric chemosensors provide a means of internal calibration so that the analyte
concentration can be determined independently of chemosensor concentration. These probes
exhibit a shift in either excitation or emission wavelengths upon binding to the analyte; the Zn2+
concentration can then be determined from a ratio of excitation or emission wavelengths.
Ratiometric probes are preferable over intensity-based probes because the emission of intensity-
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based fluorescence probes is often affected by many other factors besides the concentration of
Zn2+. These variables include the intensity of the excitation source, the efficiency of the
collection source, the distribution of the probe and the thickness of the optical section through
which the image is collected.3536
Currently, several examples of small-molecule ratiometric Zn2* probes exist. Woodroofe
and Lippard have coupled an additional fluorophore to Zn2+ probe as an internal standard (Figure
3-3a).3 7 In this design, the linker between the Zn2+ chemosensor and the additional fluorophore is
sensitive to esterases inside a cell; upon linker cleavage, the two fluorophores do not
photophysically interact and are shown to colocalize inside cells. The Lippard laboratory has also
developed two additional ratiometric chemosensors that are a hybrid between two fluorophores.
In one case, the binding of Zn2+ causes a tautomerization between fluorescein and
naphthofluorescein, which have distinct fluorescence properites (Figure 3-3b).38 In the other
case, the "rhodamnine-like" fluorescence properties of the probe is disturbed upon Zn2+ binding to
the nitrogen lone pair and the fluorescence behavior becomes "fluorescein-like" (Figure 3-3c).39
Several probes have been developed based on an internal charge transfer (ICT) mechanism, such
as IndoZin 27 (Figure 3-3d), FuraZin 27 (Figure 3-3e), and ZnAF-R2 40 (Figure 3-3f). This
mechanism is complex but the main principle is that binding of Zn2+ influences the dipole
moment of the fluorophore and changes the nature of the excited state. This most often results in
changes in excitation wavelength, but can also exhibit changes in emission wavelength
depending on the fluorophore. Additional interesting Zn2+ ratiometric fluorophores are 2-(2'-
benzenesulfonamidophenyl)benzimidazole (Figure 3-3g), where Zn2+ disrupts excited state
intramolecular proton transfer fluorescence quenching,4' and related Zinbo-5 (Figure 3-3h),
which can be excited by two-photon microscopy.4 2
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Figure 3-3. Structures of small-molecule ratiometric Zn2+ probes. (a) Coumazin;3 7 (b) ZNP1 ;38
(c) RF-1;39 (d) IndoZin; 27 (e) FuraZin; 27 (f) ZnAF-R2; 4 ° (g) 2-(2'-benzenesulfonamidophenyl)-
benzimidazole; 41 (h) Zinbo-5.4 2
Peptide and protein probes that operate via a FRET mechanism can be used to quantify
Zn2+ with a ratio of excitation or emission wavelengths. These probes include donor and acceptor
fluorophores whose relative distance is modulated upon Zn2+ binding, thereby altering the
efficiency of energy transfer. Both metallothionein43 (Figure 3-4a) and zinc finger domains44
(Figure 3-4b) labeled with organic fluorophores have extremely low detection limits for Zn2+.
The metallothionein probe responds to Zn2+ loading without stoichiometry information, because
there are multiple binding sites. The carbonic anhydrase approach mentioned previously has
been extended to a FRET sensor by labeling of a carbonic anhydrase mutant with an acceptor
fluorophore (Figure 3-4C).36
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Figure 3-4. Peptide- and protein-based Zn2+ ratiometric chemosensors. (a,b) The distance
between a pair of FRET fluorophores is altered upon Zn2+ binding to (a) metallothionein4 3 and
(b) a Zn2+ finger peptide;44 (c) The fluorescence signal from the Zn2+-bound sulfonamide can be
transferred to a FRET acceptor on carbonic anhydrase.3 6
Jimportance of Tuning Probe Affinity
Quantifying free Zn2+ is only possible at Zn2+ concentrations at or near the dissociation
constant of the chemosensor. Since the Zn2 + concentrations associated with signaling are
unknown, it is important to be able to tune the affinity of a chemosensor for Zn2+. With any
probe, Zn2+ concentrations between 10% and 90% saturation can be quantified. When Zn2+
affinities are too tight, equilibrium is not maintained and the probe is completely bound under
physiological conditions. Many of the currently available chemosensors are limited by their tight
Zn2+ affinities (subnanomolar). There exist probes with micromolar affinity for Zn2+, such as
those based on Ca2 + chemosensors (FluoZin-3, FuraZin, IndoZin) where one carboxylate ligand
has been removed.2 7 However, the selectivity of these probes in the presence of physiological
Mg2+ concentrations has not been sufficiently investigated. The ability to easily tune the affinity
by modulating the ligands is critical and can be achieved by several means. For example, the
ratiometric benzimidazole fluorophore reported by Fahrni4 has been tuned over 6 orders of
magnitude with 3 different probes by altering the chelating group denoted by L (Figure 3-3g). In
addition, the Lippard laboratory has reported convergent syntheses to tune spectroscopic and
chelate properties for their ZP20 and newer ZS45 probes. The modular nature of peptide synthesis
allowed variants of the zinc-finger probes reported by Grant Walkup to be assembled with a
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range of subnanomolar affinities. Genetic point-mutations were used to access the carbonic
anhydrase family of probes; these probes have been developed to bind Zn2+ with affinities over
several orders of magnitude up to 1 tM. However, these probes are quite large and must be
manipulated by molecular biology methods. With the exception of the carbonic anhydrase
probes, effective coverage over nanomolar concentrations of Zn2 ' has not been achieved. Thus,
optimized chernosensors are still needed to quantify nanomolar to micromolar Zn2+
concentrations.
Sox-Based Zn2+ Chemosensor Approach
Towards this end, the research presented herein is aimed at developing an addressable
family of low mnolecular weight chemosensors with a range of Zn2+ affinities in the nM-pM
range. These chemosensors would make it possible to determine Zn2+ concentration via analysis
of the relative fluorescence intensities of multiple chemosensors with different affinities for Zn2+.
Alternatively, an additional fluorophore can be appended to any peptide in the family to give rise
to a series of ratiometric Zn2+ chemosensors, enabling measurements of Zn2+ concentration
independently of chemosensor concentration.
This new generation of chemosensors is smaller and more sensitive than the original
design (Figure 3-3f) developed by Grant Walkup.3 These peptide-based chemosensors exhibit
tuned affinity for divalent zinc in the nM-pM range originating from the modular peptide
architecture. An additional advantage of the peptide scaffold is that the fluorophore chosen need
nriot form a completely selective 1:1 complex with Zn2+ because additional specificity
determinants can be incorporated into the peptide sequence.
The basic design of the chemosensor peptides includes the Sox residue and a residue that
affords an additional ligand for Zn2+ flanking a n-turn sequence, which pre-organizes the metal-
ion binding site. The basic features of the design are represented in Figure 3-5. To tune the
affinity, the additional ligand(s) and the O-turn sequence in the peptide are varied. Each peptide
contains only six to eight amino acids. Two of these are serine residues, appended to the
carboxy-terminus, to increase peptide solubility without interfering with metal binding. Further
variation may be achieved through incorporation of an N-terminal module as a functionalized
capping group instead of an amino acid derivative (Figure 3-5b). Preliminary experiments
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involving adaptation of this modular Zn2+ sensing scaffold for FRET-based ratiometric sensing is
also reported. In these probes, an additional fluorophore is appended on either side of the Zn2+
sensing motif.
Since these chemosensors are sufficiently polar not to be cell-permeable, they may be
useful for detection of extracellular Zn2+ or as a diagnostic tool for medical or environmental
samples. For applications in living cells, these chemosensors could be modified with additional
modules that have been optimized in this laboratory to permeate cell membranes.46
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Figure 3-5. Schematic representation of modular Zn2+ chemosensing peptides. To tune the KD
for Zn2+, the 1-turn sequence, additional Zn2+ ligand, and the ligand arrangement are altered.
Two of the general ligand arrangements used are pictured in a and b. The peptide in b has the
additional flexibility that a functionalized capping group can be used as a ligand instead of an
amino acid.
Results and Discussion
Background for Design Strategy
Initially, peptides similar to those containing Oxn or PhOxn amino acids reported
previously from this laboratory 3 '47 were synthesized with a 4-residue -turn sequence
sandwiched between Sox and an additional ligand for Zn2+; for example, Ac-Sox-Val-DPro-Ser-
Phe-Asp-Ser-Ser-NH2 illustrates such a design. These 4-residue 13-turn sequences were chosen
because the i and i+3 residues have been important for maintaining -turn conformations in the
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absence of metal ions (see Chapter 1 for an explanation). However, peptides containing a 4-
residue turn sequence and an additional ligand other than a cysteine exhibited complex binding
equilibria. Thus, the sequence was pared down to the 2 critical residues, i+1 and i+2, to decrease
the size and improve chelation with ligands in the i and i+3 positions.
Intensity-Based Peptide Chemosensor Design and Synthesis
Nineteen peptide sequences were designed, synthesized and characterized (Table 3-1).
These peptides were synthesized via standard Fmoc SPPS. The identity of each of the peptides
was confirmed by mass spectrometry and the purity was verified by RP-HPLC. These peptides
differ in number and type of Zn2+-binding ligands, ligand arrangement or 3-turn sequence to
modulate their affinity for Zn2+.
Table 3-1. Zn2+Chemosensors Peptide Sequences and Dissociation Constants
Peptide Sequencea Apparent KD for Complex(es)
1:1 complex formed
(nM)b (Zn2*:peptide)
P1 Ac-Sox-Pro-Ser-Pen-Ser-Ser-NH 2 c 9.6 ± 2.6 1:1
P2 Ipa-Gly-Cys-DPro-Gly-Sox-Ser-Ser-NH 2 d 11 ± 2 1:1
P3 Ac-Sox-Pro-Gly-Cys-Ser-Ser-NH 2 12 ± 1 1:1
P4 Ac-Cys-Pro-DSer-Sox-Ser-Ser-NH 2 15 + 4 1:1
P5 Ac-Sox-Pro-DSer-Cys-Ser-Ser-NH 2 19 + 5 1:1
P6 Ipa-Gly-His-DPro-Ser-Sox-Ser-Ser-NH 2 d 35 + 5 1:1
P7 Ac-Sox-Pro-DSer-pSer-Ser-Ser-NH 2 e 130 + 10 1:1
P8 Ac-Sox-Pro-DSer-His-Ser-Ser-NH 2 190 1:1 and 1:2
P9 Ipa-Pro-3Phe-Sox-Ser-Ser-NH2 df 330 1:1 and 1:2
P0 Ipa-DPro-Glv-Sox-Ser-Ser-NH 2 d 360 20 1:1
P11 Ipa-DPro-Ser-Sox-Ser-Ser-NH 2 d 530 30 1:1
P12 Ac-Sox-Pro-DSer-Glu-Ser-Ser-NH 2 730 ± 80 1:1
P13 Ac-Sox-Pro-DSer-Asp-Ser-Ser-NH 2 910 50 1:1
P14 Ipa-Pro-Gly-Sox-Ser-Ser-NH 2 d 990 1:1 and 1:2
P15 Ipa-Pro-DSer-Sox-Ser-Ser-NH 2 d 1100 1:1 and 1:2
P16 Ipa-Glyv-Asn-Sox-Ser-Ser-NH2 d 1600 1:1 and 1:2
P17 Ipa-Pro-Ser-Sox-Ser-Ser-NH 2 d 1900 1:1 and 1:2
P18 Ipa-Pro-13Phe-Sox-Ser-Ser-NH2 df 3000 1:1 and 1:2
P19 Ac-Sox-Pro-DSer-Phe-Ser-Ser-NH2 12000 1:1 and 1:2
a Ligating residues are indicated in bold, 3-turn sequence is underlined.
b Obtained via direct fluorescence titration with ZnC12 in 50 mM Hepes (pH 7.0), 150 mM
NaCl. Values reported with standard deviation are obtained from triplicate titrations with a
peptide concentration near the KD. Values without standard deviations are obtained via a
single titration at [peptide] = 50 nM. K values are calculated by a global non-linear least-
squares fit with the program Specfit/32.45
c Pen = 3-dimethylcysteine; d Ipa = 3-(imidazol-4-yl)propionic acid; e pSer = phosphoserine;
f P9 and P18 each include one of the enantiomers of DL-3Phe.
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The nineteen peptides contain thiolate, imidazole, phosphate or carboxylate ligands for
Zn2+. Several different 3-turn sequences were investigated: type I (Pro-Ser, Gly-Asn), type II
(Pro-DSer, Pro-Gly), type II' (DPro-Ser, DPro-Gly), and Pro-p3Phe, which was inspired by turn
sequences used in this laboratory for caged Zn2+ peptides.49 Variation of the ligand orientation
and number of ligands also altered the coordination environment.
Absorbance and' Fluorescence Properties
In the presence of saturating ZnC,12, the Sox peptides exhibit a maximum emission at 500
nm with a maximum excitation at 360 nm. In addition, these peptides maintain the striking
luminescence properties of the fluorophore.5 0 The extinction coefficient (ma) and quantum yield
(P) values for representative chemosensor-Zn 2 + complexes were determined following
quantitative amino acid analysis (QAA) (Table 3-2). These representative chemosensors span the
range of ligands and affinities for Zn2+. The average of these Emax and D values for representative
peptides are 6200 M -' cm-' and 0.16, respectively; the 10% standard deviation results from the
erITror in concentration of stock solutions determined by QAA. In the absence of Zn2+, the
quantum yields are less than 0.005, indicating a substantial 30-fold increase in fluorescence upon
binding Zn2+.
Table 3-2. Extinction Coefficient and Quantum Yield Values for Representative Peptidesa
Pfeptide E360 nm (M1 cm-') (complexb (peptide
P3 5800 0.18 0.005
P6 5600 0.17 0.001
P10O 5600 0.16 0.003
P12 7000 0.13 0.001
P13 6800 0.14 0.004
a Conditions: 50 mM Hepes (pH 7.0), 150 mM NaCl
b Relative to quinine sulfate ((360 = 0.55).
Summary, of Binding Studies
Peptide binding characteristics were assessed via titrations with ZnCl2 and Job plot
analysis to determine the affinity and stoichiometry of complex formation. Titration data is fit
48with the program Specfit/32,48 which analyzes multiwavelength data using an iterative method to
obtain the association constant in terms of the [Zn]f. Direct titrations were performed for all
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peptide sequences under similar conditions for comparison purposes. Only dissociation constants
for the 1:1 complex are listed in Table 3-1 and discussed in the following section because these
depend the most heavily on the 3-turn sequence and the additional Zn2 + ligand.
Binding Stoichiometry
Methods for assessing the binding stoichiometry are important to determine which
chemosensors will be useful for quantifying Zn2+. For the peptides listed in Table 3-1, four
criteria were used to determine binding stoichiometry: a Job plot, a Scatchard plot, the model
used for KD calculation and the maximum fluorescence emission wavelength. To illustrate the
conclusion from each method, data for peptides P13, which forms only a 1:1 Zn2+:peptide
complex, and P8, which forms both 1:1 and 1:2 complexes, are included. These data are
representative of all peptide sequences synthesized. The first indication of exclusive 1:1
complex formation is a Job plot that is symmetrical and exhibits a maximum at 0.5 mole
fraction of Zn2+ (Figure 3-6a). However, a Job plot with a maxima at any other value besides 0.5
indicates formation of additional complexes; in the case of P13, a 1:2 Zn2+:peptide complex is
also formed because the maximum shifts to less than 0.5 (Figure 3-6b).5' In addition, a change in
the shape of the Job plot when a different emission wavelength is monitored is indicative of
mixed complex formation.5' The second criterion for 1:1 complex formation is a linear Scatchard
plot of Zn2+ titration data (Figure 3-7)5' Third, peptides forming a 1:1 complex exclusively
throughout the course of a titration obtain a better fit with a 1:1 complexation model (Figure 3-
8a). Addition of a 1:2 Zn2+:peptide complex into the model fits the data for all other peptides
(Figure 3-8b). Finally, the wavelength of maximum emission for a peptide forming only a 1:1
complex remains constant at 500 nm throughout a titration (Figure 3-9a). On the other hand,
peptides forming 1:1 and 1:2 complexes exhibit shifts in the maximum emission wavelength
firomr 475 nm to 500 nm as increasing amounts of Zn2+ are added (Figure 3-9b). This shift is
observed because the 1:2 complex is also fluorescent, but demonstrates different photophysical
properties.
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Figure 3-6. Job plots distinguish formation of a 1:1 complex from mixed complexes. (a) Job
plot for a peptide which forms only 1:1 complexes, P13; (b) Job plot for a peptide which forms
both 1:1 and 1:2 complexes, P8. The plots indicate the fluorescence intensity at 500 nm in 50
mM Hepes (pH 7.0), 150 mM NaCl. The total [peptide] + [ZnCl2] = 0.98 M.
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Figure 3-7. Scatchard plots distinguish formation of a 1:1 complex from mixed complexes. (a)
Scatchard plot for a peptide which forms only 1:1 complexes, P13; (b) Scatchard plot for a
peptide which forms both 1:1 and 1:2 complexes, P8. The plots indicate the fluorescence
intensity at 500 nm. Titrations were performed with 500 nM peptide in 50 mM Hepes (pH 7.0),
150 mM NaCl. Data for entire titration is included.
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Figure 3-8. The complexation model that best fits the titration data indicates the type(s) of
complex(es) formned. Fit obtained from titration data for (a) P13 using a 1:1 complexation model
and (b) P8 using a 1:1 and 1:2 complexation model. With these models specified, a global non-
linear least squares fit of the data was obtained via Specfit/32.48 The plots indicate the
fluorescence intensity at 500 nm. Titrations were performed with 500 nM peptide in 50 mM
Hepes (pH 7.0), 150 mM NaCl. Data for entire titration is included.
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Figure 3-9. The behavior of the maximum emission wavelength during a titration distinguishes
1:1 complex formation from mixed complex formation. Spectra recorded for the titration of (a)
P13 (emission maximum remains constant at 500 nm) and (b) P8 (emission maximum shifts
during the titration). Only a few of the twenty-five data points collected are shown for clarity.
Titrations were performed with 500 nM peptide in 50 mM Hepes (pH 7.0), 150 mM NaCl.
55
_>1
a)
a)
C)
Qa8C)a)g
,naL0
2.5 1
C
C
a
a)
0ca)c(I)Qa
0
21
1.5 1
11
51
The rigid imidazole ligand was most sensitive to turn sequence modification and ligand
arrangement; not all peptides synthesized with this ligand formed only 1:1 complexes. With the
exception of P8, P15, P18 and P19, all peptides form only the 1:1 complex at peptide
concentrations of 50 nM. Increasing the concentrations of peptides P9, P14, P16 and P17
resulted in formation of 1:2 complexes because any two given peptides are in closer proximity. A
more favorable design exhibits a preference for 1:1 complex formation at high peptide
concentrations, where chelation can outweigh the effect of concentration.
Of the nineteen peptides synthesized, eleven form 1:1 complexes at peptide
concentrations in a useful range for biological experiments (low micromolar). For peptides that
form mixed complexes, quantifying Zn2+ concentration is complicated by the fact that the relative
concentrations of the 1:1 and 1:2 complexes change depending on both peptide and Zn2+
concentrations. Only the peptides that form 1:1 complexes (Table 3-3) will be further discussed,
because they are the most useful. These eleven peptide sequences span two orders of magnitude
in their dissociation constants. Since Zn2+ concentrations can be quantified from 10-90%
saturation with a single chemosensor, these chemosensors are useful for monitoring Zn2+
concentrations over four orders of magnitude.
Table 3-3. Dissociation Constants for 1:1 Zn2+:Peptide Complexes
Zn 2+ LigandsPeptide ZN Li Turn Apparent KDa (nM)(N -> C)
P1 Sox, Pen Pro-DSer 9.6 _ 2.6
P2 Ipa, Cys, Sox DPro-Gly 11 ± 2
P3 Sox, Cys Pro-Gly 12 ± 1
P4 Cys, Sox Pro-DSer 15 ± 4
P5 Sox, Cys Pro-DSer 19 ± 5
P6 Ipa, His, Sox DPro-Ser 35 ± 5
P7 Sox,pSer Pro-DSer 130 ± 10
P10 Ipa, Sox DPro-Gly 360 ± 20
P11 Ipa, Sox DPro-Ser 530 + 30
P12 Sox, Glu Pro-DSer 730 ± 80
P13 Sox, Asp Pro-DSer 910± 50
Obtained via direct fluorescence titrations in triplicate. KD values are
calculated by a global non-linear least-squares fit with Specfit/32.48
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Binding Trends
Inspection of the data presented in Table 3-3 allows the conclusion that the non-
fluorophore Zn: + ligand provides rough tuning of binding affinity. The affinity of a peptide for
Zn2+ decreases along the following series: thiolate > two imidazoles > phosphate > one imidazole
> carboxylate. This trend is expected based on the binding preferences of the Zn2 + ion, where
softer", or more polarizable, ligands are preferred.2 The phosphate ligand appears out of order if
solely a "soft" ligand explanation is invoked. The increased affinity of P7 for Zn2+ relative to the
"softer" imidazole ligand may be due to the increased negative charge and/or the ability to bind
as a bidentate ligand. The affinity of these peptides for Zn2+ spans two orders of magnitude
through ligand variation.
Fine-tuning of binding affinity was possible through modification of the turn sequence
and ligand arrangement. In general, a more flexible glycine residue in the turn sequence leads to
a slightly tighter-binding peptide. Further, the ligand arrangement influences the Zn2* affinity
rnore strongly for imidazole ligands than for thiolate ligands. In addition, a peptide containing
two imidazole ligands (P6) has significantly greater affinity over peptides containing a single
imrnidazole ligancd (P10, Pll). However, the addition of an imidazole ligand to a cysteine-
containing peptide barely changed the affinity (compare P2 to P4). The lack of increased affinity
could be due to domination of the binding affinity by the thiolate donor or a result of the peptide
adopting a conformation where the imidazole does not bind Zn2+.
Implications for Further Tuning
The possibility of additional Zn2+ chemosensors with altered affinities is feasible through
continued modification of this architecture considering the following trends. In general, affinity
can be increased with "softer" ligands, a more flexible turn, and additional ligands. Affinity can
be weakened with "harder" ligands and increased turn rigidity. While quantum mechanical
forcefields exist for prediction of both ligand polarizability and energy-minimized structures, the
necessary time and computing power for these calculations can be prohibitive. The structures of
metal complexes of larger proteins can be minimized based on data from similar systems, but
small peptides such as these chemosensors present a challenge. Therefore, synthesis and
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characterization of each new chemosensor is necessary to empirically confirm the utility of each
new design.
Influence of pH on Chemosensing Peptides
Because pH changes often accompany cellular signaling events,5 2-54 it is important to
investigate the effects of pH changes on both the chemosensor peptide and the chemosensor-Zn 2+
complex. For this purpose, representative peptides of each ligand type were chosen. The
fluorescence of all peptides in the absence of Zn2+ remain essentially unchanged between pH 4
and 10 (PO10 is representative of all peptides in Figure 3-10). On the other hand, there is a
dramatic change in the fluorescence intensity of the complex over the same pH range. All of the
peptide-Zn 2+ complexes are maximally fluorescent at and above pH 7 whereas the fluorescence
of each peptide-Zn 2 * complex is quenched below pH 5 (Figure 3-10). The pH profiles and pKa
values calculated from these profiles (Table 3-4) differ slightly due to ligand variation. In
particular, peptide P6 exhibits cooperative protonation of the two imidazole moieties; the pH
profile shows an extremely sharp transition and fits to a 2-site model (Hill coefficient = 2, see
Experimental). These probes all exhibit satisfactory pKa values for cellular experiments.
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Figure 3-10. pH profiles of representative peptide and peptide-Zn2+ complexes. The fluorescence
intensity at 500 nm is plotted for P10 (x) and the complexes Zn2+-P1 (), Zn2+-P2 (), Zn2+-P5
(*), Zn2+-P6 (), Zn2+-P7 (), Zn2+-P10 ("), Zn2+-P12 (), Zn2+-P13 (). See experimental
section for conditions and curve fit parameters.
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Table 3-4. pKa's for chemosensor-Zn2 + complexes.
Peptide Zn 2+ Ligands pKa
Besides Sox
P1 Pen 6.0
P2 Ipa, Cys 6.0
P5 Cys 6.1
P6 Ipa, His 6.0
P7 pSer 6.0
P10 His 5.8
P12 Glu 5.6
P13 Asp 5.5
AMetal Competition Studies
To assess possible interference by relevant competing metal ions with the detection of
Zn2+, two separate experiments were performed: one to assess false positive responses where the
competing ion forms a fluorescence complex with the chemosensor and another to identify false
negative responses where the ability of the chemosensor to bind Zn2 + is compromised. In general,
the metal-ion response variation between peptides can be explained as due to donor-atom
preference for each metal ion.
Since metal ions besides Zn2+ are known to form fluorescent complexes with 8-
hydroxyquinoline, including Mg2+ and Ca2+,55 the fluorescence response of each chemosensor
alone in the presence of each metal cation was investigated (Figure 3-1 la). Only peptides
containing "hard" carboxylate and phosphate donor ligands (P7, P12, P13) give a response with 1
mM Mg2+ and 1 mM Ca2+. The response to Mg2+ is greater likely because the size of Mg 2+ is
more comparable to Zn2+ than that of Ca2+.2 P7 gives a substantial response to Mg2+ (50%)
because Mg2+ has a particularly high affinity for phosphate, as seen by its frequent coordination
to ATP and oligonucleotide sequences.
The interference by Mg2+ and Ca2+ was investigated in greater depth for peptides P7, P12
and P13 by preliminary titrations. The dissociation constant of the P7-Mg2+ complex is roughly
10 rmM, whereas the complexes of P12 and P13 with Mg2+ are at least two-fold weaker. In all
cases, the Ca2 + complexes of these peptides have dissociation constants between 50 and 100 mM.
The fluorescence properties of these complexes were discussed in Chapter 2; briefly, the Mg2+
complex is twice as bright and the Ca2+ complex 1.5 times as bright as the Zn 2+ complex. With
the exception of the P7-Mg2+ complex, one equivalent of Zn2 + added to the Mg2+ or Ca2 +
complexes of these peptides shifts the emission wavelength maximum back to 500 nm,
59
suggesting that Zn2 + is able to efficiently compete with Ca2+ and Mg2+ binding when these ions
are present at 1 mM. It is possible that a ratio of 485/500 nm could distinguish these complexes
during analysis of an unknown sample.
Since many other metal ions do not form fluorescent complexes with 8-
hydroxyquinolinrie, the fluorescence response of the peptide-Zn2+ complex in the presence of one
equivalent of several additional metal ions was investigated (Figure 3-1 b). In this study, K+
does not interfere with fluorescence for any peptide-Zn 2+ complex up to 1 mM K+. For weaker
Zn 2+-binding peptides, Mn2+ and Co2+ compete with Zn2 + binding by no more than 10% and 20%,
respectively. Fe3? interferes for peptides with "hard" oxygen donor atoms (P7, P12 and P13).
Ni2+ causes significant quenching for peptides with imidazole and carboxylate ligands but has
little affinity for peptides with thiolate and phosphate ligands. Cu2+ interferes with Zn2+-binding
for all peptides, and it entirely competes with Zn2+ for peptides containing thiolate ligands (P1,
P2, P5).
With the exception of Ca2+, Mg2+ and K+, all metal ions investigated are unlikely to be
present as free metal ions in biological systems. Regulatory proteins which bind copper5 6 and
zinc57 ions sufficiently tightly to preclude the possibility of free amounts of these metals in the
cytoplasm of E. coli have been discovered and, most likely, similar regulatory proteins for other
metal ions exist in mammalian cells. For diagnostic purposes, a chemosensor can be chosen
based on the lack of response to a competing metal ion in addition to the dissociation constant.
In addition, these chemosensors all form fluorescent complexes with Cd2+. The
concentration of Cd2+ in biological systems is subnanomolar 2 and thus it is unlikely to interfere
vvith measurements in such systems. However, environmental and diagnostic applications exist
for a Cd2+ chemosensor due to the toxicity of this metal ion. While Cd2+ forms complexes that are
as fluorescent as the ones with Zn2+ for all peptides, the ability of P6 and P7 to differentiate
between Zn2+ and Cd2+ is notable because such discrimination is rare. This discrimination may
be explained by the size of Cd2+, which is possibly too large to efficiently bind to all four ligands
of P6. Also, Cd2+ is characterized as a "softer" metal ion than Zn2+, which would disfavor
phosphate coordination in P7. Though the trends described here favor the Zn2+ complexes, they
imply that the peptide scaffold could be tuned for the specific detection of Cd2+ as well.
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Figure 3-11. Metal ion competition plots for representative peptide and peptide-Zn2 , complexes,
based on donor ligands. (a) Fluorescence intensity of peptides in the presence of various cations.
(b) Fluorescence intensity of peptide plus equivalent of Zn2+ in the presence of various cations.
All metal ions were evaluated at one equivalent except Ca2' , Mg2' and K+, which were used at 
mM. Peptide concentrations were either 1 tM (P2, P5, P6 and P7) or 10 ~tM (PI 1, P12).
Measurements were obtained in 50 mM Hepes (pH 7.0), 150 mM NaCI.
Probes of Zn2 + Concentration
For a given application, peptides spanning the range of affinities can be used to determine
Zn 2+ concentration within a defined range if one chemosensor gives a fluorescent response when
another does not. To illustrate this approach, vials with different probes and varying
concentrations of Zn2+ were prepared (Figure 3-12a). The observed fluorescence of each peptide
at each of the three concentrations corresponds well with the data obtained from titrations
(Figure 3-12b). Zn2+ concentrations can be narrowed into a range based on the responses of two
or more peptides. This measurement does not require that the maximal fluorescence intensity be
known, but only that one peptide does not give a response. For example, a solution that
fluoresces in the presence of P5 but does not fluoresce in the presence of P7 would contain a
Zn 2, concentration between roughly 50 and 200 nM. This method avoids many of the well-
known difficulties associated with intensity-based measurements since the chemosensors are
sufficiently similar to be compared under identical experimental conditions. Further, only very
simple illumination equipment is required.
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Figure 3-12. Visual representation of the range of Zn2+ affinities of five of the chemosensing
peptides. (a) Vials were loaded with a l M solution of the appropriate peptide and the
indicated concentration of ZnCI2 in 50 mM Hepes (pH 7.0), 150 mM NaCI. Vials were
irradiated at 365 nm on a UV transilluminator. (b) Comparison of the fluorescence responses in a
with the titration curves shows the probes behave as expected.
Investigation of Sox-Based Ratiometric Zn2+ Chemosensors
To enable Zn2+ concentration determination from a single chemosensor, both excitation
and emission ratiometric chemosensors based on the Sox sensing strategy were examined. n
both designs, an appropriate additional fluorophore is incorporated via amide bond formation
into the peptide scaffold. Then, FRET is enabled between the additional fluorophore and Sox. To
develop an emission ratiometric chemosensor, the additional fluorophore is chosen for
reasonable overlap of the emission spectra with the excitation spectra of the Sox-Zn2+ complex,
such that the energy is transferred to Sox upon Zn2+ binding (Figure 3-13a). To develop an
excitation ratiometric chemosensor, an additional fluorophore is chosen whose excitation spectra
overlap with the emission spectra of the Sox-Zn2+ complex (Figure 3-13b). The remainder of this
chapter reports the choice of fluorophores for ratiometric sensing, the incorporation of these
fluorophores into the peptide scaffold, and an investigation of the fluorescence properties of
these new chemo)sensors.
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Figure 3-13. Schematic depictions of Sox-containing ratiometric chemosensors based on FRET.
(a) In the emission ratiometric sensing strategy, energy from the additional fluorophore is
transferred to the Sox-Zn2 + complex. A ratio of two different wavelengths in the emission spectra
is used to determine Zn2 + concentration. (b) In the excitation ratiometric sensing strategy, energy
from the Sox-ZnE2 + complex is transferred to the additional fluorophore. A ratio of two different
wavelengths in the excitation spectra is used to determine Zn2+ concentration.
Emission Ratiometric Chemosensors
Carbostyril 124 (cs 124, Scheme 3-1) was chosen for the emission ratiometric
chemosensor because it exhibits similar brightness to the Sox fluorophore. The cs124
fluorophore does not possess a handle for incorporation into peptide sequences. Thus, a soluble
amino acid building block was synthesized by attaching cs124 to the side chain of glutamate
(Scheme 3-1). Coupling of cs124 to Fmoc-Glu-OtBu was performed with the peptide coupling
reagent HATU. Less reactive coupling agents such as PyBOP and diisopropylcarbodiimide were
nriot effective. Deprotection of the tert-butyl group gave the final product, Fmoc-Glu(csl124)-OH
in good yield. Upon conversion to an amide, the fluorescence properties of cs124 changed quite
dramatically (Figure 3-14). Li and Selvin58 reported the altered excitation spectra for a different
cs124 amide construct, but the fluorescence emission properties were not noted. The emission of
Fmoc-Glu(csl124)-OH shifted substantially relative to cs124 such that spectral overlap with the
excitation of the P10-Zn2 complex (Figure 3-12) enabled a FRET strategy.
63
i
Scheme 3-1. Synthesis of Fmoc-Glu(cs 124)-OH
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Figure 3-14. Excitation and emission spectra for cs124 (- -), Fmoc-Glu(cs124)-OH (-), and the
Pl0-Zn 2 + complex (- -). Spectra were obtained in 50 mM Hepes (pH 7.0), 150 mM NaCl with 10
[tM of each species.
Fmoc-Glu(csl124)-OH was incorporated into three peptide sequences, based on Zn2 +
chemosensors that formed 1:1 complexes (Table 3-5). Because incorporation of the additional
fluorophore increases the hydrophobicity of these peptides, two arginine residues were included
to increase solubility. These chemosensors contain either imidazole or carboxylate ligands for
Zn2+ and the location of the cs 124 moiety relative to the Zn2+ binding motif was varied. Peptides
with thiolate ligands were avoided due to the possibility that ethanedithiol used in peptide
cleavage cocktails might disrupt cs 124 fluorescence via a Michael addition to the fluorophore.
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Table 3-5. Sequences of Emission Ratiometric Zn2+ Chemosensors
Peptide Sequence a Apparent KD Complex(es)
for 1:1 formed
complex (nM)b (Zn2+:peptide)
MDS32 Ac-Glu(cs]24)-Ser-His-DPro-Gly-Sox-Arg-Arg-NH 2 ND 1:1 and 1:2
MDS33 Ipa-DPro-Gly-Sox-Ser-Ser-Glu(cs]24)-Arg-Arg-NH 2 640 1:1
MDS34 Ac-Sox-Pro-DSer-Asp-Ser-Ser-Glu(cs24)-Arg-Arg-NH 2 2500 1:1
a Ligating residues are indicated in bold, additional fluorophore in italics. 13-turn sequence is underlined.
b Obtained via direct fluorescence titration. Values reported are obtained from a single titration where peptide] =
500 nM in 50 rnM Hepes (pH 7.0), 150 mM NaCI. KD values are calculated from a fit of the emission ratio
500/369 nm as described in the Experimental section.
Energy transfer between the two fluorophores can be observed by monitoring the
emission at 500 nm at different excitation wavelengths for these two peptides in the presence of
Zn2+. Since cs124 itself does not emit at 500 nm, the carbostyril bands present in the excitation
spectrum at 328 nm and 342 nm indicate energy transfer to the Sox-Zn2+ complex (Figure 3-15a).
Further, this spectrum also shows that the emission of the peptide at 500 nm is 2.5 times greater
when excited at 342 nm versus 368 nm (where Sox can be selectively excited). This difference is
also illustrated by emission spectra of MDS32 and the MDS32-Zn2+ complex at different
excitation wavelengths (Figure 3-15b). This figure also shows the ratiometric response to Zn2+
when the probe is excited at 342 nm.
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Figure 3-15. Evidence of FRET for peptide MDS32. (a) Excitation spectra of MDS32 for
emission at 500 nm. (b) Emission spectra with excitation at 342 nm for MDS32 (-) and
MDS32-Zn2 + (-- -), and with excitation at 368 nm for MDS32 (--) and MDS32-Zn2 + (- -).
Spectra were obtained in 50 mM Hepes (pH 7.0), 150 mM NaCl.
To characterize more carefully the response of these probes to Zn2+, titrations were
conducted (Figure 3-16). As the concentration of Zn2+ is increased, the emission band due to
cs124 at 369 nm decreases with a concomitant increase in the emission band due to the Sox-Zn2+
complex. Both the magnitude of the decrease in the 369 nm emission band and the maximum
emission intensity at 500 nm varies between peptides. These results are consistent with a FRET
mechanism based on the varied distance between the cs124 amino acid and Zn2+-binding motif.
During the course of a Zn2+ titration, MDS32 exhibited a slight shift (5 nm) in the emission
intensity at 500 nm indicative of mixed complex formation; on the other hand, titrations of
MDS33 and MDS34 revealed 1:1 complex formation. The ratio of fluorescence intensities
(500/369 nm) could be fit for MDS33 and MDS34 to determine dissociation constants; a
representative fit is shown in Figure 3-17. These dissociation constants (Table 3-5) correlate with
those for the peptides P10 and P13, upon which they were based, respectively.
66
3a)
C.)C 2
a)
gWia)0 1
a)
LL
400 500 600
Wavelength
1.6 1
. _
C1.2 11.2
C:
C~81a)
"O 8 1a)
) 410
iL
400 500 600
Wavelength
400 500 600
Wavelength
Figure 3-16. Effect of increasing concentrations of Zn2+ on fluorescence spectra of (a) MDS32;
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Figure 3-17. Representative fit of the 500/369 nm emission ratio for MDS33.
The FRET mechanism is corroborated by the complexes of these peptides with Cd2+ and
Cu2 +. Cd:+ affords a similar response to Zn2+. On the other hand, addition of high concentrations
of Cu2+ resulted in the same fluorescence decrease at 369 nm, but no increase at 500 nm was
observed due to the quenching effect of Cu2+ on Sox.
Preliminary investigations of pH sensitivity showed that the unbound probes exhibit a
decrease in fluorescence at 369 nm in response to increasing the pH from 6.5 to 8.0. The bound
probes do not exhibit a fluorescence change in this range. Since Sox has a small quantum yield in
the absence of Zn2+, it is possible that the pH sensitivity of the cs 124 fluorescence emission band
are clue to changes in protonation state of the unbound Sox fluorophore. Thus, these probes will
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be useful in a controlled environment that is not sensitive to pH fluctuations. The ratiometric
response can easily be calibrated for each peptide to determine Zn2+ concentration.
Excitation Ratiometric Chemosensors
To afford an alternative approach and enable longer-wavelength readouts, an excitation
ratiometric chemrnosensor containing Bodipy-R6G (Figure 3-18) was investigated. This approach
was inspired by the work of Fierke and Thompson (Figure 3-4c).36 Bodipy-R6G exhibits
reasonable overlap with Sox at its excitation wavelength, 528 nm, and exhibits an unusually
large Stokes' shift for Bodipy fluorophores (19 nm). Thus, the emission wavelength of Bodipy-
R6G (547 nm) should be observable independent of Sox. The Bodipy-R6G succinimidyl ester
was used to cap the free amine terminus of purified peptides in solution. The designed sequences
vary the distance between the Bodipy fluorophore and the Zn2+-binding motif (Table 3-6).
Figure 3-18. Structure of BodipyR6G succinimidyl ester
Table 3-6. Sequences of Excitation Ratiometric Zn2+ Chemosensors
Peptide Sequence
MDS35 BodipyR6G-Gly-Ser-Sox-Pro-DSer-Asp-NH 2
MDS36 BodipyR6G-Ahx-Ser-Gly-Sox-Pro-DSer-Asp-NH2
Energy transfer between the two fluorophores can be observed by a lack of fluorescence
emission intensity at 500 nm when the probe is excited at 360 nm. The photophysics of these
probes are a bit less straightforward because BodipyR6G can also be excited at 360 nm.
H[owever, addition of Zn2+ results in a decrease in fluorescence emission of BodipyR6G,
indicating that the Sox-Zn2+ complex is quenching the fluorophore. This quenching is reversible
upon addition of EDTA. The band at 360 nm appears to be an exception to the quenching, but
this band is due to the contribution from emission of the Sox-Zn 2+ complex (Figure 3-19). The
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]3odipy fluorophore experiences less of a quenching effect by the Sox-Zn2 + complex in MDS36
when it is placed further away from the Zn2+ -binding site. This quenching is reversible upon
addition of EDTA. Similarly to the emission ratiometric probes, these probes are sensitive to pH
in the 6.5-8.0 range, due to deprotonation of the Sox fluorophore. Unfortunately, determination
of binding constants from these data was problematic because the Bodipy fluorophore
photobleaches but the Sox-Zn2+ complex does not. Thus, a more stable fluorophore is necessary
for an excitation ratiometric probe.
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]Figure 3-19. Effect of increasing Zn2+concentrations on the fluorescence excitation spectra (547
nmn) of (a) MDS35; (b) MDS36. Spectra were obtained in 50 mM Hepes (pH 7.0), 150 mM
NaC1.
Conclusion
The non-natural amino acid Sox has been used as a modular building block in peptide
sequences that bind Zn2+ in the nanomolar range where few useful Zn2 + chemosensors currently
exist. The affinity for Zn2+ was tuned by variation of the ligands, scaffold, and turn sequence of
the peptide. This tuning generated eleven peptide sequences that bind to Zn2+ in a 1:1 complex
with affinities spanning 10 nM to 1 tM (Table 3-3). These chemosensors are individually useful
to study Zn2+ concentrations over four orders of magnitude where the chemosensor is between
10% and 90% saturated. The general trends gleaned from these binding constants have
implications for further tuning to generate new chemosensors. Compared to existing
c]hemosensors for Zn2 , the ease of tuning the Zn2+ affinity by altering the scaffold is superior.
The brightness of these Sox-based chemosensors is the same order of magnitude as Zinbo-5 and
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ZNP-1, but is 20-30-fold dimmer than those based on fluorescein and rhodamine (ZPs, ZnAFs,
RF-1).
Under conditions for biological experiments, these probes are not compromised by pH or
relevant competing metal ions. For diagnostic experiments, chemosensors from this family can
be chosen based on their Zn2+-affinity as well as their metal ion preferences. Finally, the
chemosensors can easily be used to determine Zn2+ concentration, if the peptide concentration is
unknown, when one chemosensor gives a positive response and another does not. For Zn2+
concentration determination via internal calibration with a single chemosensor, ratiometric
chemosensors have been developed. These ratiometric probes are not optimal at this time but
these examples illustrate that this modular scaffold is amenable to ratiometric sensing strategies.
Future Directions
To further develop the ratiometric Zn2+ sensing approach, the additional fluorophore
should be placed farther from the Zn2+-sensing motif so that it is only influenced by the strong
fluorescence of the Sox-Zn2+ complex and not the weak fluorescence of the unbound Sox
fluorophore. For the excitation ratiometric sensing strategy, an acceptor fluorophore with
closely-matched with yet distinct from the fluorescence properties of the Sox-Zn2+ complex and
with less susceptibility to photobleaching is necessary.
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Experimental
Synthetic Procedures
All chemicals were obtained from Aldrich and all peptide synthesis reagents were obtained from
Novabiochem, with the exception of trifluoroacetic acid (peptide synthesis grade, Perseptive
Biosystems). Glass-backed thin layer chromatography plates were obtained from EM Science
(silica gel 60 F 54, 0.25 micron thickness) and visualized by UV. Proton nuclear magnetic
resonance spectra were recorded on a Varian 300 MHz instrument. Chemical shifts are reported
relative to a value of 2.50 for DMSO.
Fmoc-Glu(cs]24) tert-butyl ester
0 
- 0
0 H
HN N 0O
Fmoc-Glu-OtBu (126 mg, 0.30 mmol), and HATU (126 mg, 0.33 mmol) were dissolved in DMF
(4.5 ml) and then diisopropylethylamine (78 t1l, 0.33 mmol) was added. The reaction was stirred
for 5 minutes and carbostyril 124 (60 mg, 0.33 mmol) was added. The reaction was followed by
TLC and found to be complete after 26 hours. The reaction mixture was diluted with ethyl
acetate (100 ml), washed with water (3 x 20 ml) and brine (2 x 15 ml). The organic layer was
dried (MgSO4 ) and the solvent was removed under reduced pressure. The mixture was
redissolved in dichloromethane with sonication and purified by flash chromatography (silica,
ethyl acetate/acetic acid, 99:1) to yield a white solid (109 mg, 68%). TLC Rf = 0.83 (silica,
dichloromethane/methanol, 4:1), Rf = 0.33 (silica, ethyl acetate/acetic acid, 99:1), Rf = 0.61
(silica, dichloromLethane/methanol, 9:1). H NMR (300 MHz, DMSO-d 6) 11.52 (s, 1 H), 10.18
(s, H), 7.88 (d, J = 7 Hz, 2 H), 7.77 (d, J = 2 H, 1 H), 7.59 (d, J = 8 Hz, 2 H), 7.40 (t, J = 7 Hz,
2 H), 7.26-7.40 (, 3 H), 6.23 (s, 1 H), 4.20-4.33 (m, 3 H), 3.94-4.00 (m, 1 H), 2.42-2.60 (m, 2
H), 2.36 (s, 3H), 2.00-2.10 (m, 1 H), 1.80-1.90 (m, H), 1.40 (s, 9 H).
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Fmnoc-Glu(cs12,4)-OH
H 0N H
'O '-lf'N-LoH
Fmoc-Glu(cs124)-OtBu (34 mg, 0.06 mmol) was dissolved in dichloromethane (3 ml) and
triisopropylsilane (290 Rl, 1.42 mmol) was added, followed by trifluoroacetic acid (3 ml). The
mirxture was stirred for 2 hours at 25°C. The solvent was removed under a stream of air. The
silane was removed by rotary evaporation three times with dichloromethane. The solid was dried
under high vacuum overnight to yield a white solid (25 mg, 83%). TLC Rf = 0.0 (silica, ethyl
acetate/acetic acid, 99:1). H NMR (300 MHz, DMSO-d 6) 11.50 (s, 1 H), 10.17 (s, 1 H), 7.87 (d,
J = 8 Hz, H), 7.67 (s, 1 H), 7.66-7.72 (m, 2 H), 7.59 (d, J = 9 Hz, 1 H), 7.39 (t, J = 7 Hz, 2 H),
7.26-7.33 (m, 3 H), 6.22 (s, 1 H), 4.19-4.31 (m, 2 H), 3.96-4.30 (m, 1 H), 2.42-2.47 (m 2 H),
2.34 (s, 1 H), 2.0'2-2.16 (m, 1 H), 1.80-1.94 (m, 1 H).
Peptide Synthesis
Peptides were synthesized using standard Fmoc amino acid protection chemistry on Fmoc-PAL-
PEG-PS resin (0.2 mmol equiv.). All Fmoc-protected amino acids were purchased from
Novabiochemn, and resin was purchased from Advanced Chem Tech. All couplings of Fmnoc-
protected amino acids to the resin were carried out with benzotriazole-1-yl-oxy-tris-pyrrolidino-
p]hosphonium hexafluorophosphate (PyBOP) and diisopropylethylamine (DIPEA) to generate the
activated ester. The resin was swelled in dichloromethane (5 min.) then DMF (5 min.) prior to
synthesis. All amino acids other than Sox and cysteine were added by the following
representative procedure: removal of the Fmoc group (20% piperidine solution in DMF, 3 x 5
min.), wash (DMF, 5 x 1 min.), coupling (Fmoc-Xaa-OH/PyBOP/DIPEA, 6:6:6, 0.15 M amino
acid in DMF, 45 min.), rinse (DMF, 2 x 1 min; DCM, 2 x 1 min.). To couple the Sox residue,
double coupling with 2 equivalents was used (Fmoc-Sox-OH/PyBOP/DIPEA, 2:2:2, 0.15 M
amino acid in DMF, 2 x 120 min.). To couple cysteine, the pentafluorophenyl ester was used
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(Fmoc-Cys(Trt)-OPfp/DIPEA, 6:6, 0.15 M amino acid in DMF, 30 min.) After addition of the
final residue, the peptide was either capped with an acetyl group (HOBt/acetic anhydride, 14:10,
in DMF/CH2Cl 2, 9:1) or imidazolyl propionic acid (PyBOP/3-imidazolyl propionic acid, 6:6, in
DMF/NMP, 1:1). Following capping, a final deblock cycle (20% piperidine in DMF, 3 x 5 min.)
vvas performed to cleave any aryl ester formed. The resin was dried under high vacuum
overnight prior to a two hour cleavage with one of the following mixtures: for peptide containing
a thiol moiety, trifluoroacetic acid/triisopropylsilane/water/ethanedithiol (94:1:2.5:2.5),
otherwise, trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5). The resulting solution was
concentrated, and the peptide precipitated by addition of cold 1:1 diethyl ether:hexanes solution.
The pellet was triturated with cold 1:1 ether:hexanes (3 x 1.5 ml for 15 mg resin), redissolved in
water, filtered and lyophilized overnight. Peptides were purified by preparatory reverse-phase
C,8 HPLC, and only fractions containing a single peak by analytical HPLC (C 8) with the correct
mass were used for analytical experiments.
Representative Procedure for Coupling BodipyR6G to Purified Peptides
Following purification, the unprotected peptide was dissolved in 0.1 M sodium bicarbonate pH
8.3 (200 dl). The amount of peptide in this solution was determined to be 8.0 mM by UV/VIS
(E355 = 8247 M- cm' in 0.1 M NaOH with 1 mM Na2EDTA). To this solution, Bodipy-R6G
(1.50 mg, 3.3 ffmol, 2 eq., Molecular Probes) dissolved in anhydrous DMSO (100 [tl) was added
and the reaction was left to shake gently for 1 hour. The mixture was purified by preparatory
HPLC (C,8; solvent A = water, 0.002% v/v TFA; solvent B = MeCN, 0.002% v/v TFA, 5 min.
7% B followed by linear gradient 7-50% B over 30 min. followed by 10 min. 50% B).
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Peptide Characterization Data
HPLC m/z (z+) m/z (z+)
Peptide Sequence Mol. Formula TR Calcd foundd
(min)
P1 Ac-Sox-Pro-DSer-Pen-Ser-Ser-NH 2 C3 5H 51N9 0 1 3 S2 23.4a 870.3 (+1) 870.3
P2 Ipa-Gly-Cys-DPro-Gly-Sox-Ser-Ser-NH 2 C38H52N120 13S2 2 5.0b 949.3 (+1) 949.5
P3 Ac-Sox-Pro-Gly-Cys-Ser-Ser-NH 2 C3 2 H4 5 N9 0 12 S2 22.3a 812.3 (+1) 812.3
P4 Ac-Cys-Pro-DSer-Sox-Ser-Ser-NH 2 C33H47N90 13S2 26.0a 842.3 (+1) 842.3
P5 Ac-Sox-Pro-DSer-Cys-Ser-Ser-NH 2 C 3 3 H4 7 N 90 1O 3 S 2 24.5a 842.3 (+1) 842.1
P6 Ipa-Gly-His-DPro-Ser-Sox-Ser-Ser-NH 2 C42H56N140 14 S 21.4b 1013.4 (+1) 1013.4
P7 Ac-Sox-Pro-DSer-pSer-Ser-Ser-NH 2 C33H48N901 7PS 21.3 a 906.3 (+1) 906.4
P8 Ac-Sox-Pro-DSer-His-Ser-Ser-NH 2 C 3 6H 49 NllO 1 3S 21.1 a 876.3 (+1) 876.3
P9 Ipa-Pro-tlPhe-Sox-Ser-Ser-NH 2 C40H50N100 11S 2 5 .4b 879.3 (+1) 879.4
PI0 Ipa-DPro-Gly-Sox-Ser-Ser-NH 2 C33 H44NI0011S 2 1.4b 789.3 (+1) 789.3
P11 Ipa-DPro-Ser-Sox-Ser-Ser-NH 2 C3 4H46Ni00 12S 19.5a 819.3 (+1) 819.3
P12 Ac-Sox-PFro-DSer-Glu-Ser-Ser-NH 2 C35 H4 9 N90 15 S 21.2 868.3 (+1) 868.3
P13 Ac-Sox-PF'ro-DSer-Asp-Ser-Ser-NH 2 C34 H47N90 15OsS 21.8a 854.3 (+1) 854.1
P14 Ipa-Pro-Gly-Sox-Ser-Ser-NH 2 C3 3 H4NI 0 11S 20.1a 789.3 (+1) 789.3
P15 Ipa-Pro-DSer-Sox-Ser-Ser-NH 2 C3 4H 46 NioO 12S 23.0a 819.3 (+1) 819.5
P16 Ipa-Gly-Asn-Sox-Ser-Ser-NH 2 C3 2H4 3 N, 10 12 S 18.9a 806.3 (+1) 806.3
PI7 Ipa-Pro-Ser-Sox-Ser-Ser-NH 2 C 3 4H 46 NI 00 1 2S 19.7a 819.3 (+1) 819.3
P18 Ipa-Pro-3Phe-Sox-Ser-Ser-NH 2 C40Hs50No100 11S 2 6.2b 879.3 (+1) 879.4
P19 Ac-Sox-Pro-DSer-Phe-Ser-Ser-NH2 C39Hs5 1N90 1 3S 24.4a 886.3 (+1) 886.3
MiDS32 Ac-Glu(cs124)-Ser-His-DPro-Gly-Sox-Arg-Arg-NH 2 C5 9H81N 21O15 S 2 6.6b 679.2(2+) 678.8
MDS33 Ipa-DPro-Gly-Sox-Ser-Ser-Glu(cs 24)-Arg-Arg-NH 2 C60H83N2,]0 16S 26.7b 462.5 (3+) 462.8
MDS34 Ac-Sox-Pro-DSer-Asp-Ser 2-Glu(cs 1 24)-Arg-Arg-NH 2 C61H86N20 020S 2 9.2b 726.3(2+) 726.2
MDS35a Gly-Ser-Sox-Pro-DSer-Glu-NH 2 C3 2 H4 5 N 90 13S 22.2a 796.3 (+1) 796.3
MDS35 BODIPYR6G-Gly-Ser-Sox-Pro-DSer-Glu-NH 2 C50H5 8 BF2N, 1 0 14S 37.9 c 1118.3 (+1) 1118.3
NIDS36a Ahx-Ser-Gly-Sox-Pro-DSer-Glu-NH 2 C58H5 6N100 14 s 23.9c 909.4 (+1) 909.4
/IDS36 BODIPYR6G-Ahx-Ser-Gly-Sox-Pro-DSer-Glu-NH 2 C56H69BF2NI2 0 15S 39.0c 1231.5 (+1) 1231.5
a 5 mi. 7% B followed by linear gradient 7-70% B over 30 min.
b 5 min. 10% B followed by linear gradient 10-50% B over 30 min.
5 mi. 7% B followed by linear gradient 7-50% B over 30 min.
d ES-MS data were collected on a PE Biosystems Mariner mass spectrometer.
Instrumentation
High-Performance Liquid Chromatography (HPLC): Waters 400 and 600 systems (solvent A =
water, 0.1% v/v TFA; solvent B = MeCN, 0.1% v/v TFA). Columns used: C,8 analytical,
Beckman Ultrasphere ODS, 5 tm, 150 x 4.6 mm; C 8 preparatory, YMC-Pack Pro, 5 tm,
250 x 20 mm.
Electrospray Mass Spectrometer: Applied Biosystems Mariner mass spectrometer
UV-Vis Spectrophotometer: Beckman DU 7500.
Fluorimeter: Fluoromax 2 from Jobin Yvon (ex = 360 nm or 400 nm, Xem = 485 nm).
74
Preparation of Buffers and Stock Solutions
All solutions were prepared polyproplyene that was rinsed with 10% HNO3 and Milli-Q
(Millipore) water. Care was taken that none of the solutions used for assays came in contact with
metal or glass during handling. Assays were performed in 50 mM Hepes (pH 7.0), 150 mM
NaCI. This buffer solution was prepared using high purity chemicals (SigmaUltra) and Milli-Q
water. The buffer was treated by passage through a column of Chelex resin (Na+ form,
Biotechnology Grade, BioRad) to remove trace metal impurities and the pH adjusted to 7.0. For
pH adjustment, I M solutions of acid and base were prepared using Milli-Q grade water using
high purity hydrochloric acid solution (Baseline, Seastar Chemicals) and sodium hydroxide
(99.998+%, Aldrich). All metal ion stock solutions were prepared from high purity chloride salts.
The concentration of zinc(II) chloride, magnesium(II) chloride, calcium(II) chloride and
cadmium(II) chloride solutions were determined by titration with a standardized solution of
EDTA (Aldrich) in the presence of an Eriochrome Black T (Aldrich).5 9 Stock solutions of other
metal chlorides were prepared by weight. Stock solutions of the peptides were prepared in Milli-
Q (Millipore) water. Based on the extinction coefficient of 5-(N,N-dimethylsulfonamido)-8-
hydroxy-2-methylquinoline (355 = 8247 M -l cm-' in 0.1 M NaOH, 1 mM Na2EDTA), peptide
stock solution concentrations were determined on a Beckman DU 7500 Spectrophotometer from
an average of the values from four separate solutions, each prepared using a different volume of
the stock solution. For MDS32, MDS33 and MDS34, there exists significant contribution at 355
nm from cs124, so 370 = 6542 M-' cm-' was used to quantify stocks. For MDS35 and MDS35,
stock solutions were prepared in methanol and stored at -80°C, and their concentrations were
determined based on the BodipyR6G chromophore ( 52 8 = 70,000 M-' cm-'). Peptide stock
solutions were stored at 4°C, with the exception of thiol-containing peptides, which were stored
at --80°C. Peptides containing cs124 or BodipyR6G were protected from light.
Extinction Coefficient and Quantum Yield Determination
Extinction coefficients and quantum yields were determined for representative peptide sequences
in 50 mM Hepes (pH 7.0), 150 mM NaCl. For these experiments, peptide stock solution
concentrations were determined by quantitative amino acid analysis (QAA). max values were
determined by plotting absorbance at 360 nm versus concentration for four separate solutions
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with peptide concentrations between 20 and 60 tM and 1 mM ZnCl2. Quantum yield values were
determined using quinine sulfate dihydrate (Fluka, puriss. for fluorescence) in 0.1 M H 2SO 4 as a
standard () = 0.55). The absorbance and integrated fluorescence intensity of a 4 FM solution of
each peptide with 200 [tM ZnCl2 was compared to a 4 RM solution of quinine sulfate with 360
nm excitation. The calculated 1 assumes that the refractive index of 0.1 M H2SO4 is identical to
that of 50 mM Hepes (pH 7.0), 150 mM NaCl. Since the error associated with QAA and (I of
quinine sulfate are at least 10%, the error in E and are no less than 10%.
JVD Determination
Fluorescence titrations were performed on a Fluoromax 2 from Jobin Yvon, with kex = 368 nm,
slit widths = 5 n. The titrations were carried out in triplicate by adding aliquots of ZnCl2 to a
peptide solution of known concentration. Dissociation constants were determined by a global
non-linear least-squares fit of the data with the program Specfit/32,4 8 with the exception of
MDS32, MDS33 and MDS34. The dissociation constants of these peptides were determined
from a ratio of emission intensities at 500/369 nm. The concentration of the peptide-Zn2 +
complex was determined from the fraction of the maximum fluorescence ratio attained at each
data point:
[pep - Zn2+]= f [pep],o,ai
ftotal
Then the [Zn]free is determined by:
[Zn 2+ ]f = [Zn2 +] - [pep - Zn 2+]
Then a plot of the emission ratio versus [Zn2+]f is made and fit by the following equation using
KaleidaGraph (Origins, v3.6) software:
Rmax [Zn2+]f
R=
[Zn2+]f + KD
InflQuence ofpH
The following buffers were prepared containing 150 mM NaCl, passed through a Chelex column
and adjusted to the desired pH with ultrapure acid and base solutions: 50 mM Mes (pH 5.5 and
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6.0, Fluka Biochemika), 50 mM Hepes (pH 7.0 and 8.1, SigmaUltra), 50 mM Ches (pH 9.1 and
10.1, Fluka Biochemika). For readings below pH 5.5, Chelex-treated solutions of 150 mM NaCl
adjusted to pH 4 and 4.7 were prepared and the pH of the solution was recorded after the
fluorescence measurement. Fluorescence spectra of peptides (1 [tM if KDZ, < 200 nM or 10 [tM
if KD zn > 200 nM) were recorded without and with 1 equiv. Zn2 +. The emission intensity at 500
nm was extracted and data were normalized to an average of the maximum fluorescence
readings. To determine the pKa for each chemosensor, the data were fit to the following equation:
F= Fmax
1 + 1 0 (pKa -pH)*h
The Hill Coefficient (h) was fixed to a 1 binding site model (h = 1) for all peptides except P6, for
which a 2-binding site model (h = 2) was used.
Metal Ion Competition
The fluorescence response of the peptides (1 tM if KD2zn < 200 nM or 10 [tM if KD.Zn > 200 nM)
and peptide-Zn 2 + complexes to 5 mM K+, 1 mM Mg 2+ , 1 mM Ca2+ and 1 equivalent Mn2+, Co2+,
-,~~~~~~~~~~  :MCa+ an. euvlet+
(-U2+ i2+ 3 d 2+Cu , Ni , Fe3 +, and Cd2 was investigated in 50 mM Hepes (pH 7.0), 150 mM NaCl. The
emission intensity at 500 nm was extracted and compared to the value of fluorescence intensity
at 500 nm for the Zn2+ complex.
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Chapter 4:
Versatile and Sensitive Fluorescent Chemosensors of Protein Kinase Activity:
Design and Optimization
A portion of the work described in this chapter has been published in:
Shults, M. D.; Iperiali, B. Versatile fluorescence probes of protein kinase activity. J. Am.
Chem. Soc. 2003, 125, 14248-14249.
A portion of the introduction has been submitted for publication.
Rothman, D. R.; Shults, M. D.; Imperiali, B. Chemical approaches for investigating
phosphorylation in signal transduction networks, submitted.
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Introduction
Within cellular signaling, protein phosphorylation is the post-translational modification
most frequently used to regulate protein activity.1-3 Phosphorylation is tightly regulated by the
actions of protein kinase and protein phosphatases, which perform phosphorylation and
dephosphorylation reactions, respectively.4 Protein kinases are the most abundant enzyme class,
encoded for by 1 out of every 50 human genes.2 These enzymes catalyze the transfer of the y-
phosphoryl from ATP to a free hydroxyl group in a peptide or protein substrate (Figure 4-1).
This hydroxyl group is the side chain of a serine, threonine or tyrosine amino acid in eukaryotes.
The activity of each kinase is controlled by its phosphorylation state, subcellular localization,
and binding interactions within protein complexes.' Several serious human diseases, including
many cancers5, result from aberrant phosphorylation. For this reason, protein kinase regulation
constitutes a crucial area for therapeutic development. 6 ' 7
Vh2 ~~~~~~~NHs~
0 0 0 N N
HO O OH  0 ?-0
Kinase, Mg2+
Figure 4-1. The reaction catalyzed by protein kinases.
Detecting Protein Kinase Activity
Tools to study protein kinases are invaluable for investigating the details of signal
transduction. Chemosensors for kinase activity would provide a means to screen inhibitor
candidates for therapeutics and chemical biology. In addition, these assays could be used to
determine competitive substrates to identify cellular phosphorylation motifs and improved kinase
substrates. Further, chemosensors for monitoring kinase activities in cell extracts and in living
cells will be useful for unraveling complex signaling cascades and for understanding the roles of
individual kinases in human disease.
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The most common assay for protein kinase activity is a radioactivity-based assay where
phosphoryl transfer from [- 32P]ATP to a peptide or protein substrate is quantified by
scintillation counting. Whereas 32 P-based assays can be general and sensitive, they require
special handling and are not practical for high-throughput applications. In addition, sub-
physiological ATP concentrations are required (10-50 M) to avoid overdiluting the [y-32P]ATP.
Such "ATP-starved" conditions diminish the absolute activity of most kinases, which limits the
resolution and sensitivity of radioactivity-based kinase assays. On the other hand, probes based
on fluorescence are ideal due to their sensitivity and compatibility with standard instrumentation.
To date, a variety of discontinuous and continuous fluorescence assays for protein kinase activity
have been reported. The next sections will highlight existing technologies in both categories and
discuss the merits and drawbacks of each.
Discontinuous Fluorescence Kinase Activity Assays
Discontinuous assays require that an aliquot of the reaction mixture be removed prior to
analysis of the reaction product. These assays are typically broadly applicable to any kinase of
interest. A multitude of diverse sensing strategies exist, so only the most widely-used and
creative assays will be discussed here, including assays that 1) utilize specific detection of the
incipient phosphate via a phospho-specific antibody or a metal chelate, 2) take advantage of
differential protease sensitivity upon phosphorylation, 3) quantify product formation following
separation from the substrate, and 4) monitor ATP or ADP concentrations. These assays use a
variety of methods for fluorescent readout: fluorescence intensity, a ratio of fluorescence
intensities, fluore scence polarization, and even luminescence.
A fluorescence intensity signal can be generated by a phospho-specific antibody when it
is attached to a Eu3+-chelate8 '9 or fluorescence bead'l° (Figure 4-2a). Alternatively, a phospho-
specific antibody can be used in a fluorescent enzyme-linked immunosorbent assay (ELISA)-
based approach.' 1 12 ELISA-based assays utilize a secondary antibody (that recognizes the
phospho-specific antibody) which is coupled to an enzyme which performs a fluorogenic
reaction. This coupled enzyme approach in particular allows for signal amplification, which
improves sensitivity. However, these aforementioned assays require separation of unbound
antibody from the reaction mixture.
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Homogeneous assays are desirable due to fewer processing steps and can be achieved
with labeled phospho-specific antibodies when the kinase substrate is also labeled. Following
phosphorylation when the antibody and substrate are bound, energy transfer between the two
labels is achieved. These labels can be two fluorophores that undergo fluorescence resonance
energy transfer (FRET) 3 or a singlet oxygen generator coupled to an acceptor whose
fluorescence is modulated by singlet oxygen14 (Figure 4-2b).
An alternative approach for a homogeneous assay is the use of fluorescence polarization
(EP). In this technique, the tumbling rate of a fluorophore is measured; a fluorophore attached to
a large construct tumbles more slowly than a fluorophore attached to a small construct. Thus,
when a fluorescently-labeled phosphopeptide binds to a large reagent such as a phospho-specific
antibody, the change in FP can be measured. Typically, these assays are performed as
competition immrunoassays such that a fluorescently-labeled tracer phosphopeptide is displaced
by the kinase reaction product to afford a larger signal change (Figure 4-2c). 15 1 6 A further
extension of this design is to displace a tracer that complements an enzyme fragment to restore
activity (Figure 4-2d). 17
Because the use of phospho-specific antibodies is expensive and can be poor for
detecting serine/threonine phosphorylation, synthetic receptors based on metal chelates have
been developed for phosphoamino acid recognition (Figure 4-2e). The phosphate group is a well-
known chelating moiety, with a preference for oxophilic metal ions, such as Ca2+, Mg2+, Zn2+,
Fe3 and Eu3 +. Synthetic metal chelates have been used to detect phosphopeptides via both
fluorescence intensity changes'8" '9 and fluorescence polarization.20 2 2 Some of these approaches
require separation of the phosphorylated product from the reaction mixture. Further, the assays
that operate in a homogeneous format are restricted in both ATP concentration (to prevent ATP-
binding to the receptor) and in additional chelate concentrations (to prevent the metal ion from
being stripped from the receptor).
As an alternative to specific recognition of the incipient phosphate, fluorescent
discrimination of substrate peptide and product phosphopeptide can be accomplished when these
peptides are differentially processed by a secondary enzyme. These approaches were inspired by
fluorogenic protease assays, and designed such that phosphorylation disrupts recognition by a
protease. Proteases cleave the substrate peptide preferentially to either liberate latent
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fluorophore23 or to disrupt FRET between fluorophores on opposite sides of the peptide
substrate2 4 (Figure 4-2f). In these examples, the product phosphopeptide is nonfluorescent or
exhibits FRET, respectively.
Phosphorylation also modulates the electrophoretic mobility of a substrate. Thus,
fluorescently-labeled peptide substrates can be separated from the phosphorylated products by
gel25 or capillary26' 27 electrophoresis to quantify product formation (Figure 4-2g). In these
examples, separation is time consuming and low throughput.
Finally, ATP consumption by the kinase can be monitored. Remaining ATP can be
detected via a luminescence reaction28 or newly-formed ADP can be detected with a specific
aptamer-based sensor29 (Figure 4-2h). These sensors can be problematic for kinases with ATPase
activity.
The range of discontinuous approaches, many of which are commercially available, has
afforded assays for nearly every kinase target. Assays can be chosen based on the desired
reaction conditions, instrumentation, and expertise. These assays can be quite sensitive due to
signal amplification, processing steps to reduce background fluorescence, or unlimited size and
complexity of reagents. In addition, some of the assays can be adapted for use with protein
substrates for the target kinase, which can be helpful if the target kinase does not efficiently
phosphorylate peptides or when a good peptide substrate is not known. However, most of the
sensing approaches are not compatible with physiological concentrations of ATP and are not
selective for the target kinase; thus endogenous kinase activities can only be detected by first
immunopurifying the kinase from a cell lysates, with the notable exception of single-cell assays
via capillary electrophoresis.26 27 Further, the processing steps that increase sensitivity of these
assays are time consuming, low-throughput and do not allow kinetic, real-time information for
each measurement.
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Figure 4-2. Examples of discontinuous assays for protein kinase activity. (a) Labeled antibodies
are utilized to detect phosphoproduct formation. (b) Energy transfer between labels on substrate
and antibody in proximity reveals phosphoproduct formation. 3 4 (c) Phosphoproduct disrupts
binding of fluorescently-labeled tracer peptide to antibody, which is measured by a change in
fluorescence polarization. '"6 (d) Phosphoproduct liberates a peptide fragment that complements
an inactive enzyme; then a fluorogenic reaction catalyzed by the active enzyme reports product
formation.'7 (e) A metal chelate recognizes phosphoproduct via either fluorescence intensity
changes or fluorescence polarization changes. (f) Phosphorylation renders a peptide resistant to
protease digestion as measured by FRET;24 (g) Reaction progress is quantified by electrophoretic
separation. (h) Conversion of ATP to ADP can be quantified by specific reagents for either
molecule. 2 8 ,2 9
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Continuous Fluorescence Kinase Activity Assays
On the other hand, continuous assays allow the reaction to be easily monitored while it is
proceeding without additional experimental effort. Systems designed to exhibit fluorescence
changes upon phosphorylation allow for a continuous readout in real time and enable facile
kinetic analyses and in vivo imaging. In addition, these assays are typically compatible with cell
lysates, living cells, physiological ATP concentrations, and high-throughput analysis. These
strategies all generate a change in fluorescence upon phosphorylation either via dual fluorophore
(by FRET) or single fluorophore approaches. Both protein- and peptide-based chemosensors
have been designed (Figure 4-3). These approaches will be discussed below, and their properties
are demonstrated in Table 4-1.
Continuous Protein-Based Kinase Activity Probes
FRET-based probes include donor and acceptor fluorophores whose relative distance is
modulated upon probe phosphorylation, thereby altering the efficiency of energy transfer and
thus the fluorescence signal. Protein kinase assays based upon FRET most commonly include
appropriate pairs of donor and acceptor fluorophores that are derived from the Aequorea victoria
fluorescent proteins (AFPs), although small-molecule fluorophores are also used (Figure 4-3a-c).
Chemosensors based on both increases and decreases in FRET efficiency have been reported and
the magnitude of the fluorescence changes significantly affects sensitivity and utility.
Endogenous proteins exhibiting a phosphorylation-dependent conformational change have been
employed to develop fluorescence-based chemosensors of kinase activity (Figure 4-3a,b).3°0 -33 A
more general approach involves a modular design, which includes a peptide substrate for a target
kinase, a linker region, and a phosphopeptide recognition domain such as a phosphotyrosine-
binding SH2 domain (Figure 4-3C).34-40 Upon phosphorylation, the phosphopeptide binds to its
cognate recognition domain, which alters the distance between the flanking AFPs to afford a
fluorescence response. These modular probes can in principle be used for any kinase by
modifying the substrate sequence and corresponding binding domain.
An alternative strategy involves a single-fluorophore protein construct that has been
developed using a circularly-permuted AFP (cpAFP). 4" cpAFPs are created by linking the N- and
C-termini of an AFP and making a disconnection at an alternate location in the sequence.
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Substrate and phosphopeptide recognition modules are then appended to the new N- and C-
termini. Sensing is achieved when phosphorylation affords intramolecular binding, which
modifies the conformation of the AFP, affording a fluorescence change (Figure 4-3d). In
principle, several different kinase activities can be monitored simultaneously with this approach
due to the variety of AFPs with different spectral properties that are available. However, only
one of the three cpAFPs attempted to date was found to be useful. Additionally, this probe
exhibited a decrease in fluorescence intensity upon substrate peptide phosphorylation, which is
less desirable than an increase in signal, since the loss of signal could be mistaken for
photobleaching.
Careful characterization of the properties of the protein-based probes, such as
phosphorylation stoichiometry and fluorescence changes upon complete phosphorylation, can be
challenging. It has been noted that some probes respond even in the absence of a
phosphorylatable residue in the substrate sequence. The size of AFPs (often significantly larger
than other sensor domains) and their ability to be phosphorylated may also complicate
predictable changes in FRET, signal characterization, and recognition. Finally, the small
fluorescence changes limit the sensitivity of these probes.
Continuous Peptide-Based Kinase Activity Probes
Synthetic environment-sensitive and chelation-sensitive fluorophores have been
successfully incorporated into peptide-based probes for detecting kinase activities. Generally, a
sequence of amino acids recognized by the target kinase is incorporated into a substrate peptide
next to the residue to be phosphorylated, while the fluorophore is placed on the other side with
an optional linker.
Environment-sensitive fluorophores (also called solvatochromic dyes) exhibit a change in
their fluorescence properties (both intensity and maximum emission wavelength) due to the
polarity of the immediate environment. Introduction of a phosphoryl group in proximity to the
fluorophore then alters the local polarity and results in a fluorescence change (Figure 4-3e).
Many researchers have attached environment-sensitive fluorophores to amino acid side chains
one to five residues from the phosphorylation site, but this distance usually yields low
sensitivity.4 2-45 However, attachment of the solvatochromic dye directly to the peptide backbone
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on the N-terminus of the residue to be phosphorylated has provided a strikingly sensitive probe
for PKC when the solvatochromic 7-nitrobenz-2-oxa-1,3-diazole (NBD) is used.46
Chelation-sensitive fluorophores utilize biologically-available metal ions, such as Ca2+ or
Mg2+ , to aid in sensing phosphorylation. A chelation-enhanced fluorescence (CHEF)
chemosensing strategy has exploited elevated Ca2+ levels that activate PKC with appropriate
positioning of a Ca2+ indicator fluorophore for effective metal-binding following phosphorylation
(Figure 4-3f).4 7 The alternative use of Mg 2+ in this case would enable a general approach since
Mg2+ is present in low millimolar concentrations in the cytoplasm. However, an attempt to
mnodify the Ca2+-based probes for Mg2+-chelation to sense PKA activity was unsuccessful.4 8
These existing peptide-based approaches have not yet been proven general for application
to additional kinases. It is likely that many kinases are more sensitive to large fluorophores
adjacent to the phosphorylation site.
Table 4-1. Properties of individual continuous fluorescent sensors of protein kinase activity
Sensor Target Mechanism kex (nm) ken(nm) Signal Ref.
Kinase changea
Protein-based
ART PKA FRET 380 (BGFP) 450/510 (RGFP) 22% $ 30
Picchu Abl/EGFR FRET 433 (CFP) 475/527 (YFP) 60% I 31
KCP-1 PKC FRET 405 (GFP2) 530/500 (EYFP) 50% 1 33
Rh-CrkA-Fl Abl FRET 490 580/520 20% A 32
(fluorescein) (rhodamine)
Umezawa
Phocus IR FRET 440 (CFP) 535/480 (YFP) 15-20% t 34
Aktus Akt FRET 10% t 35
Cyan sinphos IR AFP conform- 10% 41
ational change
Tsien
AKAR PKA FRET 440 (ECFP) 535/480 25-50% I 37
(Citrine/EYFP)
CrkII-based reporter Abl FRET 15-30% t 38
Src-reporter Src FRET 25-30% 38
EGFR-reporter EGFR FRET 25-35% t 38
CKAR PKC FRET 440 (mCFP) 535/480 (mYFP) 15-20% 39
BKAR Akt FRET 4 10-25% ~ 40
Peptide-based
Lawrence
NBD-based PKC Environment- 520 540 2.5-fold 1 47
sensitive
Ca:--based PKC CHEF 490 525 3.6-fold t 46
aFluorescence increase for protein-based probes reported as range visualized by maximally stimulating target kinase in vivo.
Fluorescence increase for peptide-based probes reported as fluorescence difference between phosphorylated peptide and substrate
peptide b = fluorescence increase: = fluorescence decrease
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Figure 4-3. Fluorescence response generation for continuous assays of protein kinase activity.
(a,b) A protein that undergoes a conformational change upon phosphorylation which alters the
distance between (a) AFPs appended to the N- and C-terminus,30 31 33 or (b) Two small molecule
fiuorophores.3 2 (c) A modular sensor with two AFPs flanking a phosphorylation recognition
domain, linker and substrate sequence for the target kinase. Intramolecular binding of the
phosphoamino acid to the recognition domain alters the distance between the two AFPs.34 37' 38 (d)
A phosphorylation recognition domain and substrate sequence for the target kinase appended at
the newly-generated N- and C-termini of cpAFP, such that the conformation of the AFP is
altered upon phosphorylation. 4 (e) Phosphorylation alters the local environment of an adjacent
fluorophore and changes its fluorescence intensity.47 (f) Appropriate placement of chelation-
sensitive fluorophores relative to the phosphorylation site on a peptide substrate results in both
metal ion binding and fluorescence increase upon phosphorylation. 4 6
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ideal Characteristics for a Chemosensor of Kinase Activity
Since the ultimate goal is to understand kinases signaling in the complex environment of
the cell, chemosensors with substantial improvements over existing approaches are highly
desirable. In addition to the characteristics of an ideal chemosensor discussed in Chapter 1,
]kinase chemosensors should measure the catalytic competence of the target kinase in a complex
environment consisting of phosphate-containing species and related kinases. In addition, the
strategy should be broadly applicable to any kinase but not involve radioactivity, specialized
antibodies or multiple handling steps. Further, probe design should afford a fluorescence increase
upon phosphorylation without the need for separating substrate and product for analysis and to
allow for a continuous readout in real time. The magnitude of this increase should be large for
high sensitivity. Finally, the probe should exhibit good reactivity with the target kinase at
physiological substrate concentrations (low micromolar) to minimize reactivity with off-target
kinases and perturbation of cellular signaling process.
This chapter will detail a versatile phosphorylation chemosensing strategy that is general
for detection of serine, threonine and tyrosine phosphorylation. These probes utilize a CHEF
mechanism with the nonnatural amino acid Sox and physiological Mg2+ concentrations. Each
chemosensor comprises a small sensing module appended either the C- or N-terminal to the
serine, threonine or tyrosine of an optimized peptide substrate for the target kinase. The sensing
module contains a 2-3 residue 3-turn element to preorganize Mg2+-binding between the Sox
fluorophore and the incipient phosphate. In addition, the Mg 2+-binding affinity of the product
phosphopeptide is shown to be much greater than the substrate peptide, which results in a large
fluorescence increase upon phosphorylation. Optimization of the 3-turn sequence to improve the
fluorescence increase and reactivity towards the target kinase is reported. Details of the
chemosensing mechanism will be presented, along with recommendations for the generation of
addition chemosensors. Finally, preliminary experiments towards high-throughput and biological
applications will be introduced.
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Results:
Substrate Design and Synthesis
Chemosensor design begins from an optimized peptide substrate from the literature. The
important residues for kinase recognition are preserved on one side of the residue to be
phosphorylated. The sensing module is positioned on the other side of the serine, threonine, or
tyrosine from this optimized peptide substrate, and includes the Sox amino acid and a -turn
sequence (Figure 4-4). A two-residue 13-turn sequence is used for chemosensors of the
serine/threonine kinase activity, while an additional residue is necessary in the O-turn for sensing
tyrosine phosphorylation to allow for chelation between Sox and the large phosphotyrosine side
chain.
Several important kinases were targeted for development of chemosensors: protein kinase
'C (PKC),4 9 cAMP-dependent protein kinase (PKA),5°' 51 Akt,52 '53 mitogen-activated protein
kinase-activated protein kinase-2 (MK2),54'55 Pim2,56 and Abl57 . Initially, peptide substrates were
synthesized for PKC, PKA and Abl (PKC-S 1, PKC-S2, PKA-S 1, Abl-S 1; Table 4-2) to evaluate
the scope of this design strategy. Then, the 13-turn sequences of the PKC and PKA probes were
optimized for signal and reactivity. This knowledge was applied to generate additional kinase
chemosensors for the serine/threonine kinases Pim2, Akt, and MK2.
Substrate peptides (e.g. PKC-S 1) and corresponding product phosphopeptides (e.g. PKC-
P1) were synthesized by Fmoc SPPS. Standard protocols were used, with two special
considerations for these chemosensing peptides. First, peptides with a C-terminal sensing module
should contain a C-terminal glycine residue to suppress diketopiperazine formation during
synthesis. Also, an additional deblock cycle must be performed following acetyl capping of all
peptides to cleave any Sox aryl ester formed. All peptides are purified to >95% by HPLC and
identified by electrospray mass spectrometry.
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Figure 4-4. Design of fluorescent chemosensors of protein kinase activity. The chemosensor
peptide contains three important design modules: critical kinase specificity determinants, the
chelation-enhanced fluorophore (CHEF) Sox, and a 1-turn to preorganize Mg2 -binding between
Sox and the incipient phosphate. Phosphorylation increases the affinity of the peptide for Mg2 +
and the fluorescent signal is generated by chelation of Mg2+. The kinase recognition elements
may be placed on either (a) the C-terminus or (b) the N-terminus of the serine, threonine or
tyrosine residue to be phosphorylated.
Fluorescence Properties
The absorption and fluorescence properties of the Mg2+-Sox complex were introduced in
Chapter 2. To summarize, the absorbance band at 360 nm gives rise to a fluorescence emission at
485 nm.
The max and quantum yield ()) values for the Sox-Mg2 + complex were determined with
the peptide MK2-P1. The UV-Vis spectra of the Mg2+ and Zn2+ complexes of MK2-P1 are
identical, thus the max for the Mg2+ complex is identical to that reported for Zn2+-chemosensing
peptides (6200 M-1 cm -', Chapter 3). The quantum yield of the Mg2+ complex is 0.34, which is
twice that of the Zn2+ complex. The quantum yield for the unbound form ( = 0.004) was
reported in Chapter 3.
Chemosensing Mechanism
These chemosensors exhibit a change in fluorescence upon phosphorylation due to an
order of magnidue difference in Mg2+ affinities between the substrate and product peptides, as
illustrated by the Mg2+-titration curves of PKC-S2 and PKC-P2 (Figure 4-Sa). Importantly, the
magnitude of the fluorescence increase depends on the concentration of Mg2+, and an increase is
observed over a wide range of Mg2+ concentrations. Thus, a change in fluorescence upon
phosphorylation will occur with a variety reaction conditions. Notably, a substantial fluorescence
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increase is observed for both in vitro kinase reaction conditions (10 mM, Figure 6b) and free
cytoplasmic Mg2+ (0.5 - 5 mM). 58
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Figure 4-5. Origin of the difference in fluorescence intensity between substrate peptide and
product phosphopeptide. (a) Mg2 + titration curves for PKC-P2 () and PKC-S2 () in 20 mM
Hepes (pH 7.4), 150 mM NaCI. (b) Fluorescence spectra of PKC-P2 (-) and PKC-S2 (--) with 10
mrnM MgC12 in 20 mM Hepes (pH 7.4), 150 mM NaC1.
The magnitude of the fluorescence increase depends most strongly on the Mg2+
concentration, but it is also influenced by temperature, instrumentation, high concentrations of
other metal ions, and species that chelate Mg2+. The ability to chemically synthesize the product
phosphopeptide allows empirical determination of the fluorescence increase for facile adaptation
of the assay to a variety of assay conditions and Mg2+ concentrations.
Magnitude of the Fluorescence Increase
Fluorescence increase values for first generation PKC, PKA and Abl substrates (PKC-S 1,
PKC-S3, PKA-S1, Abl-S1; Table 4-2) illustrate that the chemosensing strategy detects serine,
threonine and tyrosine phosphorylation with excellent sensitivity. In addition, the design is
compatible with both a C- or N-terminal kinase recognition motif. These first-generation
substrates utilized a Pro-Gly or Gly-Pro -turn. However, certain kinases have strong
requirements for residues in the -1 and +1 positions relative to the phosphorylation site. For
94
example, PKA-S 1 is a poor substrate for PKA because the glycine residue replaces a preferred
l[eucine residue at the -1 position (KM - 40 FM, Vma. - 0.3 Rimol/min/mg). Thus, reactivity must
be taken into consideration when designing a substrate. To improve and generalize the approach,
we evaluated probe sensitivity with an additional recognition element in the -turn sequence.
Inclusion of a leucine residue in the 3-turn sequence to create the PKA chemosensor
PKA-S2 resulted in both a larger fluorescence increase and improved reactivity with PKA. This
chemosensor exhibited maximum fluorescence emission at 474 nm instead of at 485 nm, which
indicates formation of mixed complexes with Mg2+ (stoichiometry evaluated as in Chapter 3).
Mlixed complex formation is not problematic for chemosensing when the peptide concentration is
significantly below the Mg2+ concentration, since the ratio of complexes remains constant when
the metal ion concentration is constant. However, 1:1 complexes should afford a larger
fluorescence increase.
With one residue in the 3-turn fixed for kinase recognition, the stereochemistry at proline
was varied in an attempt to obtain a larger fluorescence increase. Both PKC and PKA substrates
were synthesized with D-proline in the turn sequence (PKC-S4 and PKA-S3). For PKC
chemosensors, which contain an N-terminal sensing module and glycine in the -1 position, Pro
gave the largest fluorescence increase. On the other hand, for PKA chemosensors, which contain
a C-terminal sensing module and leucine in the +1 position, D-Pro gives the largest fluorescence
increase. In addition, the product phosphopeptide PKA-P3 exhibited maximum fluorescence
intensity at 485 nm, indicating only 1:1 complex formation.
In order to evaluate the application of these design principles to other kinase substrates,
substrates for Pim2, Akt, and MK2 were synthesized. The trend observed for the best PKA
chemosensor was confirmed, because the largest fluorescence increase for a Pim2 chemosensor
was obtained with D-Pro in the C-terminal sensing module. When the chemosensors Akt-S 1 and
MK2-S 1 were designed utilizing this optimized Xaa-D-Pro 3-turn sequence, they exhibited the
most substantial fluorescence increases to date.
The best 3-turn sequence for serine phosphorylation was also optimal for threonine
phosphorylation with a C-terminal sensing module. This was determined by comparing the
fluorescence spectra of Akt-P2 and a similar phosphopeptide where a proline residue was used in
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the -turn (Ac-ARKRERAYpTF-Pro-Sox-Gly-NH2 , Akt-P3). Not only did Akt-P3 exhibit less
fluorescence at 485 nm, but it also formed mixed complexes ( =emmax  474 nm).
To improve the affinity of the product phosphopeptide for magnesium, an additional
chelating aspartate residue was incorporated in the sensing module, either one (PKC-S5) or two
'(PKC-S6) residues from Sox. This additional chelating moiety does increase the fluorescence
intensity of the product phosphopeptide, but it also increases the Mg2+ affinity of the substrate
peptide. As such, it did not generate a more substantial fluorescence increase over the closely-
related peptide PKC-S4. Notably, though PKC-S5 and PKC-S6 do not have the largest
fluorescence increase of all PKC chemosensors, the useful fluorescence increase suggests that
the Sox-based chemosensing approach will be compatible with acidic residues.
Table 4-2. Peptide substrate sequences and fluorescence increases with 10 mM Mg2 +
s r Residue to be Location Sequencea FoldSubstrate of sensing Fluorescencephosphorylated phosphorylate module Increaseb
PKC-S Ser N Ac-Sox-Pro-GSFRRR-NH 2 5.7
PKC-S4 Ser N Ac-Sox-DPro-GSFRRR-NH2 3.0
PKC-S2 Thr N Ac-Sox-Pro-GTFRRR-NH 2 3.8
PKC-S5 Ser N Ac-Asp-Sox-DPro-GSFRRR-NH 2 3.0
PKC-S6 Ser N Ac-Asp-Gly-Sox-DPro-GSFRRR-NH 2 2.7
PKA-S Ser C Ac-LRRAS-Gly-Pro-Sox-NH 2 2.5
PKA-S2 Ser C Ac-LRRASL-Pro-Sox-NH 2 4.0
PKA-S3 Ser C Ac-LRRASL-DPro-Sox-Gly-NH 2 5.5
Abl-S Tyr N Ac-Sox-Pro-Gly-IYAAPFAKKK-NH 2 3.6
Pim2-S 1 Ser C Ac-ARKRRRHPSG-DPro-Sox-Gly-NH 2 3.7
Pim2-S2 Ser C Ac-ARKRRRHPSG-Pro-Sox-Gly-NH 2 3.2
Akt-SI Ser C Ac-ARKRERAYSF-DPro-Sox-Gly-NH 2 10
Akt-S2 Thr C Ac-ARKRERAYTF-DPro-Sox-Gly-NH2 6.0
MK2-S 1 Ser C Ac-AHLQRQLSI-DPro-Sox-Gly-NH 2 12
a The portion of the peptide sequence obtained from the literature is indicated by one-letter amino acid
codes, with the residue to be phosphorylated in bold. b Assay conditions: 20 mM Hepes (pH 7.4), 10 mM
MgC12, 0.1 mM EGTA, Xex = 360 nm, 3 nm excitation and emission slit widths. Fluorescence increase is
determined by dividing the fluorescence of the phosphopeptide (10 tM) at 485 nm by the fluorescence
of the substrate peptide (10 tM) at 485 nm.
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Origin of the Large Fluorescence Increase
To assess the relationship between phosphopeptide affinity for Mg2+ and fluorescence
increase, the Mg2+ dissociation constants of a few peptides spanning the range of fluorescence
increases were determined. Binding affinities were assessed by Mg2+ titrations (Figure 4-6) and
fit to a 1:1 binding model utilizing Specfit/3259; these peptides fulfill the criteria for 1:1
complexes from Chapter 3. Inspection of the dissociation constants for MK2-P1, PKC-P1, and
Akt-P1 (Table 4-3), allows the conclusion that a product phosphopeptide with higher affinity for
Mg2+ results in a more sensitive probe. To maintain constant ionic strength near the KD, 150 mM
NaCI was included in the buffer. Since the KD depends on the ionic strength60 and addition of
Mg2+ rapidly increases the ionic strength, inclusion of 150 mM NaCl ensures that accurate
comparison between peptides are made. The dissociation constants of the substrate peptides are
challenging to measure, because it is difficult to maintain constant ionic strength for KD values
greater than 100 mM and thus to compare binding affinities. It is likely that the Sox residue itself
is the only contributor to the binding of the substrate peptides to Mg 2 + in the absence of an
additional chelating residue.
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Figure 4-6. Mg2+ titration curves for MK2-P1 (o), Akt-Pl () and PKC-P1 (). Fluorescence
intensities at 485 nm were extracted from spectra obtained in 20 mM Hepes (pH 7.4), 150 mM
NaCl. Fits were obtained by Specfit/32.59
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Table 4-3. Apparent dissociation constants for select phosphopeptide-Mg2 + complexes
Peptide Apparent KD (mM)a Fluorescence increaseb
PKC-P1 12 +2 5.7
Akt-Pl 6.8 0.4 10
MK2-P1 1.8 + 0.3 12
Values reported are an average ±+ std dev for triplicate titrations, each performed by adding
aliquots of a standardized MgCl, solution to peptide (1 tM) in 20 mM Hepes (pH 7.4), 150
mM NaCl. Dissociation constants were obtained from experimental data with the program
Specfit/32.5 9
' Fluorescence increase is determined by dividing the fluorescence of the phosphopeptide (10
AM) at 485 nrn by the fluorescence of the substrate peptide fluorescence (10 tM) at 485 nm in
20 mM Hepes (pH 7.4), 10 mM MgCl 2, 0.1 mM EGTA.
Fluorescence Increase Quantifies Product Formation
When a substrate peptide is incubated with a target kinase, an increase in fluorescence
over time is observed as expected (Figure 4-7a). The magnitude of the increase was confirmed to
correspond with the values reported in Table 4-2 for complete phosphorylation of PKC-S1 and
Abl-S 1 with their respective kinases.
The fluorescence intensity at any intermediate time is the sum of the contributions from
both substrate ad product peptides. At time t, the fluorescence intensity () can be determined
from:
[(t)= fSS(t)+ fpP(t) (1)
where S(t) is the amount of substrate (M), P(t) is the amount of product (M), fs is the
fluorescence intensity per tM of substrate, and fp is fluorescence intensity per [tM of product.
The constants f, and f are determined empirically under the desired assay conditions by
obtaining the slope of fluorescence intensity versus concentration of P and S, respectively. It is
imperative that the fluorescence signal for each substrate peptide and product phosphopeptide is
linear with respect to concentration. These constants depend on the concentration of Mg 2+ and
the Mg 2 + affinity of each peptide. Because the concentration of peptide used is significantly
lower than the M4g2+ dissociation constant, the fraction of peptide bound to Mg2+ is constant
regardless of peptide concentration. However, measured fluorescence is nonlinear when the
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absorbance is significantly greater than 0.05.61 In practice, if the range of peptide concentrations
investigated includes concentrations greater than 30 tM, 400 nm should be used as the excitation
wavelength for the entire experiment.
The amount of substrate and product at time t are related by:
S(t) + P(t) = S (2)
where So is the initial amount of substrate. The amount of product formed at time t is determined
by substituting equation (2) into (1):
P(t) = I(t)- fs( (3)
fP - A(
In addition to confirming that the fluorescence intensity upon 100% turnover matched
that for synthetic phosphopeptide, the ability of equation (3) to predict the extent of product
formation at time t by fluorescence measurements was investigated. Subjection of aliquots of the
reaction mixture to HPLC (Figure 5-7b) and electrospray mass spectrometry analysis (Figure 4-
7c) confirmed that product turnover can be quantified by fluorescence (Table 4-4).
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Figure 4-7. Confirmation of product formation and calculation of kinetic parameters from the
continuous fluorescence response of the peptide chemosensor during a kinase reaction. (a)
Fluorescence intensity over the reaction time-course of PKC-S1 (10 [tM) with PKC ; (b) HPLC
of aliquot from reaction mixture at 700 s; (c) ESI-MS spectra of each peak from the HPLC plot
in (b); (d) A representative Hanes plot of initial slopes data for this substrate where one point
was obtained from the data in (a).
Table 4-4. HPLC and ESI- MS verification and quantification of product formation observed by
fluorescence.
Kinase Initial Reaction Substrate Product
Substrate [Substrate] Time HPLC m/z (z+) HPLC m/z (z+) Concentration (M)
(tM) TR Found Calcd TR Found Calcd Fluor- HPLCd
(min) (min) escence c 228 nm 280 nm
PKA-S2 46 tM 300 s 26.2a 587.8 (2+) 587.8 25.Oa 627.8 (2+) 627.8 1.6 1.3 1.9
PKA-S2 7.8 tM 700 s 25.6a 587.8 (2+) 587.8 24.4a 627.8 (2+) 627.8 3.4 3.3 3.5
P]KA-S2 7.8 M 18 min 26.0 'a 587.8 (2+) 587.8 24.8a 627.8 (2+) 627.8 4.6 4.4 4.8
P]KC-SI 30 M 12 min 33.2b 413.2 (3+) 413.2 32.5 659.2 (2+) 659.2 3.3 3.2 4.7
a HPLC gradient: 10 min. 15% B followed by linear gradient 15-50% B over 30 min. b HPLC gradient: 10 min. 0% B, linear
gradient 0-10% B over 2 min. followed by linear gradient 10-50% B over 30 min. ' Calculated by equation (3) d Calculated from
the integrated area on the HPLC trace where total area equals S,.
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Determination of Kinetic Parameters for Chemosensors
The continuous nature of the Sox-based kinase assay allows initial rates to be determined
fiom a single reaction mixture without extra effort to isolate and process aliquots. An additional
benefit of the Sox-based chemosensing strategy is the compatibility with millimolar
concentrations of ATP, which is significantly above the KM for this substrate and allows an ATP-
independent KM to be calculated for the peptide substrate.
To obtain KM and Vmax for each substrate by fluorescence, the initial fluorescence increase
(boxed in Figure 9a) needs to be converted to a product formation rate. Since the initial velocity
of the reaction is the amount of product formed over time, taking the derivative of equation (3)
with respect to time gives:
dI(t)
dP(t) dtv ... (4)dt fp - fs
This equation accounts for a fluorescence increase due to product formation and a slight decrease
in fluorescence over time due to substrate consumption. The initial slope of the reaction, dI(t)/dt,
is measured within the first 10% of substrate turnover for several substrate concentrations
between 0.5 and 5 x KM. A linear fit of a Hanes plot ([S]/v vs. [S]) is used to find KM and Vmax
(Figure 4-7d), where the X-intercept is -KM, the slope is /Vmax. Hanes plot analysis was chosen
because the data does not need to be weighted compared to Lineweaker-Burke analysis. In
addition, this plot emphasizes higher substrate concentrations, where any error in substrate
concentration produces only a small error in the rate.6 2
The kinetic parameters for optimized chemosensors are listed in Table 4-5. Importantly,
the KM and Vmax values illustrate that these peptides are good substrates for their respective
enzymes. The K,,, values for most peptides are in good agreement with the reported KM for the
kinase recognition motif. Values are not available for threonine phosphorylation, but weaker
phosphorylation of threonine by PKC (PKC-S2) has been noted for many substrate sequences,6 3
and equivalent threonine phosphorylation by Akt (Akt-S2) was expected.6 4 Peptides PKA-S2,
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F'KA-S3, and Abl-S1 have significantly different values from the literature. The improved KM
values for PKA-S2 and PKA-S3 is most likely due to a difference in ATP concentrations. The
poorer KM for Abl-S1 is likely because an important glutamate residue at the -3 position6 5 was
substituted with a proline residue as part of the -turn. In general, comparison with KM values
from the literature demonstrates that the reporter motif does not interfere with reactivity of the
substrate.
Table 4-5. Kinetic parameters for select kinase chemosensors
Substrate KM Vm KM ([tM) Ref.
([tM)a (tmol min -' mg) a literature
PKC-S1 8.6 + 2.9 5.9 -+ 1.9 10 66
PKC-S2 23 3 2.3 ± 0.6 --
PKA-S2 1.8 0.5 3.7 - 1.6 16 67
PKA-S3 2.9 + 0.6 6.3 ±+ 0.5 16 67
Akt-S1 3.8 + 0.2 0.59 ±+ 0.14 8.8 68
Akt-S2 2.9 0.59 --
MK2-S1 21 ±+ 2 2.3 0.2 31 69
Abl-S 1 26 ±+ 5 9.3 ±+ 0.5 4.0 65
a Values reported are from triplicate Hanes plots with substrate
concentrations 0.5-5 x KM.
Substrate specificity
As a preliminary assessment of the selectivity of some of these probes, PKC-S 1, PKA-
S3, Akt-S 1, and MK2-S 1 were assayed against recombinant PKC, and PKA. PKC0
phosphorylated its designed substrate but also MK2-S 1, and PKA phosphorylated PKA-S3 and
to a slight extent, Akt-S 1 (Figure 4-8). These measured selectivities likely parallel those for the
substrates upon which these chemosensors were based.
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Figure 4-8. Cross-reactivity of peptide substrates with PKCa and PKA. The rate of product
formation was determined from equation (4) and was normalized to the designed substrate for
each kinase.
Influence of Relevant Metal Ions on Kinase Chemosensing Ability
The ability of other biologically-relevant metal ions to compromise detection of kinase
activity was investigated. In these experiments, the concentrations of all components were
chosen to resemble physiological conditions: 10 tM peptide, 10 mM Mg2+, and physiological
concentrations or higher of other metal ions.70 The fluorescence intensity of both the substrate
peptide (Figure 4-9a) and the product phosphopeptide (Figure 4-9b) was investigated 1) in the
absence of Mg 2+ to detect fluorescence complexes (possible for Ca2+ and Zn2), and 2) in the
presence of Mg2+ to detect quenched complexes (possible for all other metal ions).
With the exception of Zn2 , no metal ions interfere at physiological concentrations. Even
so, the response to Zn2+ is less than 20%. Fluorescence values for the substrate peptide with all
metal ions in the presence of Mg2' are within error due to low total fluorescence. The quenching
effect of NaCl on the product phosphopeptide is a result of increased ionic strength, which alters
the Mg2+ dissociation constant.
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Figure 4-9. Effect of physiological metal ions on kinase chemosensors. Peptides (a) PKA-S2 and
(b) PKA-P2 (10 [tM each) were evaluated with the indicated metal ion concentrations in the
presence and absence of MgCl2 (10 mM). Fluorescence intensity for each measurement is plotted
relative to the complex with 10 mM Mg2 +.
Finally, some kinases require significantly higher concentrations of Mn2+ for in vitro
activity (e.g. EGFR), so the fluorescence of substrate and product peptides were tested with 1
mM Mn2+. The probes are much less sensitive under these conditions; Mn2+ quenches substrate
fluorescence by 70% and product fluorescence by 95% such that phosphorylation results in a
30% fluorescence decrease.
Application to High-Throughput Kinase Inhibitor Screening
To illustrate the immediate utility of these probes in high-throughput screening
applications, the chemosensor PKC-S2 was used to interrogate PKC inhibition. Commercially
available PKC inhibitors with distinctly different inhibitory constants (IC50) were chosen:
bisindolylmaleimides I (GF109203X), IV and V. In high-throughput 96-well plate format, three
different doses of each inhibitor were tested against PKC. The initial fluorescence increase of
each reaction was normalized against the fluorescence increase in the absence of inhibitor. The
PKC-S2 assay easily detects that bisindolylmaleimide I is the most potent PKC inhibitor, as
expected (Figure 4-10). Additional high-throughput applications include analysis of kinase
activity in crude cell lysates, which will be discussed in the next chapter.
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Figure 4-10. Influence of varying concentrations BIM I, BIM IV, and BIM V on PKC activity.
Discussion
The successful design of fluorescent chemosensors of protein kinase activity containing
the Sox amino acid is reported. The versatility of the approach allows generation of probes for
both serine/threonine and tyrosine kinases with recognition residues on either the N- or C-
terminus. Compared to other sensors for kinase activity, Sox-based probes are easily synthesized
and their use is incredibly straightforward, without complicated handling steps.
Many general conclusions can be drawn from the fluorescence increase values in Table
4-2. First, the fluorescence increase for phosphorylation of serine, threonine and tyrosine is quite
large (3-12-fold) across the range of 14 probes synthesized. Even sub-optimal designs give
larger fluorescence increases than any other probe reported to date. The chemosensing strategy is
compatible with acidic residues and additional proline residues in the kinase recognition motif
(Pim2-S 1). The fluorescence increase for each chemosensor depends on the residue to be
phosphorylated; serine affords the largest increase in fluorescence, followed by threonine and
tyrosine. The flexibility of the phosphoserine side chain as compared to phosphothreonine and
phosphotyrosine likely improves the propensity for chelate formation.
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The R-turn is the other important factor that determines the magnitude of the fluorescence
increase. Kinase recognition is crucial for excellent reactivity; one recognition element must
remain fixed in the turn sequence for serine/threonine kinase chemosensors, thus the
stereochemistry at proline is used to tune the fluorescence increase. The fluorescence increase
trends for these kinase chemosensors suggest that Mg2 + prefers a type II O-turn, either Xaa-DPro
or Pro-Gly. The fact that Xaa-DPro gives a larger fluorescence increase than a turn containing
glycine suggests that Mg 2+ prefers a rigid 1-turn. This differentiates the coordination preferences
of Mg2+ from those of Zn2+, which might be expected because Mg2* prefers octahedral
coordination geometry whereas Zn2+ prefers tetrahedral.
From the chemosensors presented herein, optimal design recommendations can be made
for all serine/threonine kinase chemosensors containing N-terminal kinase recognition elements
and for a subset of serine/threonine kinase chemosensors containing C-terminal kinase
recognition elements (with Gly in the -1 position) (Figure 4-1 la). Kinase substrates with a C-
terminal recognition elements with a residue other than Gly at the -1 position need to be further
investigated. The type II R-turn that is optimal in the PKA, Akt, MK2 and Pim2 substrates is not
possible when the -1 position is fixed with an L-amino acid; either Pro-Xaa (Type I) or DPro-
Xaa (Type II') remain as options.
Optimal peptide chemosensors for PKC, PKA, Akt, MK2, Pim2 are shown in Figure 4-
1 lb. To generate additional probes, the best design principles presented herein (Figure 4-1 la)
can be applied and then the fluorescence increase can be determined empirically.
While the design principles for serine and threonine phosphorylation were investigated in
most depth herein, one chemosensor for a tyrosine kinase was developed (Abl-S1). Tyrosine
kinase chemosensor design requires an additional element in the -turn sequence, and it is likely
that similar optimization to that performed for serine/threonine kinases will lead to improved
probes for tyrosine kinase activity,
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a Sensing module
(Xaa)-Se r/Thr-Xaa-DPro-Sox-Gly-NH2
N-terrninal kinase Aturn
recognition motef
b
PKC GSFRRR
PKA LRRASLG
Akt ARKRERAYSFHFHA
MK2 AHLQRQLSIAHH
Pim2 ARKRRRHPSGPPTA
Sensing module
Ac-Sox-Pro-Gly-Ser/Thr-(Xaa)-NH 2
fi-turn Ctermnal kinase
recognition motef
Ac-Sox-Pro-GSFRRR
LRRASL-DPro-Sox-G
ARKRERAYSF-DPro-Sox-G
AHLQRQLS-DPro-Sox-G
ARKRRRHPSG-DPro-Sox-G
Figure 4-11. Optimized kinase chemosensor design based on results presented herein for
serine/threonine phosphorylation. (a) The critical kinase specificity determinants in the
chemosensor peptide sequence are derived from an optimized peptide substrate, including one
residue in the sensing module as part of the -turn sequence. (b) Specific optimized peptide
substrates from the literature are converted to kinase chemosensors as described in (a). The
residues to be phosphorylated are indicated in bold.
A method for determining the kinetic parameters from fluorescence data has been
established and validated. The KM and Vma, values determined for the optimized chemosensors
show that these probes are good substrates for their respective kinases. Desirable kinetic
parameters aid probe sensitivity, as large Vma/KM ratios result in faster turnover and thus a larger
fluorescence slope. High-throughput assays are even more facile than determination of kinetic
parameters because the slopes can be compared without converting to turnover.
The chemosensing approach should be adaptable to studying kinases in living cells. The
chemosensing strategy is compatible with physiological Mg2+ concentrations and is not
influenced by other biologically-available metal ions. The fluorescence of Sox is similar to that
of NBD in water, which has been used by the Lawrence laboratory4 7 to visualize kinase activity
in cells. A necessary first step will be to investigate the utility of these chemosensors in cell
extracts, which will be undertaken in Chapter 5.
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Conclusion
In conclusion, we have developed a widely applicable, continuous fluorescence assay for
protein kinase activity. In contrast with other existing sensing methodologies, this assay is
extremely versatile, straightforward and exhibits a large signal increase. The ability to
chemically synthesize the product phosphopeptide enables careful characterization of the
fluorescence behavior and substrate turnover. In addition, the stable fluorescence of the Sox-
Mg2+ complex permits a continuous assay, which obviates problems with the termination steps of
endpoint assays. In general, the substantial fluorescence changes of these peptide-based probes
will be important for sensing the activity of less abundant endogenous kinases. A mere 1%
turnover corresponds to a 5-10% fluorescence increase, which is easily measured under the
prescribed conditions.
The -turn sequence in the sensing module was optimized for improved reactivity and
sensitivity by incorporating an additional amino acid recognition element and evaluating which
isomer of proline affords the largest fluorescence increase. The large signal increase is
compatible with all types of kinase peptide substrates but does vary depending on the
requirements of the target kinase, including 1) the residues nearby the Mg2 chelating moiety; 2)
the type of residue to be phosphorylated and 3) the presence of additional chelating residues.
The ability to quantify substrate turnover by fluorescence allowed determination of the
kinetic parameters for each substrate. The kinase chemosensing peptides have similar kinetic
parameters to the optimal peptides for these kinases, which indicates that the sensing module
does not affect specific activity. The best design principles determined were easily applied to
additional peptide chemosensors, suggesting that a chemosensor for any kinase can be developed
based on the results presented herein. These probes are immediately applicable to high-
throughput screening assays.
Assays utilizing Sox-based chemosensors offer many advantages over discontinuous
assays of protein kinase activity. Importantly, real-time analysis of reaction progress is possible.
In addition, handling steps to separate incompatible reaction components or to manipulate the
substrate are not required to analyze reaction outcome. Even discontinuous assays that are
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homogeneous and allow for a simple one-step quenching procedure are not compatible with
physiological ATP concentrations and complex reaction mixtures.
The Sox-based chemosensors share several common advantages of continuous probes of
protein kinase activity and are superior in some regards. They are compatible with physiological
ATP concentrations and complex reaction components. As readily-synthesized peptide-based
probes, they are amenable to in vitro studies with recombinant kinases. On the other hand,
protein-based probes are more useful for work in living cells due to the effort to isolate the
sensor following expression. Similar to the modular AFP-based probes, Sox-based chemosensors
can be easily modified for analysis of any desired kinase by altering the kinase recognition motif.
The brightness of the Sox-based probes is comparable to that of NBD, and is roughly an order of
magnitude dimmer than the Ca2+ CHEF probes and protein-based constructs. While the Sox-
based probes are limited in their ability to accommodate residues on both sides of the
phosphorylation site, modular expressible probes suffer limitations on the sequence to be
phosphorylated due to the requirement for intramolecular binding of this sequence to the
recognition domain. In addition to the aforementioned advantages, the most important advantage
of the Sox-based chemosensing strategy is the dramatic fluorescence increase, rendering these
probes the most sensitive.
Future Directions
Further improvements in sensitivity, reactivity, specificity and scope will increase the
utility of all probes. To augment sensitivity of the chemosensing strategy in general, a brighter
fluorophore with red-shifted fluorescence is desirable, especially considering that AFP-based
probes are extremely bright and excited in the visible spectrum. Such a fluorophore may be
possible by designing additional aromatic rings onto the Sox chromophore. In addition, such a
probe with an alternate excitation and emission wavelength could be used in concert with a probe
ccntaining Sox for simultaneous imaging of two kinase activities.
The specificity and reactivity of these probes could be optimized by incorporation of
recognition elements on both the C- and N-terminus of the phosphorylation site. This would
likely afford a better substrate for Abl. For this purpose, modifying an amino acid side chain with
the Sox chromophore will be investigated.
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Incorporation of Sox into full-length protein substrates7" would provide a means to study
kinases that do not effectively phosphorylate peptide substrates. Additionally, the generation of
protein-based probes would allow inclusion of docking domains to improve specificity when
current peptide substrates are nonspecific.
In addition to high-throughput screening in solution, these chemosensors could also be
immobilized in arrays for diagnostics or proteomics research. For cellular studies, functionalities
such as peptide transduction domains, targeting peptide sequences, or additional fluorophores as
internal standards can be readily incorporated.
These versatile and powerful chemosensors provide tools for researchers studying the
roles of protein kinases in signal transduction. The design principles presented herein provide
guidelines for the generation of additional probes. The application of these probes to high-
throughput screening and cellular studies should aid in signal transduction research.
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Experimental
PFeptide Synthesis
Peptides were synthesized using standard Fmoc amino acid protection chemistry on Fmoc-PAL-
PEG-PS resin (Applied Biosystems, 0.2 mmol equiv). All Fmoc-protected amino acids and
coupling reagents were purchased from Novabiochem. Couplings of Fmoc-protected amino acids
to the resin were carried out with either 1) 1-benzotriazolyoxytris(pyrrolidino)phosphonium
hexafluorophosphate (PyBOP), 1-hydroxybenzotriazole (HOBt) and diisopropylethylamine
(DIPEA) or 2) -(7-azabenzotrazol- l-yl)-l,l ,3,3-tetramethyluronium hexafluorophosphate
((HATU) and DIPEA to generate the activated ester. The resin was swelled in dichloromethane (5
min.) then DMF (5 min.) prior to synthesis. All amino acids other than the Sox, phosphoserine,
phosphothreonine and phosphotyrosine were added by the following representative procedure:
removal of the Fmoc group (20% piperidine solution in DMF, 3 x 5 min.), wash (DMF, 5 x 1
miTLn.), coupling (amino acid/PyBOP/DIEA, 6:6:6, 0.05 M in DMF, 30 min.), rinse (DMF, 2 x 1
mir; DCM, 2 x 1 min.). To couple the Sox residue, double coupling with 2 equivalents each
time was used (Fmoc-Sox-OH/PyBOP/DIPEA, 2:2:2, 0.15M in DMF, 2 x 30 min.). When Sox
was coupled after a proline residue, longer coupling times were used (120 min). To couple the
phosphoamino acid residues, HATU was. used (Fmoc-Xaa(PO(OBzl)OH)-OH/HATU/DIPEA,
3:3:3, 0.05 M in DMF, 30 min.), with care to avoid an excess of HATU because this often leads
to capping of the N-terminus with a guanidinium moiety. After addition of the final residue, the
peptide was acetyl-capped (pyridine/acetic anhydride, 20:20, 0.15 M in DMF, 30 min.), and a
final deblock cycle (20% piperidine in DMF, 3 x 5 min.) was performed to cleave any Sox aryl
ester formed. The resin was dried under high vacuum overnight prior to a 2.5-hour cleavage
with trifluoroacetic acid/triisopropylsilane/water (95:2.5:2.5, 40 [tl/mg resin for substrate
peptides and 140 [tl/mg resin for product phosphopeptides). The resulting solution was
concentrated under a stream of nitrogen. The pellet was triturated with cold 1:1 ether:hexanes (3
x 1.5 ml for 15 mg resin), redissolved in 50:50 water/acetonitrile, filtered and lyophilized
overnight. Peptides were redissolved in water containing 0.1% TFA and were purified by
preparatory reverse-phase HPLC (C18) to greater than 95% (confirmed by analytical HPLC, C18).
Peptidcle identities were confirmed by electrospray mass spectrometry (ESI-MS).
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Peptide Characterization Data
HPLC m/z (z+) m/z
Peptide Sequence Mol. Formula TR calcd found
(min)
PKC-S 1
PKC-P1
PKC-S2
PKC-P2
PKC-S4
PKC-P4
PKC-S5
PKC-PS
PKC-S6
PKC-P6
PKA-S 1
PKA-P1
PKA-S2
PKA-P2
PKA-S3
PKA-P3
Akt-S I
Akt-PI
Akt-S2
Akt-P2
Aklt-P3
MK2-S 1
MK2-P1
Piim2-S 
Pim2-P1
Pim2-S2
Pim2-P2
AbI-S 1
AbI-P1
Ac-Sox-Pro-Gly-Ser-Phe-Arg-Arg-Arg-NH2
Ac-Sox-Pro-Gly-pSer-Phe-Arg-Arg-Arg-NH2
Ac-Sox-Pro-Gly-Thr-Phe-Arg-Arg-Arg-NH2
Ac-Sox-Pro-Gly-pThr-Phe-Arg-Arg-Arg-NH2
Ac-Sox-DPro-Gly-Ser-Phe-Arg-Arg-Arg-NH 2
Ac-Sox-DPro-Gly-pSer-Phe-Arg-Arg-Arg-NH2
Ac-Asp-Sox-DPro-Gly-Ser-Phe-Arg-Arg-Arg-NH2
Ac-Asp-Sox-DPro-Gly-pSer-Phe-Arg-Arg-Arg-NH2
Ac-Asp-Gly-Sox-DPro-Gly-Ser-Phe-Arg-Arg-Arg-NH2
Ac-Asp-Gly-Sox-DPro-Gly-pSer-Phe-Arg-Arg-Arg-NH2
Ac-Leu-Arg-Arg-Ala-Ser-Gly-Pro-Sox-NH2
Ac-Leu-Arg-Arg-Ala-pSer-Gly-Pro-Sox-NH2
Ac-Leu-Arg-Arg-Ala-Ser-Leu-Pro-Sox-NH2
Ac-Leu-Arg-Arg-Ala-pSer-Leu-Pro-Sox-NH2
Ac-Leu-Arg-Arg-Ala-Ser-Leu-DPro-Sox-Gly-NH 2
Ac-Leu-Arg-Arg-Ala-pSer-Leu-DPro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Glu-Arg-Ala-Tyr-Ser-Phe-DPro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Glu-Arg-Ala-Tyr-pSer-Phe-DPro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Glu-Arg-Ala-Tyr-Thr-Phe-DPro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Glu-Arg-Ala-Tyr-pThr-Phe-DPro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Glu-Arg-Ala-Tyr-pThr-Phe-Pro-Sox-Gly-NH2
Ac-Ala-His-Leu-Gln-Arg-Gln-Leu-Ser-Ile-DPro-Sox-Gly-NH2
Ac-Ala-His--Leu-Gln-Arg-Gln-Leu-pSer-Ile-DPro-Sox-Gly-NH 2
Ac-Ala-Arg-Lys-Arg-Arg-Arg-His-Pro-Ser-Gly-Pro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Arg-Arg-His-Pro-pSer-Gly-Pro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Arg-Arg-His-Pro-Ser-Gly-DPro-Sox-Gly-NH2
Ac-Ala-Arg-Lys-Arg-Arg-Arg-His-Pro-pSer-Gly-DPro-Sox-Gly-NH2
Ac-Sox-Pro-Gly-Ile-Tyr-Ala-Ala-Pro-Phe-Ala-Lys-Lys-Lys-NH2
Ac-Sox-Pro-*Gly-Ile-pTyr-Ala-Ala-Pro-Phe-Ala-Lys-Lys-Lys-NH,
C5 3H 8oN2 o0013S
C53H8 ,N20 0,16PS
C54 H8 2N2003
S
C54H8 3N200 6PS
C53H 80N 20Ol 3S
C53H8 N20 0, 6P
S
C57H8 s5N2 1O,6S
C57H8 6N2 1,0,gPS
C59H88 N22 O, 7S
C59H89 N2 20 2 o
P S
C47H75 N,7013S
C47H76N, 70 6 PS
C5 lH83NI7,0,3S
C51H84N, 70, 6 PS
C53H86N,80,4S
C53H87N, 8017PS
C79 H, ,8N260 21S
C 79H11 9N 26 024 PS
C80 H120 N26 0 2 ,1S
C80H, 21N260 24 PS
C80Hi2 1N26 024PS
C69Hi 08 N22 0,9
S
C69H1 09 N2 20 22 P
S
C72 H, ,7 N3 10, 8S
C72H1 ,8N310 21 PS
C72Hi 17N310,8S
C72H, ,8N3 10 2 PS
C79H 17N, 9018S
C,H, ,N,oO,,PS
a 5 min. 10% B followed by linear gradient 10-50% B over 30 min. b 5 min. 15% B followed by linear gradient 15-50% B over 30
min. 5 min. 20% B followed by linear gradient 20-70% B over 30 min. d 5 min. 10% B followed by linear gradient 10-40% B
over 30 min.
Instrumentation
High-Performance Liquid Chromatography (HPLC): Waters 400 and 600 systems (solvent A =
water, 0.1% v/v TFA; solvent B = MeCN, 0.1% v/v TFA). Columns used: C18 analytical,
Beckman Ultrasphere ODS, 5 [tm, 150 x 4.6 mm; C 8 preparatory, YMC-Pack Pro, 5 [tm,
250 x 20 mm.
Electrospray Mass Spectrometer: Applied Biosystems Mariner mass spectrometer spattered with
a random assortment of dead flies and fly parts thanks to building 18 renovations.
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26.7a
25.7a
22.8b
21.6b
30.05a
28.77a
29.05 a
27.86a
28.92a
28.16 a
28.92a
28.68a
25.9b
25.1b
30.0 a
29.1a
31.0a
30.0 a
29.64a
28.73a
27.43a
31.4a
30.1 a
24.42d
23.84 d
24.2d
24.21 d
21.1 c
20.1c
413.2 (+3)
659.3 (+2)
417.9 (+3)
666.3 (+2)
413.2 (+3)
659.2 (+2)
451.5 (+3)
478.4 (+3)
470.6 (+3)
497.4 (+3)
559.8 (+2)
599.8 (+2)
587.8 (+2)
627.9 (+2)
616.3 (+2)
656.3 (+2)
600.6 (+3)
627.3 (+3)
605.4 (+3)
632.0 (+3)
632.0 (+3)
791.4 (+2)
831.4 (+2)
435.0 (+4)
455.0 (+4)
435.0 (+4)
455.0 (+4)
551.6 (+3)
578.3 (+3)
413.2
659.2
417.9
666.3
413.2
659.2
451.5
478.2
470.5
497.2
559.7
599.7
576.8
627.8
616.2
656.2
600.6
627.6
605.3
632.0
632.0
791.4
831.4
435.0
455.0
435.0
455.0
552.0
578.3
- -
UV-Vis Spectrophotometer: Beckman DU 7500 and Shimadzu UV-2401PC.
Fluorimeter: Fluoromax 3 from Jobin Yvon (e = 360 nm or 400 nm, kem = 485 nm).
Fluorescence Plate Reader: HTS7000 Bio Assay Reader from PerkinElmer with 360 nm
excitation filter (35 nm bandpass), 485 nm emission filter (20 nm bandpass), 40 ts
integration, 3 flashes/well, 120 gain.
Materials
Cuvette: Starna Cells (16.100F-Q-10) 100 tl sub-micro cuvette, 1 cm path length, 120 1
reaction volume.
96-well plates: FluoroNunc PolySorp black 96-well plate (475523), 400 yl well volume with
150 tl reaction volume/well.
Quantum Yield D)etermination
The quantum yield (I) was determined for MK2-P1 in 20 mM HEPES (pH 7.4). Quinine sulfate
dihydrate (QS, Fluka, puriss. for fluorescence) in 0.1 M H 2 SO 4 was used as a standard ( =
0.55). A 4 tM solution of MK2-S1 with 50 mM MgCl 2 was compared to a 4 tM solution of
quinine sulfate to assure that the absorbance (A36 0) is less than 0.05 at identical excitation
wavelengths. The following equation was used to calculate the quantum yield:
, IAQs(IQs
AIQS
where A = A360 and I = integrated fluorescence intensity (ex = 360 nm). The calculated 
assumes that the refractive index of 0.1 M H2SO4 is identical to that of 20 mM HEPES (pH 7.4).
The error associated with the P of quinine sulfate is at least 10%, the error in 4 is no less than
1 o %.
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Stock Solutions:
Stock solutions were prepared by weight and stored in plastic at room temperature unless
otherwise noted.. Reagents with the highest purity and lowest metal content were used, including
ultrapure water (18 MQ).
1) Concentrations of peptide stock solutions were determined by UV-Vis (based on the
determined extinction coefficient of the fluorophore unit, 5-(N,N-dimethylsulfonamido)-
8-hydroxy-2-methylquinoline, 355 = 8247 M -1 cm -' in 0.1 M NaOH with 1 mM
Na2EDTA). These solutions were stored at 4C for two months, or -20°C for longer
periods.
2) Stock solutions of magnesium chloride (Puratronic grade, Alfa Aesar, 3 M) and calcium
chloride (Puratronic grade, Alfa Aesar, 0.3 M) were prepared in 1 mM HCl (Baseline,
Seastar Chemicals). High purity is essential, because most commercially available salts
contain Zn2+ as significant impurities.7 2 The Mg 2+ and Ca2+ concentrations were
determined by titration with a standardized solution of EDTA (Aldrich) in the presence of
the indicator Eriochrome Black T (Aldrich).7 3
3) 200 mM Hepes (SigmaUltra) was adjusted to pH 7.4 with sodium hydroxide (99.998+%,
Aldrich) solution (1 M) and stored at 4°C.
4) 10 mM dithiothreitol (Biotechnology grade, Mallinckrodt) and prepared in degassed
ultrapure water and stored at-20 ° C.
5) 100 mM ATP was prepared with adenosine 5'-triphosphate (Disodium salt, Low Metals
Grade, Calbiochem) and stored at-20 ° C.
6) 10 [tg/ml phosphatidylserine and 2 [tg/ml diacylglycerol in 20 mM HEPES pH 7.4 were
prepared by combination of appropriate volumes of chloroform solutions of 10 mg/ml
porcine brain phosphatidylserine (Avanti Polar Lipids, Inc.) and 2 mg/ ml 1,2-dioleoyl-
sn-glycerol (Avanti Polar Lipids, Inc.). The chloroform was evaporated and 20 mM
Hepes (pH 7.4) was added. The solution was sonicated in a bath sonicator for 12 min,
stored in aliquots at -20°C, which were each sonicated upon thawing.
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7) 2 mg/ml BSA was prepared by dissolving bovine serum albumin (Heat Shock Fraction V,
Roche) in ultrapure water and then filtering through a 0.45 micron syringe filter to
remove particulates.
8) 10% Brij-35 was prepared from Brij-35P (Biochemika grade, Fluka) and serially-diluted
to a working stock of 0.1%.
9) 500 mM EGTA was prepared from ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-
tetraacetic acid (SigmaUltra) dissolved in 2 M NaOH and stored at 4°C.
10)5 M NaCl was prepared by dissolving sodium chloride (SigmaUltra) in ultrapure water.
Spectral Comparison of Phosphorylated and Unphosphorylated Peptides:
10 FM each of substrate peptide and product phosphopeptide in 20 mM Hepes (pH 7.4), 10 mM
MgCl2, 0.1 mM EGTA were independently measured with an excitation wavelength of 360 nm
and 3 nm excitation/emission slit widths.
Mg2 + Dissociation Constant Determination:
Single titrations were performed with 1 tM peptide in 20 mM Hepes (pH 7.4), 150 mM NaCl.
Aliquots of MgCl2 stock solutions were added and the data were fit with the program
Specfit/3259.
Recombinant Enzyme Assays
Recombinant enzyme was added to begin each reaction unless otherwise noted to varying
chemosensor concentrations (0.5-5 x KM) at 30°C. Reactions to obtain kinetic parameters were
performed in the fluorimeter within 10% turnover. Readings were obtained every 10 s for 5 min
(Qex = 360 nm for PKC, PKA, Akt; kex = 400 nm for MK2, Abl; kem = 485 nm; slit widths = 5
nim). For high-throughput inhibitor screening in polystyrene plates, an extra 0.2 mg/ml BSA was
used to prevent enzyme activity loss. Assay conditions were optimized for each kinase to assure
that the enzyme did not lose activity either the stock solution or the reaction mixture. If no
activity loss occurrs in the enzyme stock solution, assays with identical substrate and enzyme
concentrations repeated 1 hour apart will exhibit identical slopes. To confirm that the enzyme
did not lose activity upon dilution into the reaction mixture, Selwyn's test was used. In this test,
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the concentration of substrate is held constant and the concentration of enzyme is varied. If an
enzyme does not lose activity upon dilution, the rate of turnover doubles when the amount of
enzyme is doubled. Final assay conditions were as follows:
PKC: 20 mM Hepes (pH 7.4), 10 mM MgCl 2, 0.3 mM CaCl2, 0.1 mM EGTA, 1 mM ATP, 1 mM
DTT, 0.5 [tg/ml phosphatidylserine, 0.1 Itg/ml diacylglycerol, PKC, (5.5 ng for serine
phosphorylation and 11 ng for threonine phosphorylation, Calbiochem, diluted 1:20 with
20 mM Hepes (pH 7.4), 5 mM DTT). Substrate peptide was added to begin the reaction.
]PKA: 20 mM Hepes (pH 7.4), 10 mM MgCl 2, 1 mM ATP, 1 mM DTT, 0.1 mM EGTA, 8 ng
PKA catalytic subunit (Catalytic Subunit, Calbiochem, diluted 1:80 with 50 mM Tris-HCl
pH 7.5, 10 mM MgCl2, 1 mM DTT, 0.15 mg/ml BSA).
Aktl: 20 mM Hepes (pH 7.4), 10 mM MgCl 2, 1 mM ATP, 1 mM DTT, 0.1 mM EGTA, 40 ng
Aktl (Upstate, diluted 1:20 with 20 mM Hepes pH 7.4, 1 mM DTT, 0.1% Brij-35, 1 mg/ml
BSA).
MK2: 20 mM Hepes (pH 7.4), 10 mM MgCl 2, 1 mM ATP, 1 mM DTT, 0.1 mM EGTA, 0.01%
Brij-35, 0.1 mg/ml BSA, 20 ng MAPKAP kinase 2 (Upstate, diluted 1:10 with 20 mM
Hepes pH 7.4, 1 mM DTT, 0.1% Brij-35, 1 mg/ml BSA).
Abl: 20 mM Hepes (pH 7.4), 10 mM MgCl 2, 1 mM ATP, 1 mM DTT, 0.01 % Brij-35, 4 ng Abl
(New England Biolabs, diluted 1:5 with 20 mM TRIS pH 7.5, 10 mM MgCl2, 0,1 mM
EGTA, 0.01% Brij-35 and 1.0 mg/ml BSA).
Data Workup
Fluorescence slopes were determined by a least-squares fit using KaleidaGraph (3.6.2, Synergy
Software). This slope averages out scatter in individual fluorescence readings. This slope was
then either converted to a rate (equation (4)) or compared directly to the slopes of other reactions
with the same peptide concentration. Values reported are an average ±+ standard deviation for
triplicate experiments.
I1PLC and MS Data for Kinase Reactions
All reactions were monitored by fluorescence and quenched with 40 jil of a 0.1 M Na2EDTA
stock solution and then stored on ice prior to HPLC analysis.
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Metal Competition Studies
Metal ion solutions were prepared from hydrates of their chloride salts and the concentrations
determined based on salt weight, with the exception of MgC12, CaCl2 and ZnC2, which were
determined by titration with a standardized solution of EDTA (Aldrich) in the presence of the
indicator Eriochrome Black T (Aldrich).73
inhibitor Screening
1 mM stock solutions of Bisindolylmaleimides I, IV and V (Calbiochem) in DMSO
(spectrophotometric grade, Aldrich) were protected from light. Serial dilutions were prepared in
DMSO such that the volume added to each reaction was constant. In addition, an identical
volume of DMSO was used as a control in reactions lacking inhibitor. Assays for PKC activity
were conducted as for kinetic parameter determination, with inhibitor added with reaction
components prior to addition of either enzyme or peptide substrate.
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Chapter 5:
A Multiplexed Homogeneous Fluorescence-Based Assay
for Protein Kinase Activity in Cell Lysates
My collaborator, Kevin Janes, made significant intellectual contributions to this work, prepared
all cell lysates and performed all immunodepletions and western blot analyses.
Nearly all of the work described in this chapter has been published in:
Shults, M. D.; Janes, K. A.; Lauffenburger, D. A.; Imperiali, B. A multiplexed homogenous
fluorescence-based assay for protein kinase activity in cell lysates. Nat. Methods. 2005, 2, 277-
284.
A portion of the introduction has been submitted for publication:
Rothman, D. R.; Shults, M. D.; Imperiali, B. Chemical approaches for investigating
phosphorylation in signal transduction networks, submitted.
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Introduction
New methods to quantify protein kinase activities directly from complex cellular
mixtures are critical for understanding biological regulatory pathways. Since the catalytic
activities of these enzymes are the clearest measure of signaling information "flow",' there is
tremendous interest in quantifying the dynamics of kinase activities in complex cellular media.
As discussed in Chapter 4, the most common methods for measuring cellular kinase
activities involve isolation of the target kinase from cell lysates.23 Then, in vitro kinase assays
are performed, such as with [y-32 P]ATP or one of the discontinuous methods discussed in
Chapter 4. The processing steps needed to isolate the kinase and measure activity are time-
consuming and inherently low-throughput. To more directly and rapidly analyze crude cell
lysates, a continuous, fluorescence-based, homogeneous kinase activity assay is very desirable.
Despite numerous reports of kinase chemosensors in the literature, only a fraction are compatible
with unfractionated cell lysates or within cells.4 -16 These continuous sensing strategies were all
introduced in Chapter 4; their application to assessing cellular kinase activities will be discussed
in further detail here.
Assessing Cellular Kinase Activities with Genetically-Encoded Sensors
The genetically encoded probes containing AFP variants have begun to provide valuable
spal:io-temporal information about cellular signaling in living cells. One example is an AFP-
based FRET sensor for Abl, which provided the first real-time evidence that an increase in Abl
activity is localized to membrane ruffles following PDGF stimulation." In a different example, a
single-color AFP-based probe cyan sinphos imaged the timing of insulin receptor activity
relative to the subsequent translocation of GFP-labeled mitogen-activated protein kinase from
the cytoplasm to the nucleus.5
Since these probes are expressible, straightforward genetic modifications allow the probe
to be directed to a specific location or signaling complex within a cell. In general, targeting
improves spatial signal resolution, because probes distributed in the cytosol diffuse too rapidly
for resolution. Kurokawa et. al. showed that a membrane-targeted version of their CrkII-based
reporter responded more quickly to EGF stimulation than an analogous cytosolic probe; the use
of the two probes simultaneously illustrate the progression of the signal from the membrane into
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the cytosol.'3 Zhang et al. tethered their PKA probe (AKAR) to proteins and peptides that bind
the PKA catalytic subunit; these constructs were phosphorylated faster than nontargeted
constructs. In particular, AKAR tethered to the PKA regulatory subunit provided the most rapid
response. 12
In addition, probe targeting allows the probes to mimic endogenous substrates. Sasaki et.
al. found that localization of their Akt sensor (Aktus) to either the mitochondria or the golgi
apparatus influenced the type of stimuli to which it responded.7 Finally, the most elegant
experiments involving targeting by Violin et. al. show that membrane-targeted PKC sensor
(CKAR) responds to histamine with an oscillatory pattern of phosphorylation.8 The careful
design and characterization of CKAR enabled a report on these periods of PKC activity and
inactivity (lack of active PKC allows the probe to be dephosphorylated by phosphatases).
Concomitant use of a longer-wavelength Ca2+ indicator showed this pattern to be coupled with
Ca2+ oscillations.
The small signal changes of all of these probes may limit use in living cells with less
abundant kinases. In fact, kinase overexpression is necessary in some instances, such as Aktus7 .
This illustrates the importance of a larger fluorescence change and good reactivity. For these
reasons, the Akt :sensor reported by Kunkel et. al. is sufficiently sensitive to detect endogenous
Akt.9
Despite their small fluorescence changes, these probes have been useful because their
genetic templates are easily and noninvasively incorporated into cells by transfection. In
addition, the reversible nature of many of these probes reports the dynamic interplay between
kinase and phosphatase activities within a cell. New strategies for both site-specific labeling of
proteins and native chemical ligation approaches to attach small-molecule fluorophores to
proteins in vivo may ultimately prove valuable for overcoming some of the limitations presented
by the AFP-basecl probes.
Assessing Cellular Kinase Activities with Peptide-based Chemosensors
Abiotic peptide-based probes have been used to detect kinase activities from cells and
cell lysates, though these probes are still in early stages of development compared to their
expressible counterparts. Capillary electrophoresis analysis on lysates from single cells has been
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used to monitor phosphorylation of fluorescently-labeled peptide substrates for protein kinases.
These assays are quantitative and show extremely high resolution. Their use has demonstrated
that insulin-stimulated cell populations exhibit significant cell-to-cell variation in Akt activities.4
Flowever, they require technically challenging microfluidic setups and are limited in throughput.
Peptides exhibiting a fluorescence change have the advantage that they do not require separation
for analysis. The Lawrence laboratory has demonstrated selectivity of their NBD-based PKC
chemosensor with preliminary, qualitative studies in cell lysates and in living cells.'6
The substantial fluorescence changes attainable with peptide-based probes will be
important for sensing the activity of less abundant endogenous kinases. The ability to chemically
synthesize the corresponding phosphopeptide product provides knowledge of the maximal
response that is critical for quantifying turnover. In addition, functionalities such as cell
permeable peptide sequences, targeting peptide sequences, or additional fluorophores as internal
standards can be readily incorporated.
Adaptation of Sox-based Probes to Assessing Kinase Activities in Cell Lysates
The fluorescence-based chemosensor strategy introduced in Chapter 4 should provide a
sensitive measure of endogenous kinase activities. The chemosensor comprises a small sensing
module appended to an optimized peptide substrate for the target kinase. The fluorescence signal
is generated when the nonnatural Sox amino acid undergoes chelation-enhanced fluorescence in
the presence of divalent magnesium. The Mg2+-binding affinity of the product phosphopeptide is
much greater than the substrate peptide, which results in a large fluorescence increase upon
phosphorylation. These chemosensors are excellent reporters of recombinant kinase activity in
vitro and the versatility of their design allows the generation of a chemosensor for any target
kinase.
Herein we report that the sensitivity and selectivity of Sox-based chemosensors are
sufficient to measure kinase activities directly from unfractionated cell lysates. We established
optimized assay conditions for preferential, quantitative detection of cellular Akt, MK2, and
PKA activation. The homogeneous assay format is high-throughput, remarkably straightforward,
and reproducible; notably, it is also compatible with physiological concentrations of ATP (1
rmM). The general protocol was developed for the kinase Akt and then easily extended to
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measure protein kinase A (PKA) and mitogen-activated protein kinase-associated protein kinase
2 (MK2) activities. This strategy was also successful due to a combination of the selectivity and
reactivity of the optimized peptide substrate upon which these chemosensors were based, as well
as the knowledge and use of appropriate inhibitors for off-target kinase. This work establishes an
important tool for studying the roles of protein kinases in cellular regulation.
Results:
Chenosensor Properties
The optimized chemosensors for Akt, MK2 and PKA described in Chapter 4 were used.
Due to the significantly different assay buffer composition and instrumentation used for these
experiments, the fluorescence response of these peptides were re-evaluated (Table 5-1).
Table 5-1. Fluorescence response of chemosensors under lysates assay conditionsa
Fold fluorescence
Sensor Sequence increase
Akt-S 1 AcARKRERAYSF-DPro-Sox-Gly-NH 2 9.3
MK2-S 1 AcAHLQRQLSI-DPro-Sox-Gly-NH 2 8.5
PKA-S3 AcLRRASL-DPro-Sox-Gly-NH2 5.6
a 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 15 mM MgCl 2, 5 mM -
glycerophosphate, 1 mM EGTA, 0.2 mM Na3VO4, 0.2 mM DTT, 1 mM
ATP, 10 tM peptide, off-target kinase inhibitors (see Experimental).
D)evelopment of an Akt-S1 Kinase Activity Assay
The sensitivity and efficacy of these kinase chemosensors prompted an investigation of
how each would perform in more complex environments. Whereas direct in vivo applications are
a common next step for most kinase activity chemosensors,4 '5 there are several advantages to
testing chemosensor properties in cell extracts. For instance: a) sensitivity and specificity can be
improved by adding inhibitors of phosphatases and off-target kinases, b) quantification of
fluorescence changes is more straightforward, and c) many distinct lysate-based assays can be
performed using different aliquots of the same sample.
An Akt-S 1 activity assay was first developed, because this chemosensor had the largest
fluorescence increase after phosphorylation. An initial concern for a homogeneous assay was
compatibility between the lysis buffer (containing crude cellular proteins, nonionic detergents,
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and various inhibitors) and a typical kinase assay buffer1 (containing kinase and phosphatase
inhibitors, ATP, and substrate).
Initial attempts to analyze lysates led to precipitation and increased fluorescence emission
due to light scattering. When precipitation was observed visually, centrifugation of the sample
decreased emission at 400 nm back to the same level as a lysis buffer control and removed the
contribution of light scattering from the fluorescence emission at 485 nm. Inclusion of 150 mM
NaCI in the final assay mixture remedied the precipitation problem, as verified by a stable
emission at 400 nm. Under these conditions, up to 150 [tg of lysate protein in 7.5 vol% of the
total reaction could be assayed without precipitation.
Typically, 40-100 [tg of cell lysate in 7.5 vol% of the total reaction was used in the Akt-
Si1 assay. Radioactive Akt assays' 7 typically use 500 ¢tg lysate and micromolar concentrations
of ATP. Here, less lysate is needed because the Akt-S 1 assay is compatible with 1 mM ATP.
Assay sensitivity improves by an order of magnitude when the ATP concentration was increased
from 10 [tM to 1 mM (Figure 5-1).
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Figure 5-1. Akt-S 1 kinase assay sensitivity improves by an order of magnitude when the ATP
concentration is increased from 10 [tM to 1 mM. Insulin-treated HT-29 lysates were assayed as
described in Methods, but in a fluorescence microcuvette.
Another challenge for a crude lysate assay was the presence of competing cellular
processes, such as off-target kinases and phosphatases. To improve specificity for Akt, a cocktail
of phosphatase and kinase inhibitors was included in the assay buffer. This cocktail included the
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phosphatase inhibitors -glycerophosphate and sodium orthovanadate, as well as inhibitors for
PKA (PKItide 8), PKC isoforms (PKC peptide inhibitor and GF109203X) and CaMK
(calmidazolium chloride). These kinase inhibitors did not affect recombinant Aktl activity, but
they completely inhibited their target enzymes (Figure 5-2). For the Akt-S 1 assay, it was critical
to add the small-molecule bisindolylmaleimide PKC inhibitor, GF109203X, which targets all
PKC isozymes as well as p70S6 kinase and MAPKAP-K1.'9 Inclusion of 5 [tM GF109203X in
the assay buffer reduced non-specific Akt-S 1 kinase activity by 75%.
Inhibitor
5/.M 4pM
GF109203X PKC inhibitor peptide.
0.4pM 4pJM
PKltide calmidazolium
ARt PKUa MK2 PKA
Kinase
Akt 'MK2'PKA Akt 'MK2' PKA'Ak MK PKA | kt MK2 P A
Figure 5-2. Kinase inhibitors used in the assay mixture do not affect recombinant Akt, MK2 and
PKA activity, but each inhibitor does completely inhibit its target enzyme. Recombinant Aktl,
MK2, PKA and PKC, were assayed with the indicated concentrations of GF109203X, PKC
inhibitor, PKItide and calmidazolium. Fluorescence slopes are normalized a kinase reaction
lacking inhibitor. Recombinant Aktl, MK2, PKA and PKC,, assay conditions are described in the
Experimental section. Plotted values indicate mean _ s.e.m for triplicate measurements.
Additional inhibition studies verified that atypical PKC isoforms, p70S6 kinase, and
MAPKAP-K1 did not affect Akt-S1 fluorescence under the final assay conditions. To verify
inhibition of atypical PKC isozymes, 5 M Go 6983 was included in the assay buffer with
insulin-treated lysates. To verify inhibition of p70S6 kinase and MAPKAP-K1, in vivo inhibition
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of the upstream kinases, mTor and MEK, was performed, respectively. HT-29 cells were
pretreated prior to insulin stimulation with either rapamycin or PD 98059, respectively. No
influence on measured Akt-S 1 activity was observed in any of these assays when compared to
the standard insulin-treated lysates.
The Akt-S 1 kinase activity assay was optimized in a fluorescence microcuvette and then
adapted to a 96-well glass-plate format. In polystyrene plates, significant absorption of assay
components occurred, especially peptide (observed as a 10% fluorescence decrease over 20 min).
A variety of traditional enzyme-linked immunosorbent assay (ELISA) blocking conditions were
tried unsuccessfully. In glass plates, peptide adsorption is minimal and the assay is highly
reproducible. In a plate format, longer path lengths improve the signal but require larger volumes
per well. For efficient use of reagents, a compromise of 250 ~tl/well (for 500 tl/well volume
plates) or 150 pl/well (for 300 [tl/well volume plates) was reached, corresponding to a path
length of 4 mm.
To obtain Akt activity measurements, cell lysates were added to the complete assay
mixture, and fluorescence readings were taken each minute for 60 min. The change in
fluorescence is linear during this time (Figure 5-3a), and the slope was used as the measure of
activity because it is the best aggregate metric for the increase in fluorescence. All subsequent
data were collected in this high-throughput format.
Validation of the Akt-S1 Kinase Assay
After generically characterizing lysate activity, the assay format was applied to
quantitatively detect changes in activity from cell samples stimulated with known Akt activators.
HfT-29 cells were treated with insulin for 5 min and lysed by standard techniques (see
Experimental section). Then, Akt-S 1 fluorescence changes were monitored in triplicate with
insulin-stimulated or untreated control lysates (Figure 5-3a). The assay revealed a threefold
increase in Akt-S1 kinase activity (Figure 5-3b). Using recombinant active Aktl, the untreated
and insulin-treated lysates were found to correspond to about 8 ng and 23 ng active Aktl
equivalents per 93 [tg lysate, respectively. The amount of turnover in the insulin-treated samples
after 60 min was 7%.
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The Akt--S 1 fluorescence slope varied linearly with dilutions of both insulin-treated and
untreated lysates over at least a fivefold concentration range of cellular protein (Figure 5-3b
Figure 5-3c). In addition, the fold difference between insulin-stimulated and unstimulated
activities correlates with the activation measured by a quantitative radioactive assay' (Figure 5-
3d). These results indicate that the fluorescence-based readings quantitatively report Akt-Sl1
kinase activity in cell lysates.
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Figure 5-3. Akt-S kinase activity is quantitatively linear and correlates with an established
radioactivity assay. (a) Triplicate fluorescence measurements of lysis buffer (,O,A), untreated
HT..29 lysates ( O,X) and insulin-stimulated HT-29 lysates (+,Y,*) over 60 min. R2 values
range from 0.72 to 0.97 (b) Summary of fluorescence slopes from data in a. (c) Summary of
fluorescence slopes for the insulin-treated (-) and untreated (- -) samples that were diluted in
lysis buffer to vary the total protein content; the volume of lysis buffer was kept constant for all
data points. (d) Results of a radioactive assay' using the same lysates as in a. Plotted values
indicate mean + s.e.m for triplicate measurements.
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Akt-S 1 also could report Akt activity in a quenched-point fluorescence assay with
iimmunopurified Akt (Figure 5-4a). Quantitatively, the extent of Akt activation by insulin was
smaller and less reproducible than the Akt-S 1 kinase assay (Figure 5-3b), single time-point
readings from the Akt-S 1 kinase assay (Figure 5-4b), and the radioactive Akt assay (Figure 5-
3d). In fact, the magnitude of the fluorescence increase after 30 min for both the quenched-point
immunopurification assay (1250 [tg lysate) and single time-point readings from the Akt-S 
kinase assay (90 [tg lysate) are identical, though the lysate amount is an order of magnitude less
for the crude cell lysates assay. This suggests that kinase activity loss and diffusional reaction
limitations for plate-bound kinase are problematic with immunopurification strategies. It is likely
that kinase activity is compromised with several hours of manipulations and/or upon binding to
the antibody. Also, comparison of fluorescence slopes (Figure 5-3b) leads to the same fold-
difference in activity as single time-points (Figure 5-4b) but with less error. Thus, verification of
reaction specificity by other means than immunopurifying the target kinase is desirable.
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Figure 5-4. Quenched-point fluorescence assays with immunopurified Akt report insulin-
stimulated phosphorylation of Akt-S 1. (a) Fluorescence intensities after 30 min with Akt
immunopurified from 1250 tg HT-29 cell lysates. (b) Fluorescence intensities of Akt-S 1 kinase
assays after 30 min with 90 [tg crude cell lysate. Plotted values indicate mean s.e.m for
triplicate measurements.
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Next, we tested whether the Akt-S 1 kinase assay was specific for measuring Akt activity
in crude biological samples by using two small-molecule inhibitors (wortmannin and LY294002)
of phosphatidylinositol 3-kinase (PI3K). P3K initiates recruitment of Akt to the plasma
20 wr
membrane; this recruitment is required and sufficient for Akt activation.2 Cells were
preincubated with the indicated concentration of each P3K inhibitor for one hour, then
stimulated with insulin for 5 min. Dose-dependent inhibition of Akt-S1 kinase activity was
observed for both wortmannin (Figure 5-5a, IC50 = 3.6 nM) and LY294002 (Figure 5-5b, IC50 =
8.2 [tM). These values agreed with reported IC50 values for the upstream P3K inhibition by
wortmannin (5 nM) and LY294002 (1.4 FM), considering differences in ATP concentrations. 2
because wortmannin and LY294002 inhibit PI3K by different mechanisms,2 sensitivity to both
strongly implicates a PI3K pathway in Akt-S 1 phosphorylation.
Since other P3K-dependent kinases might nonspecifically phosphorylate Akt-S1, Akt
was removed in vitro by immunodepletion. Insulin-stimulated lysates were depleted with an Akt-
specific antibody, and Akt-S 1 kinase activity was compared to both the input lysate and a sample
that had been deplted with naive mouse IgG. Akt-immunodepleted lysates showed threefold less
activity than naive IgG-immunodepleted lysates (Figure 5-Sc), strongly suggesting that the Akt-
S1 signal predominantly is due to Akt-mediated phosphorylation. Immunodepletion was
confirmed by western blot analysis with the immunodepleting antibody (Figure 5-Sc, inset), as
well as with an independent anti-Akt antibody. Slightly reduced activity in the naive
immunodepletion sample was due to nonspecific loss of Akt (23% loss, estimated by
clensitometry). Also, there was a small but detectable amount of residual Akt in the Akt-depleted
lysates (5% of input). Therefore, the measurements in the immunodepleted samples are a
conservative estimate for the selectivity of the assay.
To test the general applicability of the Akt-S1 kinase assay to other mammalian cell
types, Akt-S1 activity in Chinese hamster ovary (CHO) cells was measured. Here, epidermal
growth factor (EGF) was used as the Akt agonist. Similarly to the insulin-stimulated Akt activity
in H-IT-29 cells (Figure 5-3b,d), EGF-induced Akt activation in CHO cells quantitatively
correlated with the activation observed in a radioactive Akt assay' (Figure 5-6). Together, these
results indicate that the Akt-S1 assay is a quantitative, selective and generalizable format for
studying Akt signaling.
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Figure 5-5. The Akt-S 1 kinase activity assay is preferential for Akt. (a,b) HT-29 lysates were
pretreated with various concentrations of the PI3K inhibitors (a) wortmannin and (b) LY294002
for one hour prior to stimulation with 500 ng/ml insulin. The carrier (DMSO) was kept constant
at 0.1% for all stimulation conditions. (c) Kinase activity was measured from an insulin-treated
]HT-29 lysate (input), and after immunodepletion of this lysate with anti-Aktl/2 or naive mouse
][gG. Inset: western blot for Akt in the measured samples (asterisk indicates a nonspecific band).
Plotted values indicate mean _ s.e.m for triplicate measurements.
T1
5,000-
4,000-
130
T
3,000-
2,000-
1,000-
0-
Untreated -ar--treated
Sample
b
T
Untreated EGF- treated
Sample
Figure 5-6. Measured Akt-S 1 kinase activity in CHO cell lysates is quantitatively comparable to
a radioactive assay. (a) Akt-S 1 fluorescence slopes were monitored over 60 min in triplicate with
EGF-stimulated or untreated-control CHO cell lysates. (b) Results of a radioactive assay using
the same lysates as in a. Plotted values indicate mean _ s.e.m for triplicate measurements.
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Development of MK2-S1 and PKA-S3 Kinase Activity Assays
After successfully developing an Akt-S1 kinase activity assay, we investigated whether
the protocol could be applied more broadly to the other target kinases. To design activity assays
for PKA and MK2 in HT-29 cell lysates, the assay mixture from the Akt assay was used as a
starting point and then refined for each kinase. The panel of inhibitors for each assay mixture
was confirmed not to affect recombinant MK2 and PKA activities (Figure 5-2). The MK2-S1
and PKA-S3 activity assays were evaluated in HT-29 lysates similarly to the Akt-S1 activity
assay.
Validation of the MK2-S1 Kinase Activity Assay
The MK2-S 1 activity assay was linear for 15 min (Figure 5-7a) and over a fivefold range
of lysate concentrations (Figure 5-7c). MK2 activation by NaCl treatment resulted in a 4.6-fold
increase in MK2-S 1 phosphorylation (Figure 5-7b). 53 [tg of the stimulated lysate contains the
equivalent of 51 ng recombinant MK2 with 18% turnover in 15 min. There was a somewhat
weaker correlation between the MK2-S1 assay (Figure 5-7b) and a radioactive MK2 assay
(Figure 5-7d), so the chemosensor selectivity was examined in detail.
MK2-S 1 phosphorylation was abrogated in NaCl-treated lysates when cells were
pretreated with SB202190, a small molecule inhibitor of the MK2 kinase p38 (Figure 5-8a). The
apparent IC50 value (430 nM) correlates reasonably well with that reported for upstream p38
inhibition (50-100 nM), considering differences in ATP concentrations.9 When MK2 was
removed in vitro, the immunodepleted lysate lost 50% of its activity as compared to that of the
input lysate (Figure 5-8b). In addition, western blot analysis showed that the immunodepleted
sample had retained 25% of input MK2, and the naive immunodepleted sample had
nonspecifically lost 15% of input MK2 (Figure 5-8b, inset). Together, these data suggest that
75% of MK2-S 1 activity is due to MK2. The residual 25% of nonspecific activity likely explains
the higher untreated background activity observed with the MK2-S1 assay relative to the
radioactive MK2 assay' (Figure 5-7d).
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Figure 5-7. MK2-S 1 kinase activity is quantitatively linear and correlates with an established
radioactivity assay. (a) Triplicate fluorescence measurements of lysis buffer (,0,), untreated
HT-29 lysates (,O,X) and NaCl-stimulated HT-29 lysates (+,VY,*) over 15 min. R2 values
range from 0.93 to 1.0 (b) Summary of fluorescence slopes from data in a. (c) Summary of
fluorescence slopes for the NaCl-treated (-) and untreated (- -) samples that were diluted in
lysis buffer to vary the total protein content; the volume of lysis buffer was kept constant for all
data points. (d) Results of a radioactive assay' using the same lysates as in a. Plotted values
indicate the mean s.e.m. for triplicate measurements.
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Figure 5-8. The MK2-S kinase activity assay is preferential for MK2. (a) HT-29 lysates were
pretreated with various concentrations of the p38 inhibitor SB202190 for one hour prior to
stimulation with 250 mM NaCl. The carrier (DMSO) was kept constant at 0.1% for all
stimulation conditions. (b) Kinase activity was measured from an NaCl-treated HT-29 lysate
(input), and following immunodepletion of this lysate with anti-MK2 or naYve sheep IgG. Inset:
western blot for MK2 in the measured samples. Plotted values indicate mean s.e.m for
triplicate measurements.
MK2-S 1 also reported MK2 activity in a quenched-point fluorescence assay with
imnmunopurified MK2 (Figure 5-9a). The extent of MK2 activation by NaCl was smaller and less
reproducible than single time-point readings from the MK2-S1 kinase assay (Figure 5-9b) and
the radioactive MK2 assay (Figure 5-7d). These results again illustrate some of the limitations of
immunopurification strategies.
Finally, using the MK2-S1 activity assay, we also detected MK2 activation in CHO cell
lysates treated with tumor necrosis factor (TNF) (Figure 5-0la). This activation correlated with a
radioactive MK2 assay' (Figure 5-lOb) and demonstrated that the assay could be used with
dCiverse stimuli and cell types.
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Figure 5-9. Quenched-point fluorescence assays with immunopurified MK2 report osmolarity-
stimulated phosphorylation of MK2-S1. (a) Fluorescence intensities after 15 min with MK2
immunopurified from 750 [tg HT-29 cell lysates. (b) Fluorescence intensities of MK2-S 1 kinase
assays after 15 min with 90 tg crude cell lysate. Plotted values indicate mean s.e.m for
triplicate measurements.
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Figure 5-10. Measured MK2-S1 kinase activity in CHO cell lysates is quantitatively comparable
to a radioactive assay. (a) MK2-S1 fluorescence slopes were monitored over 15 min in triplicate
with TNF-stimulated or untreated-control CHO cell lysates. (b) Results of a radioactive assay
using the same lysates as in a. Plotted values indicate mean ± s.e.m for triplicate measurements.
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Validation of the PKA-S3 Kinase Activity Assay
The PKA-S3 activity assay was linear for 15 min (Figure 5-1 la) and over a fivefold
range of lysate concentrations (Figure 5-11 c). PKA activation by forskolin treatment resulted in a
3.5-fold increase in PKA-S3 phosphorylation (Figure 5-1 lb), which corresponds to 12 ng
recombinant PKA in 18 tg of HT-29 cell lysate with 9.1% turnover in 15 min. An adequate anti-
PKA antibody was not commercially available to perform a radioactive PKA assay.
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Figure 5-11. PKA-S3 kinase activity is quantitatively linear. (a) Triplicate fluorescence
mneasurements of lysis buffer (,O,A), untreated HT-29 lysates (OX) and forskolin-
stimulated HT-29 lysates (+,V,*) over 15 min. R2 values range from 0.60 to 0.97 (b) Summary
of fluorescence slopes from data in a. (c) Summary of fluorescence slopes for the forskolin-
treated () and untreated (- -) samples that were diluted in lysis buffer to vary the total protein
content; the volume of lysis buffer was kept constant for all data points. Plotted values indicate
mean + s.e.m for triplicate measurements.
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Two mechanistically distinct PKA inhibitors were used to interrogate the selectivity of
the PKA-S3 kinase assay: H89, a small molecule ATP-competitive inhibitor, and PKItide, the
active fragment of a PKA-specific inhibitor protein.8 PKA-S3 activity was abolished in a dose-
dependent manner with both inhibitors (Figure 5-12a,b). The calculated IC50 values (3.6 [LM for
1H189 and 0.91 nM for PKItide) match those for the inhibition of recombinant PKA activity
measured under identical conditions (Figure 5-12c,d). This inhibition data provides strong
evidence that the PKA-S3 assay is highly preferential, because an adequate antibody is not
available to rigorously quantify specificity.
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Figure 5-12. Dose-dependent inhibition of (a,b) endogenous PKA in forskolin-treated lysates by
1-89 and PKItide parallels that for (c,d) recombinant PKA; this data suggests that the PKA-S3
activity assay is highly preferential. (a,b) Forskolin-treated HT-29 lysates were assayed in the
presence of various concentrations of (a) H89 and (b) PKItide. (c,d) Recombinant PKA was
assayed in the presence of various concentrations of (c) H89 (IC50 = 2.6 iM) and (d) PKItide
(][C50) = 1.0 tM). Plotted values indicate mean + s.e.m for triplicate measurements.
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The multiplex Akt-MK2-PKA kinase assay
To illustrate how these chemosensors can be used in a multiplex assay format, the
signaling responses of Akt, MK2, and PKA to two growth factors, insulin and EGF, were
examined. HT-29 cells were treated with saturating concentrations of insulin or EGF and lysed in
triplicate at various times between zero and two hours. These lysates were then analyzed for Akt,
MK2 and PKA activity with their respective kinase assays, and activation levels were calculated
by normalizing to the zero minute samples. For each growth factor, 63 independent activity
assays were performed in parallel with less than 170 tg cell lysate. By comparison, a similar
quantitative radioactive assay' for Akt and MK2 would require at least 700 Fog cell lysate and
would not be possible for PKA.
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Figure 5-13. The multiplex kinase assay reveals differential responses of Akt, MK2 and PKA to
stirmulation by EGF and insulin. Akt-S (), MK2-S1 () or PKA-S3 () kinase activities were
measured in HT-29 lysates after stimulation by (a) EGF or (b) insulin for various times as
described in the Experimental section. Plotted values indicate mean + s.e.m for triplicate
measurements. Changes in kinase activity were normalized to the baseline (0 min) fluorescence
slope.
The multiplexed three-kinase assay revealed qualitatively and quantitatively different
responses to EGF (Figure 5-13a) and insulin (Figure 5-13b). EGF activated MK2 more potently
and transiently. Akt was also activated transiently in response to EGF, but to a lesser extent, and
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PKA was not activated at all. In contrast, insulin activated Akt potently, and the response was
sustained over the time course. MK2 was slightly activated in response to insulin, and again,
PKA was not activated at all. The features of these time courses correlate with those reported for
Akt22 23 and MK22 4 (or upstream p3825) activity dynamics in other mammalian cell lines. To the
best of our knowledge, there is no evidence that either EGF or insulin activate PKA.
Discussion
For biological applications, the specificity of any peptide substrate must be validated
amidst total cellular proteins. Here, this issue was addressed in several ways. First, the design of
each substrate peptide was based on the optimal peptide sequences, implying that it is least likely
to be out-competed as a substrate for off-target kinases. Second, the Sox-based fluorescence
readout is specifically attributable to Akt-S 1, MK2-S 1 or PKA-S3 phosphorylation, in contrast to
other assays that measure bulk phosphotyrosine- or 32 P-labeled proteins. Third, assay selectivity
was explicitly verified in vivo by small-molecule inhibitors and in vitro by immunodepletion.
When inhibitor selectivity was questionable, another inhibitor that operates by a different
mechanism was also used. These overlapping selectivity controls showed that the Akt-S 1, MK2-
Sl, and PKA-S3 kinase activity assays are preferential, solution-phase assays for endogenous
Akt, MK2, and PKA activities in cell lysates.
The homogeneous, fluorescence-based kinase activity assays reported here have several
advantages over existing assays. The Sox-based chemosensors are uniquely quantitative in their
ability to estimate enzymatic activity and phosphorylated product generated from cell samples.
The amount of lysate activity can easily be related to recombinant protein standards or
normalized to untreated control lysates (Figure 5-13). In addition, the assay is compatible with
physiological concentrations of ATP. Together with the solution-phase format, this dramatically
increases the sensitivity of the assay.
Whereas most immune complex kinase activity assays require 200-500 [tg total cell
protein,' 7 the kinase assays presented here can make equivalent measurements at less than 100
pLg (Figures 6-3b,d and 6-7b,d). This sensitivity is critical for applications where cell samples are
limited, such as high-throughput cell-based screening and clinical diagnostics.
Immunopurification approaches are typically used both to ensure signal specificity and also to
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remove cellular components that interfere with the in vitro assay. While this approach could be
adapted for an immune complex assay with improved immunopurification protocols, crude cell
lysate assays eliminate several hours of manipulations, such as incubation and washing steps,
before and after the in vitro reaction. During the kinase reaction, the 60 time points collected
provide additional activity information and reduce error without extra experimental effort. In
addition, the crude cell lysates assay avoids a significant loss in kinase activity upon
immunopurification.
An important feature of these lysate-based assays is that selectivity can be improved by
pharmacologically inhibiting kinases with overlapping substrate specificity. Because the relevant
off-target enzymes will depend upon the peptide chemosensor, kinase-by-kinase optimization
will be needed to ensure maximum possible specificity. Although some residual off-target
activity is inevitable (here, < 30% for Akt and 25% for MK2, Figures 6-5c and 6-8b), this
singular limitation is outweighed by the many benefits of these fluorescent kinase activity assays,
in that they are straightforward, rapid, continuous, non-radioactive, quantitative, and sensitive.
The format is conceptually similar to many fluorogenic protease assays26 that, because of these
same benefits, have found widespread use in a number of applications27 . Finally, this work
provides a general protocol for developing lysates assays using other Sox-based chemosensors.
because it is straightforward to multiplex chemosensors to measure several cellular kinase
activities in parallel (Figure 5-13), this assay platform is of immediate and expanding utility in
drug discovery and molecular biology.
Conclusion
A homogeneous kinase assay was developed for Akt, MK2 and PKA from unfractionated
cell lysates that is reproducible, linear, and highly preferential for monitoring changes in cellular
activity of the target kinase. The general protocol was developed for the kinase Akt and then
easily extended tlo measure PKA and MK2 activities. This assay platform is immediately useful
for studying protein kinase signaling in crude cellular extracts.
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Future Directions
These probes can now be used to assay lysates to map normal and disease-state signaling
networks. Due to the successful development of the lysate assay and the understanding of probe
specificity, these chemosensors can be used to monitor signaling inside living cells. For this
purpose, the creation of more specific probes is underway, because the use of off-target kinase
inhibitors is undesirable for studies in living cells. Additionally, lysate assays will be enhanced
by the use of more specific probes. Preliminary experiments toward a PKC-S1 lysate assay
showed little increase in PKC activity relative to untreated control HT-29 lysates, despite the use
of an extremely potent activator of PKC, phorbol myristate acetate (PMA) (Figure 5-14).
Inclusion of the PKC-specific inhibitor Go 6983 in the assay mixture for PMA-treated lysates
reduced the activity to the untreated control levels. Together, these results indicate that there is a
significant amount of phosphorylation of PKC-S1 by kinases other than PKC. Thus, the lack of
selectivity of the PKC-S1 peptide is problematic without knowing which off-target kinase
inhibitors to include in the assay mixture.
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Figure 5-14. PKC-S1 kinase activity is not yet sufficiently specific. (a) Summary of
fluorescence slopes for data from untreated HT-29 lysates, PMA-treated HT-29 lysates and
PMA-treated HT029 lysates where 5 mM Go 6983 has been included in the assay buffer. Plotted
values indicate the mean ± standard deviation for triplicate measurements.
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Experimental
Materials: All small-molecule kinase inhibitors were obtained from Calbiochem unless
otherwise noted.
Peptide Synthesis: Peptide chemosensors used in this chapter were reported in Chapter 4.
Additional peptide inhibitors for PKA and PKC were synthesized here by the same methods.
Concentrations of peptide inhibitor stock solutions were determined by quantitative amino acid
analysis.
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Peptide Characterization Data
HPLC m/z (z+) m/z
Peptide Sequence Mol. formula ret. time calcd foundb
(min)a
PKItide H2N-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg- C8oH30N28024 20.6 c 623.3 (+3) 623.1
Asn-Ala-Ile-NH 2 C8 H130N280 24
PKC H2 N-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-NH 2 C6 7H1 19N 27 01 5 24.0C 386.5 (+4) 386.4inhibitor
a C1 , Beckman Ultrasphere ODS, 5 tm, 150 x 4.6 mm; solvent A = water, 0.1% v/v TFA; solvent B = MeCN, 0.1% v/v TFA, 5
min 7%7 B followed by linear gradient 7-70% B over 30 min. b ESI-MS data were collected on a Applied Biosystems Mariner
mass spectrometer.
Fluorescence Instrumentation:
Fluorimeter: Fluoromax 3 from Jobin Yvon (ex = 360 nm, kem = 485 nm, slit widths = 5 nm, integration
= 1 s). Cuvette: Starna Cells (16.100F-Q-10) 100 [1 sub-micro cuvette, 1 cm path length.
Plate Reader: HTS7000 Bio Assay Reader from PerkinElmer with 360 nm excitation filter (35
nm bandpass), 485 nm emission filter (20 nm bandpass), 40 its integration, 3 flashes/well,
120 gain. 96-well glass plate: Zinsser #3600500 with 500 ~tl well volume or Zinsser
#3600501 with 300 [1 well volume.
Buffer Recipes
Buffer A: 20 mM Hepes pH 7.4, 10 mM MgCl2, 1 mM ATP, 1 mM DTT, 0.1 mM EGTA.
Buffer B: 20 mM Hepes pH 7.4, 1 mM DTT, 0.1% Brij-35, 1 mg/ml BSA.
Buffer C: 1% Triton X-100, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 50 mM -
glycerophosphate, 10 mM sodium pyrophosphate, 30 mM NaF, 1 mM benzamidine,
2 mM EGTA, 100 [tM Na 3VO 4 , 1 mM DTT, 1 mM PMSF, 10 [tg/ml aprotinin, 10
ptg/ml leupeptin, 1 tg/ml pepstatin, 1 tg/ml microcystin-LR.
]3uffer D: 20 rmM Tris-HCl pH 7.5, 150 mM NaC1, 15 mM MgCl2, 5 mM f3-glycerophosphate,
1 mM EGTA, 0.2 mM Na3 VO4, 0.2 mM DTT.
Assays with Recombinant Enzymes
Recombinant enzyme was added to 10 [tM of each chemosensor. Assay conditions were as
follows: Aktl: Buffer A with 40 ng Aktl (Upstate, diluted 1:20 with Buffer B). MK2: Buffer A
with 0.01% Brij-35, 0.1 mg/ml BSA, 20 ng MAPKAP kinase 2 (Upstate, diluted 1:10 with
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Buffer B). PKA: Buffer A with 8 ng PKA catalytic subunit (Calbiochem, diluted 1:80 with 20
r1 Tris-HCl (pH 7.5), 1 mM DTT, 0.15 mg/ml BSA). PKCa: Buffer A with 0.3 mM CaCl2, 10
[tg/ml phosphatidylserine (porcine brain, Avanti Polar Lipids) 0.2 [tg/ml diacylglycerol
(dioleoyl, Avanti Polar Lipids), 11 ng PKC (Calbiochem, diluted 1:20 with 20 mM Hepes (pH
7.4), 5 mM DTT).
Cell Stimulation and Lysis
h'T-29 cells for assay development and validation: HT-29 human colon epithelial cells (ATCC)
were grown according to the manufacturer's recommendations. Confluent ten-cm plates (15
irnillion cells) of HT-29 cells were left untreated or stimulated with 500 ng/ml insulin for 5 min,
'2:50 mM NaCl for 30 min, 25 FM forskolin for 30 min, or 1 M PMA for 1 h, and lysed in 300
[tl Buffer C. Whole cell lysates were incubated on ice for 15 min, then clarified by centrifugation
at 16,000 x g for 15 min at 4°C. Protein concentrations of clarified extracts were determined with
a bicinchoninic acid assay (Pierce). For inhibitor studies, cells were pretreated with various
concentrations of wortmannin, LY294002, SB202190, rapamycin (300 nM), or PD 98059 (50
[xM) for one hour before stimulation. The carrier concentration (0.1% DMSO) was maintained
constant for all pretreatments.
Chinese Hamster Ovary (CHO) Cells
CHO cells stably overexpressing the EGF receptor28 were grown in DMEM supplemented with 2
mM L-glutamine, 1 mM sodium pyruvate, 1 mM nonessential amino acids, 100 U/ml penicillin,
100 [tg/ml streptomycin and 500 gxg/ml G418. Cells were stimulated with 100 ng/ml EGF for 5
min or 100 ng/ml TNF (Peprotech) for 15 min and lysed as described for HT-29 cells. 250 [tg
CHO cell lysate was used for the Akt assay, and 200 [tg CHO cell lysate was used for the MK2
assay..
Insulin and EGF Time Courses: Time courses were performed as described previously'. Briefly,
HT-29 cells were plated at 50,000 cells/cm 2 for 24 hours. The cells were sensitized with 200
U/ml interferon- (Roche) for 24 hours and then treated with 500 ng/ml insulin (Sigma) or 100
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ng/ml EGF (Peprotech), each dissolved in 50% DMSO/50% H20. At various time points after
stimulation, clarified lysates were collected as described above.
Fluorescent Kinase Activity Assays
Activity assays were performed in a glass 96-well plate (Zinsser #3600500 with 250 [ or
Zinsser #3600501 with 150 [tl per well) at 30°C in a fluorescence plate reader in Buffer D with 4
!.M PKC inhibitor, 4 tM calmidazolium (Sigma), 10 tM substrate peptide, 1 mM ATP
(Calbiochem, Low Metals Grade) and for Akt, 0.4 [tM PKItide, S [tM GF 109203X; for MK2, of
0.4 p.M PKItide, 25 M GF 109203X; for PKA, 5 [tM GF 109203X. For preliminary
experiments with PKC, the assay buffer was composed of Buffer D without EGTA and with 10
p.M PKC-S1, 1 mM ATP, 0.4 tM PKItide, 0.3 mM CaCl 2, 10 tg/ml phosphatidylserine, 0.2
p.g/ml diacylglycerol. This assay buffer was prepared in bulk at 30°C and aliquoted to each well
to ensure equal concentrations of the chemosensor. To begin each reaction, 7.5 vol% lysis buffer
(Buffer C) or lysate (18.5 [tl1 in 250 [tl for Akt, and 11 p.l in 150 [tl1 for MK2 and PKA) was
added and the contents of each well mixed gently. 60 data points were collected over each
reaction. Akt-S 1 activity was monitored over 60 min typically with 93 [tg lysate. MK2-S1 and
PKA-S3 activities were monitored for 15 min typically with 50 ptg and 20 ptg lysate,
respectively. To quantify product formation, different turnover amounts (5%, 10%, 15%) were
simulated in triplicate and lysis buffer was added as for a blank sample. For recombinant enzyme
comrparison, different amounts ( 3) of recombinant enzyme were added with lysis buffer to
begin the reaction. For PKA inhibition studies, the indicated concentration of H89 or PKItide
was included in the assay buffer. Chemosensor sensitivities were determined by comparing the
absolute fluorescence of 10 [tM substrate and 10 tM corresponding product phosphopeptides in
triplicate under the optimized assay conditions.
Data Workup
Fluorescence slopes were determined by a least-squares fit using KaleidaGraph (3.6.2, Synergy
Software). This slope averages out scatter in individual fluorescence readings, because it is
determined from 60 readings over the reaction time-course. To average out well-to-well
variations in path length due to sample loading, each set of data points are normalized based on
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their starting values. Plotted values are an average ± standard error for triplicate experiments. For
all samples except Figure 5-13, these triplicate measurements are separate reactions from the
same cell population. For Figure 5-13, the results from 3 different populations were averaged for
each data point. Average slopes of wells containing lysis buffer only were subtracted from
average slopes of samples and the error propagated accordingly. Slight day-to-day variation in
plate reader lamp intensity and in solution preparation were observed and thus comparisons were
only made between samples run at the same time. Thus, the fluorescence slope in figures is not
comparable between graphs. For comparisons of absolute fluorescence readings, wells were
loaded carefully to obtain equivalent path lengths and measurements were performed in triplicate
with multiple readings averaged for each well. Percent turnover was determined based on the
fluorescence endpoint reading of each assay and a linear fit of absolute fluorescence vs.
simulated turnover (see also Kinase Activity Assays Section). Recombinant enzyme equivalents
were determined by comparison of the fluorescence slope with a linear fit of the fluorescence
slope vs. amount of recombinant enzyme (see also Kinase Activity Assays Section). IC50 values
were calculated by fitting the data to the following equation:
/I. - Imin
m 1+ 1 0 X-lo°g IC50 )
where I = fluorescence intensity.
Radioactive Akt and MK2 Activity Assays
A mrnicrotiter-based kinase activity assay was performed as previously described.'
Very briefly, Protein A or G microtiter strips were coated overnight with 10 [tg/ml anti-Akt PH
domain (Upstate) or anti-MK2 (Upstate) and washed three times with blocking buffer (1% BSA,
50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% Trition X-100). Either 500 tg lysate for Akt and
200 ~tg lysate for MK2 was added for 3 h, and washed twice with Buffer D. Assays were
conducted at 37`C in 60 [tl Buffer D with 0.4 ![M PKItide, 4 [tM PKC inhibitor, 4 M
calmidazolium, ATP (10 tM for Akt and 25 M for MK2), [y-32 P]ATP (5 gCi for Akt and 2 [ICi
for MK2) and 10 ptM Atkide or 10 FM MK2tide. The Akt assay was quenched after 30 min with
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60 jtl 75 mM H3PO 4 and the MK2 assay was quenched after 15 min with 60 l 20 mM EDTA.
The reactions were prepared for scintillation counting as described.'
Quenched-point Fluorescence Assay
Akt and MK2 were immunopurified from HT-29 lysates in multiples of nine as described for the
radioactive activity assays. Assays were then conducted at 37°C in 60 jil Buffer D with 0.4 RM
PKItide, 4 [tM PKC inhibitor, 4 [tM calmidazolium, 1 mM ATP and 10 FM Akt-S1 or 10 iM
MK2-S 1. 50 [tl from three identical wells was transferred into a single well of the 96-well glass
plate after 15 min for MK2 and 30 min for Akt at 25°C. Multiple fluorescence readings were
averaged for each well. This resulted in triplicate measurements of 1250 tg lysate for Akt and
750 jig lysate for MK2 with a 4 mm fluorescence path length. A control reading of assay mixture
that was not exposed to immunopurified kinase was subtracted from average sample readings.
Inmnunodepletions
For Akt immunodepletions, 500 jig of insulin-stimulated HT-29 lysate was incubated with 4 tig
anti-Akt PH domain (Upstate) or naive mouse IgG (Santa Cruz) for two hours at 4C on a
rotating shaker. The immune complexes were precipitated with 40 jil Protein G sepharose beads
(Arnersham) for one hour with mixing at 4C. For MK2 immunodepletions, 40 [1l Protein G
sepharose beads were incubated with 8 Fag anti-MAPKAP kinase 2 (Upstate) or naive sheep IgG
(Santa Cruz) for one hour at 4°C on a rotating shaker. The beads were washed two times with 1
ml of blocking buffer (1% BSA in 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.05% Triton X-
1100) and then incubated with 200 Fag NaCl-stimulated HT-29 lysate for three hours with mixing
at 4°C.
1Western blot analysis
To confirm immunodepletion, 100 jig of the starting lysate, kinase-immunodepleted lysate, and
naive-immunodepleted lysate were run on a 10% SDS-PAGE gel and transferred to PVDF
(Millipore). The membrane was blocked with 5% nonfat skim milk in 20 mM Tris-HCl (pH 7.5),
137 mMl NaCl, 0.1% Tween-20 and probed overnight with anti-Akt PH domain (Upstate), anti-
Akt (Cell Signaling), or anti-MAPKAP K2 (Stressgen) at 1:1,000 dilution. The membranes were
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then probed with horseradish peroxidase conjugated anti-mouse or anti-rabbit secondary
antibody (Amersham) at 1:10,000 dilution and visualized by enhanced chemiluminescence
(Arnersham) on a Kodak Image Station (Perkin Elmer). Bands were selected and quantified
according to manufacturer recommendations. Additional rounds of immunodepletion
substantially depleted Akt and MK2 from the naive lysate.
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2-Bromomethyl-8-tert-butyldiphenylsilyloxy-5-(N,N-dimethyl)sulfonamidoquinoline (5)......157
(S)-2-Amino-3-(8-hydroxy-5-(N,N-dimethylsulfonamido)quinoline-2-yl)propionic acid
hydrochloride salt (Sox-HCl) .............................................................................. 158
(S)-2-Amino-N'-(9-fluorenylmethyloxycarbonyl)-3-(8-hydroxy-5-(N,N-
dimethylsulfonamido)quinoline-2-yl) Propionic Acid (Fmoc-Sox-OH) ........................... 159
Fmoc-Glu(cs124) tert-butyl ester........................................................................ 160
Fmoc-Glu(cs 124)-OH ..................................................................................... 161
153
-©0)
.
Ca,
E
6
ct0
C.
0
-o
z
tIe
o,C
0)
-o;Y
15400
- EX
- a~
I- CI7K
-(D
_=_
I
I
I
I
I
-N
I
I-
- 00
I
- en
.. 4
-j
,Fe
.
._
:7
._
-
a
J.O
<:3
tr
~.-
;Y
r- Zo
z(4
X% - f- to
"e~~~~~~~~~~~~~~~~~~~~~~~~~~~~>f
t
'-- 155C_
-E;YI
Lb ~~~~~~~~~155
L 
-i2.
- ,
1,-
i
II
Fi 
. f4
l
I
i
I
i
11 I.
(- -4
N~
L¼
V-
=
;z
V)
a _ 
to
'a
tt e ._~~~~~~~~~~~~~~~~~~~~~~~~ m
156I)
oc
I aI  Q,
I
I
; ICL
I II
I 
i
i
I
; r.,
....I .......
.-I .. 77 1
Ii .
4 .
1-1
2._...... CiJ -
tn as 
I
C5
C.,
=F I -.. .................It ~~~ ~~~  ~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
'_ I
_-
:: 
r.
i!
i
I ,
4_t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ t t
'i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ ''t
IAr 
trI
-x0
C.
j 
". - .. - - ( vi
-0~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~U
i_ I
or
00
I
S . i I
E
: 
IC1
157
i .
i
t"
........ ....- ,
................
....
I
i
I
158
o..
ITcU
cn©
©
!
"tC
o
o e~
'< Ux
IC_
r 2 :
r
x
- 4
- N~
- Ln
-
I
Co
-
N,
II
i
* E
-H
-C(l
Lnc,
-09
-Oh
0
r--
,2r
C
-c1
C-
C
.p
.C
ECC.
C
C.' 159
O!SZ6H5
4.
.-
r.
0*_1
v-
3R
HzOOgHO160
E
_ (4
-0
- UM
-t
w
- -4
-4
'-4
OS(CHO)
Xi:
7rZ
)=o
0to~~22
161
E
-CL
- -4
.1 X
- t
- PI
l- 0
-- 
-.
-.
--
t-
I
MELISSA DAWN SHULTS
EDUCATION
Massachusetts Institute of Technology (MIT), Cambridge, MA
Ph.D. Organic Chemistry, 2005
University of California San Diego (UCSD), La Jolla, CA
B.S. Chemistry with Honors, 2000
EXPERIENCE
RESEARCH
MIT Department of Chemistry
Graduate Research Assistant, Advisor: Professor Barbara Imperiali, 2000-2005
Chemosensing Strategies Utilizing the Nonnatural Sulfonamidohydroxylquinoline Amino Acid Sox
UCSD Department of Chemistry and Biochemistry
Undergraduate Research Assistant, Advisor: Professor Jay Siegel, 1997-2000
Synthesis of Ligand Precursors for Topologically Interesting Molecules
TEACHING
MIT Department of Chemistry
Teaching Assistant, Bioorganic Chemistry 5.55 (Spring 2003 and Spring 2004)
Teaching Assistant, Organic Chemistry 5.12 (Fall 2000)
UCSD Department of Chemistry and Biochemistry
Teaching Assistant, Organic Chemistry 140A (Fall 1998 and Fall 1999)
Teaching Assistant, Organic Chemistry 140B (Winter 2000)
AWARDS
National Science Foundation Graduate Research Fellowship (2000-2003)
Barry M. Goldwater and Excellence in Education Foundation Scholarship (1998-2000)
Pfizer Summer Undergraduate Research Fellowship (1999)
PUBLICATIONS
Shults, M. D.; Janes, K. A.; Lauffenburger, D. A.; Imperiali, B. "A multiplexed homogenous
fluorescence-based assay for protein kinase activity in cell lysates," Nat. Methods, 2005, 2, 277-283.
Shults, M. D.; Imperiali B. "Versatile fluorescence probes of protein kinase activity," J. Am. Chem.
Soc. 2003, 125, 14248-14249.
Shults, M. D.; Pearce, D. A.; Imperiali, B. "Modular and tunable chemosensor scaffold for divalent
zinc," J. Am. Chem. Soc. 2003, 125, 10591-10597.
162
MELISSA DAWN SHULTS
PATENTS
Imperiali, B.; Shults, M. D. "Versatile and continuous fluorescence assay for kinase activity utilizing
the fluorescent amino acid Sox," U.S. Patent Application Filed October 8, 2003.
PRESENTATIONS
Shults, M. D. Imperiali, B. "Versatile fluorescence probes of protein kinase activity," Poster, Gordon
Research Conference in Bioorganic Chemistry, Andover, NH, June 2004.
Shults, M. D.; Imperiali, B. "Readily tunable fluorescent peptidyl sensors for zinc(II)," Poster, 224th
ACS National Meeting, Boston, MA, August 2002.
AFFILIATIONS
American Chemical Society (1997-present)
Phi Beta Kappa (1999-present)
American Peptide Society (2005-present)
FUTURE PLANS
Scientist I/Post-doc at Illumina, Inc. in San Diego, CA
163
